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Oligodendrocyte progenitor cells (OPCs) are the dominant tissue-specific stem cell of the 
central nervous system (CNS). In the adult, OPCs primarily differentiate into oligodendrocytes, 
the cell type that wraps neurons with myelin allowing for efficient signal transduction down 
the axon. Increasingly, the process of adult myelination is understood as a key process in 
learning, memory formation, and promoting overall CNS health. With ageing, the capacity for 
OPCs to both self-renew and differentiate into myelinating oligodendrocytes is impaired. This 
loss of function is particularly detrimental for patients with demyelinating diseases such as 
Multiple Sclerosis. The failure of OPCs to differentiate into oligodendrocytes contributes to 
the progressive worsening of the symptoms with ageing. As such, there is a therapeutic 
imperative to better understand the ageing process of OPCs in order to find possible 
interventions that will overcome their age-related dysfunction. Recent advances in the 
generation of induced pluripotent stem cells provide proof that all cells, regardless of age, can 
be reconverted into embryonic pluripotent stem cells, thereby shedding all the hallmarks of the 
ageing process. This work provides evidence that the ageing process on a cellular level is not 
immutable; rather, all cells can be rejuvenated.  
In each of the results chapters included in this thesis, I ask and then address four outstanding 
questions in the field of OPC ageing biology: 1. What governs the activity-state of adult OPCs? 
2. Do OPCs irreversibly lose their plasticity during physiological ageing? 3. What causes this 
loss of activity in aged OPCs? 4. Are there molecular interventions that might overcome the 
age phenotype of aged OPCs? Addressing these questions in my thesis, I identify a vascular 
niche for OPCs in the adult animal and find that Wnt signaling underlies the activity-state of 
the quiescent adult OPC. I identify that overexpression of the reprogramming factor Myc can, 
alone, coax an aged quiescent OPC to behave more like a neonatal one. I describe how age-
related changes in niche matrix mechanics drive the ageing-phenotype of OPCs, and how OPCs 
sense and respond to these changes with the mechano-transduction protein Piezo1. Finally, I 
have developed a novel, systemically delivered, cell-type-specific, genome engineering 
technique to perturb age-related genes in adult rodents.  
The work presented in this thesis provides a new understanding of OPCs in homeostasis and 
in ageing. By identifying multiple interconnecting signalling-pathways by which adult and 
aged OPCs can re-activate, I have identified multiple points of therapeutic intervention. 
Finally, this systemically-administered but cell-type specific genome-engineering technology 
could be used to construct one-generation transgenic animals in an adult rodent and could have 
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Summary
Oligodendrocyte progenitor cells (OPCs) are the dominant tissue-specific stem cell of the central ner-
vous system (CNS). In the adult, OPCs primarily differentiate into oligodendrocytes, the cell type that 
wraps neurons with myelin allowing for efficient signal transduction down the axon. Increasingly, 
the process of adult myelination is understood as a key process in learning, memory formation, and 
promoting overall CNS health. With ageing, the capacity for OPCs to both self-renew and differenti-
ate into myelinating oligodendrocytes is impaired. This loss of function is particularly detrimental for 
patients with demyelinating diseases such as Multiple Sclerosis. The failure of OPCs to differentiate 
into oligodendrocytes contributes to the progressive worsening of the symptoms with ageing. As such, 
there is a therapeutic imperative to better understand the ageing process of OPCs in order to find pos-
sible interventions that will overcome their age-related dysfunction. Recent advances in the genera-
tion of induced pluripotent stem cells provide proof that all cells, regardless of age, can be reconverted 
into embryonic pluripotent stem cells, thereby shedding all the hallmarks of the ageing process. This 
work provides evidence that the ageing process on a cellular level is not immutable; rather, all cells can 
be rejuvenated.  
In each of the results chapters included in this thesis, I ask and then address four outstanding ques-
tions in the field of OPC ageing biology: 1. What governs the activity-state of adult OPCs? 2. Do 
OPCs irreversibly lose their plasticity during physiological ageing? 3. What causes this loss of activity 
in aged OPCs? 4. Are there molecular interventions that might overcome the age phenotype of aged 
OPCs? Addressing these questions in my thesis, I identify a vascular niche for OPCs in the adult ani-
mal and find that Wnt signaling underlies the activity-state of the quiescent adult OPC. I identify that 
overexpression of the reprogramming factor Myc can, alone, coax an aged quiescent OPC to behave 
more like a neonatal one. I describe how age-related changes in niche matrix mechanics drive the age-
ing-phenotype of OPCs, and how OPCs sense and respond to these changes with the mechano-trans-
duction protein Piezo1. Finally, I have developed a novel, systemically delivered, cell-type-specific, 
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genome engineering technique to perturb age-related genes in adult rodents. 
The work presented in this thesis provides a new understanding of OPCs in homeostasis and in ageing. 
By identifying multiple interconnecting signaling-pathways by which adult and aged OPCs can re-ac-
tivate, I have identified multiple points of therapeutic intervention. Finally, this systemically-adminis-
tered but cell-type specific genome-engineering technology could be used to construct one-generation 
transgenic animals in an adult rodent and could have therapeutic implications for a broad-spectrum 
of human diseases. 
Regeneration in the Kingdom Animalia 
Cellular regeneration is a widespread and diverse phenomenon across the animal kingdom. Re-
generation describes the process by which damaged tissue is replaced with new healthy tissue 
that re-establishes the appropriate tissue shape, size, and function. Fully understanding and being 
able to harness the cellular events that underpin regeneration has real implications for biomedi-
cal science as it would allow for therapeutic treatments that could replace diseased or damaged 
tissue.   
To understand the processes of regeneration, it is important to appreciate the diversity of its 
form. There are three main methods by which adult animals regenerate following injury: cellular 
trans-differentiation, cellular-de-differentiation, and stem cell pool activation (Fig. 1). The ear-
liest formal description of animal regeneration is in the cnidarian H. vulgaris or the hydra over 
200 years ago  (Glass, 1988). The hydra replaces damaged or lost tissue through the trans-differ-
entiation of existing fully differentiated somatic cells into the missing cells, without proliferation 
(Holstein et al., 1991). Only following this complete re-patterning of the hydra, can the organism 
grow.  This process of regeneration by trans-differentiation is echoed across the animal kingdom. 
In humans, following pancreatic injury or inflammation, non-endocrine cells can transdifferenti-
ate to replace the damaged insulin-producing ß-cell  (Hao et al., 2006).  
 
Another paradigm of animal regeneration is the process by which a fully differentiated cell 
de-differentiates into a more developmental-like progenitor cell, proliferates, and then re-differ-
entiates into the missing tissue. In amphibians, the axolotl or the Mexican salamander can fully 
regrow its limbs and tail following amputation. This is done by the de-differentiation of the var-
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ious cell types  (e.g. muscle, cartilage, schwann cells, skin), proliferation, and re-patterning of 
the lost appendage  (Stocum, 1979). Again, this paradigm of regeneration is repeated in higher 
order animals. In the injured neonatal mouse heart, cardiomyocytes de-differentiate, prolifer-
ate, and fully regenerate the damaged heart without fibrosis or hypertrophy. This regenerative 






Figure 1. Models of regeneration in the animal kingdom. Illustration of the dominant methods of regen-
eration in the animal kingdom. To replace damaged tissue, cells can differentiate from previously com-
mitted cells, as they do in the hydra. In the axolodtl, cells first de-differentiate into a stem-like cell and 
then subsequently differentiate. In the adult human, the dominant method of regeneration is for speci-
fied, tissue-specific adult stem cells to activate and regenerate the damaged tissue. 
The most conserved mechanism of regeneration in animals is through a reserved pool of adult 
stem-cells, which, upon activation, proliferate and differentiate into new tissue  (Wagers and 
Weissman, 2004). One of the best described examples of this mode of regeneration is observed 
in the freshwater flatworm planaria.  Planaria have a reserved pool of adult stem cells known 
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as neoblasts  (Rossi et al., 2008). These cells are adult pluripotent stem cells, meaning they are 
able to differentiate into all cell types of the planaria. It has been shown that the planaria can be 
cut into 279 pieces, and the neoblasts can activate and fully regenerate the worms—resulting in 
279 new fully reformed worms  (Morgan, 1901).  Conserving a pool of adult multipotent stem 
cells is the dominant mechanism by which adult mammals maintain both tissue homeostasis 
and regenerate damaged tissue in the context of disease and injury. 
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Dynamics of Adult Stem Cells in the Central Nervous System 
In mammals, stem cells in the adult are far more restricted than the planaria in their regenerative 
capacity. Like planarian neoblasts, mammalian embryonic stem cells, which are derived from 
the inner cell mass of a blastocyst, are pluripotent, meaning they can differentiate into all the 
germ layers of the organism  (Kleinsmith et al., 1964). Yet, throughout embryonic, fetal, and 
post-natal development, these embryonic stem cells differentiate into the multiple, tissue-spe-
cific cell types that comprise the adult organism. However, not all of these cells terminally 
differentiate with development—some remain incompletely differentiated and act as a reserved 
pool of tissue specific adult progenitor cells. Unlike the pluripotent embryonic stem cell, these 
cells are at most multipotent, meaning they can only turn into a limited number of cell types 
specific to their respective tissue.
Stem cells that persist for the entirety of adult life are known as adult stem cells. Some of the 
best understood of the adult stem cells are those of the blood, the skin, the intestine, and the 
muscle. To understand the biology of adult stem cells, it is important to understand the many 
ways they function in the adult. Long term hematopoietic stem cells, the stem cells of the blood, 
reside in the bone marrow and can give rise to all the cell types of the blood  (Spangrude et al., 
1988); however, these cells rarely divide even over the lifespan of the mouse, instead leaving 
most haematopoiesis to fast cycling daughter cells  (Bernitz et al., 2016). Intestinal stem cells 
can only give rise to the cells of the intestinal villi but are  perpetually active, providing a con-
stant supply of new enterocytes, Paneth cells, goblet cells, and enteroendocrine cells (Bjerknes 
and Cheng, 1999). These two stem cell populations exemplify the diversity of activity-states 
that adult stem cells exhibit across the different tissues; each tissue-specific adult stem cell be-
haves in accordance with the needs of its niche. 
 
In the central nervous system, there are three distinct adult stem cell populations: the neural 
stem cells of the subventricular zone; the neural stem cells of the hippocampal subgranular 
zone; and the oligodendrocyte progenitor cell (Fig. 2). The neural stem cell of the subventricu-
lar zone following division, migrates to the olfactory bulb and differentiates into interneurons 
(Doetsch et al., 1999). In rodents, these newly differentiated interneurons contribute to smell 
memory and other smell-linked behaviour  (Lazarini and Lledo, 2011). Indeed, these neural 
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stem cells have been identified in the human, but their activity is negligible in the adult human 
brain  (Sanai et al., 2004). As such, the role of these cells in normal human brain function and 
disease remains unclear. 
SVZ Neural Stem Cells
•Limited to SVZ
•Migrate to olfactory bulb
•Involved in smell
•Likely limited role in humans
SGZ Neural Stem Cells
•Limited to hippocampus
•Replace dying neurons
•Involved in short term memory
•Remain active in humans 
through adulthood
OPCs
•Spread even across CNS
•Differentiate into oligodendro-
cytes
•Involved in learning and memory
•Remain active in humans 
through adulthood
Figure 2. Stem cells of the adult rodent CNS. Illustration and brief description of CNS stem cells in a sagittal 
representation of the rodent CNS. The location of the stem cell population is coloured in red, yellow, and 
green.  OPCs are the most widespread and abundant stem cell population in the adult CNS. 
The neural stem cell of the subgranular zone in the hippocampus is likely more relevant for hu-
man biology. Upon differentiation into neurons, neural stem cells integrate fully into the hippo-
campus and are able to receive and transmit inputs from the rest of the brain  (Song et al., 2002). 
As the hippocampus is a centre for memory processing in the brain, it is widely speculated that 
neural stem cell activation and differentiation is important for memory formation (Deng et al., 
2010)—the theory being that new memory formation comes from the formation of a new neu-
ron or a new set of neurons. Recent evidence using in vivo human radioactive carbon integration 
suggests that nearly a third of hippocampal neurons turn over throughout a human’s postnatal 
life  (Spalding et al., 2013). This rate of turnover, however, is age dependent and declines by 
fourfold in adulthood and ageing. While there are indeed high rates of turnover, this study also 
revealed that these neural stem cells are not adding new neurons to the hippocampus. Rather, 
they are simply replacing already existing ones that have been lost, and ultimately more neu-
rons are lost than are generated in the hippocampus. It remains unclear whether these neuronal 
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stem cells are additive in terms of memory and cognition or simply compensatory, replacing the 
dying neurons of the hippocampus. 
Even in rodents, the roles of the SVZ and hippocampal neural stem cells are limited, providing 
new neurons only in spatially-limited regions across the central nervous system. By compar-
ison, the third type of adult stem cell, the oligodendrocyte progenitor cell, is scattered across 
the central nervous system, comprising 5-10% of total adult brain cells  (Dawson et al., 2003). 
Throughout development and adulthood, the oligodendrocyte progenitor cell  (OPC) gives rise 
to the oligodendrocyte, the cell-type that myelinates axons thereby allowing for efficient neu-
ronal signal transduction and providing vital trophic support for neurons  (Lee et al., 2012; 
Waxman, 1977). However, OPCs are not merely uni-potent progenitor cells; they maintain 
multipotent capacity and are able to self renew and differentiate both in vitro and in vivo into 
astrocytes and schwann cells (Zawadzka et al., 2010; Zhu et al., 2008). Taken together, these 
studies highlight the OPC as the most abundant and multipotent of the adult CNS stem cells. 
Moreover, more than any other progenitor cell population, the OPC may tell us how learning 
and complex thought is continued throughout adult life.  
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OPCs in development and the rise of the oligodendrocyte
To best understand the biology of OPCs and oligodendrocytes, it is important to understand 
how the oligodendrocyte  lineage cells are generated in development. Following fertilisation 
in development, secreted signalling proteins orchestrate the differentiation of the early embryo 
into the multicellular organism. The key canonical signals throughout development and adult-
hood are Notch, Hedgehog, bone morphogenetic protein  (BMP), Wnt, and fibroblast growth 
factor  (Fgf) proteins. These signalling proteins are implicated in some way in the activation 
and differentiation of virtually all  cell types, both embryonic and adult. This consistency of sig-
nalling pathways belies the shared evolutionary ancestry across all the stem cell niches (Brunet 
and King, 2017).
At mouse embryo day 7, the gastrula is formed in which all three germ layers are specified: the 
mesoderm, endoderm, and the ectoderm (Fig. 3). The ectoderm, the pool of cells that forms the 
central nervous system, is specified by supressing BMP and Nodal signalling  (Dupont et al., 
2005). The neural plate and the subsequent neural tube are similarly patterned, at least in part, 
by the modulation of BMP signalling on embryonic day 7.5 and 9.5, respectively  (Wilson and 
Hemmati-Brivanlou, 1995). Once the neural tube is formed, the most ventral cells in the neural 
tube are the pool of motor neuron progenitors. 
In all cells, combinations of proteins called transcription factors regulate the transcription of 
specific cell-type specific genes, acting as the ultimate downstream effectors of signalling mole-
cules.  This pool of motor neuron progenitor cells express the transcription factors Olig2, Pax6, 
Nkx6.1, and Nkx2.2  (Lu et al., 2002). Interestingly, without Olig2 at this stage in development, 
both motor neurons and oligodendrocytes fail to develop—revealing a common developmental 
dependency on the transcription factor Olig2. 
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Figure 3. The development of OPCs. An illustration of the development of OPCs in the rodent. Each panel 
represents a timepoint in development that is crucial for the differentiation of OPCs. From E12.5 to P7 OPCs begin 
to proliferate across the developing CNS following exposure to Noggin, Hedgehog, Notch, Wnt, Fgf, and Pdgf 
signalling. Finally at p7, OPCs begin differentiating into oligodendrocytes. The nuclear hormones RA and T3 have 
been implicated in the differentiation of developmental oligodendrocytes. In adulthood, OPCs maintain self-re-
newal and differentiation capacity, though the signals that underlie both remain incompletely understood.
?
OPCs begin to appear following exposure to hedgehog protein and inhibiting BMP signal-
ling at mouse embryonic day 12.5 as shown by their upregulation of the OPC-specific marker 
platelet-derived-growth-factor-receptor-alpha (Pdgfra) (Lu et al., 2000). Following exposure 
to hedgehog signalling, OPCs are specified from the motor neuron pool by the upregulation of 
Olig2 and Nkx2.2, and the down regulation of the neuron factors Nkx6.1 and Pax6  (Qi et al., 
2003).  At mouse embryonic day 15.5, a second wave of hedgehog-independent OPCs develop 
more dorsally along the neural tube following exposure to Fgf2, activating Olig2 using an al-
ternative pathway  (Cai et al., 2005). Using lineage tracing, the ventrally developed OPCs are 
dominant in the spinal cord, whereas the dorsally-developed OPCs dominate in the forebrain 
(Kessaris et al., 2005). Following the upregulation of Olig2 in proto-OPCs, the transcription 
factor binds the enhancer region of the oligodendrocyte-lineage specific region of Sox10, which 
in turn upregulates the expression of the OPC-specific Pdgfra  (Finzsch et al., 2008; Küspert et 
al., 2011).
Following specification, OPCs migrate through the central nervous system along the blood 
vessels in the neonate  (Tsai et al., 2016). Along with Fgf2, the signalling protein platelet de-
rived growth factor alpha (Pdgfa) acts as a chemoattractant, directing OPCs across the central 
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nervous system in development  (Bribián et al., 2006; Zhang et al., 2004). Moreover, OPCs, 
which uniquely express the receptor for Pdfra in the CNS, require PdgfAA for survival. By the 
end of development, between 20-50% of OPCs undergo apoptosis, and this survival is highly 
dependent on OPC exposure to PdgfAA  (Barres et al., 1992; Richardson et al., 1988). As OPCs 
proliferate and migrate along the blood vessels, they express high levels of the receptor for 
the protein Wnt . At this stage in development, Wnt, along with FGF and Notch1 signalling, 
maintain OPCs in an undifferentiated and proliferative state  (McKinnon et al., 1990; Wang et 
al., 1998). 
Eventually, OPCs begin to differentiate into oligodendrocytes. In mice, a handful of differenti-
ated oligodendrocytes are present at birth in the spinal cord. By post-natal day 6, a handful of 
cells begin to appear in the cerebellum and the brainstem. The differentiation of oligodendro-
cytes continues progressively into post-natal day 23, when the number of differentiated oligo-
dendrocytes peaks  (Foran and Peterson, 1992). Eventually the number of total oligodendro-
cytes decreases after post-natal day 23 as extra oligodendrocytes produced during development 
undergo apoptosis. 
The exact cause of the developmental switch from migrating and proliferating progenitor cells 
to developmental myelination remains unknown.  Moreover, it is unclear why certain white 
matter tracts become hyper-myelinated while grey matter regions don’t. However, some mo-
lecular signals are, at present, understood.  To differentiate into oligodendrocytes, many of the 
canonical signalling pathways mentioned (FGF, BMP, Hedgehog, Notch, Pdgf, and Wnt) must 
be downregulated. The nuclear receptors’ retinoic acid and thyroid hormone have been shown 
to be positive regulators of OPC differentiation into oligodendrocytes  (Barres et al., 1994). The 
importance of thyroid hormone regulation for OPC differentiation is highlighted by the fact that 
neonatal rats with hyperthyroidism and an excess of thyroid hormone have elevated levels of 
myelination  (Marta et al., 1998).
While the initial steps of OPC differentiation remain unclear, much is known once the differen-
tiation programme of oligodendrocytes has begun. Upon differentiation, the transcription factor 
Sox10 binds the promoter region of the transcription factor myelin regulatory factor  (Myrf) 
(Hornig et al., 2013).  Myrf along with Sox10 bind directly to the promoter regions of myelin 
component genes and upregulate their expression  (Bujalka et al., 2013; Niu et al., 2012). To-
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gether these genes enable the expression of myelin specific genes, the best understood of which 
are  myelin oligodendrocyte glycoprotein (Mog), myelin-associated glycoprotein (Mag), my-
elin proteolipid protein (Plp1),  2’,3’-Cyclic-nucleotide 3’-phosphodiesterase  (CNPase), and 
myelin basic protein (Mbp) (Emery et al., 2009). 
As mentioned previously, myelin is lipid rich membrane that wraps axons, allowing for effi-
cient signal propagation down the axon. Oligodendrocytes wrap the axons several times to form 
a dense and complex membrane around the axon. Upon differentiation, OPC microfilaments 
polymerise and begin to form filapodia that branch out from the body of the cell (Bacon et al., 
2007). Cytoplasmic channels deliver myelin proteins to the growth areas and Mbp and CNPase 
compact the myelin proteins in a cell-body-proximal to cell-body-distal manner (Snaidero et al., 
2014). In this way, a single oligodendrocyte cell can ensheath up to 50 axons at once (Pfeiffer 
et al., 1993) . The amount of myelin wrapping of the axon is dictated by cell-intrinsic mTOR 
signalling. The wrapping occurs segmentally along the axons and the regions in between the 
myelin wraps are known as the nodes of Ranvier.  While it is unclear why certain regions of 
axons are myelinated and not others, there is some evidence to suggest that region-specific cell 
surface markers on the axons inhibit myelination in certain areas of the CNS (Redmond et al., 
2016).
The production of myelin and its wrapping of axons to promote saltatory conduction has long 
been established as the main function of oligodendroctyes (Waxman, 1977). By acting as the 
insulator on the axon membrane, oligodendrocytes increase the speed with which depolarisa-
tion events can occur down an axon by 500-5000%, thus increasing neuron signalling speed and 
transduction. Recent evidence has emerged that oligodendrocytes provide additional trophic 
support to the axon. Mouse models that were  heterozygous knockouts for the Plp1 or Cnp1 
gene showed only slight deficits in compact myelin wrapping, but both knockouts caused large-
scale axonal degeneration (Griffiths et al., 1998; Lappe-Siefke et al., 2003). These two studies 
were amongst the first to highlight the possibility that oligodendrocytes perform roles in addi-
tion to the literal the wrapping of the axons. 
Transporters that export pyruvate and lactate into the ensheathed neuron are embedded within 
the myelin wrapped sheaths (Fünfschilling et al., 2012; Lee et al., 2012). Without the transport 
of lactate and pyruvate into the axon, which are used in the neuronal citric acid cycle to gener-
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ate cellular energy, the axon cannot sustain itself and degenerates. Finally, an even more recent 
and surprising study showed that oligodendrocytes deliver exosomes full of growth factors and 
RNA to stressed axons in order to help with their survival (Frühbeis et al., 2013).
The role of the oligodendrocyte lineage in adult CNS homeostasis 
In the adult CNS, OPCs are thought to be scattered evenly throughout the CNS parenchyma 
(Pringle et al., 1992). They self-repulse one another and thereby maintain cell density, never 
invading one another’s territory in the brain. If, however, an OPC is lost, the neighbouring OPC 
divides and the daughter cell replaces the differentiated OPC (Hughes et al., 2013).  This pro-
cess of OPC number maintenance must be sustained throughout adult life, as the total number 
of OPCs in the CNS remains constant even with ageing (Rivers et al., 2008). The outcome of 
adult stem cell division may be symmetric or asymmetric; after cell division, the mother cell 
can remain the resident stem cell while the daughter cell goes on to form the differentiated cell 
(Gurevich et al., 2016). Alternatively, both mother and daughter cell can divide symmetrically 
with both either differentiating or staying as stem cells (Snippert et al., 2010). In this way, the 
tissue retains the stem cell pool for future use, while also turning over old or damaged tissue. For 
now, the consensus is that OPCs can undergo both symmetrical and asymmetrical cell division: 
an OPC can divide and become two oligodendrocytes, two OPCs, or an oligodendrocyte and 
an OPC (Zhu et al., 2011). The signals underlying these distinct fate-decisions remain unclear. 
In normal adult tissue homeostasis, OPCs primarily give rise to the oligodendrocyte. Unlike 
the neural stem cells of the SVZ, OPCs remain in the cell cycle throughout young adulthood 
(Psachoulia et al., 2009); in rodents, over a third of total brain oligodendrocytes are generated 
by OPCs after reaching sexual maturity (Rivers et al., 2008). Again, using radioactive carbon 
cell tracing, oligodendrocytes in the grey matter are found to be generated at a high rate well 
into the fourth decade of adult human life (Yeung et al., 2014). Once differentiated, oligoden-
drocytes are highly stable, with the vast majority  (>90%) of oligodendrocytes born at p60 sur-
viving for the remainder of the mouse’s lifetime (Tripathi et al., 2017). These data suggest that 
adult myelination is not simply replacing dying oligodendrocytes; but that de novo myelination 
is occurring in previously unmyelinated axonal areas. 
As OPCs remain active throughout adulthood, one of the most pressing issues in the field is how 
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and why OPCs activate and differentiate into oligodendrocytes in specific regions across the 
central nervous system. Some of the first work on OPCs revealed that they have the ion chan-
nels glutatmate and GABA (Barres et al., 1990). Throughout the adult brain, OPCs form syn-
apses with both glutamatergic and GABAergic neurons (Bergles et al., 2000; Lin and Bergles, 
2004). While the function of these synapses remains a mystery, in vitro studies have revealed 
that agonising AMPA receptors on OPCs with glutamate can stimulate their activation, both in 
terms of proliferation and differentiation. These studies suggest that OPC activation in the adult 
brain is tightly correlated with the activity of proximal neurons. However, the exact orientation 
of OPCs in the brain in relation to other cell types remains largely unknown. 
In conjunction with the previous findings that OPCs form synapses with oligodendrocytes, the 
activation and differentiation of OPCs is context and situationally dependent. Upon activation 
of certain neuronal pathways, either using optogenetics or by rodent wheel running, OPCs 
activate and differentiate into myelinating oligodendrocytes. By genetically preventing OPC 
activation, in the case of the running wheel, animals were less able to learn how to run on the 
wheel (Gibson et al., 2014; McKenzie et al., 2014). Additionally, mice housed in isolation have 
behavioural problems tied to aberrant myelination in the prefrontal cortex  (Makinodan et al., 
2012). A recent study has shown that not only does myelination persist in middle-aged rodents, 
but also that myelination is enhanced in sensory rich environments  (Hughes et al., 2018). 
Conversely, mice without whiskers, and thus sensory deprived, have a deficit in myelination in 
the cerebral cortex.  These studies coalesce around the central hypothesis that OPCs and adult 
oligo-dendrogenesis are critical for adult learning and post-natal myelination.
Despite this recent interest in ‘adaptive myelination’  (the hypothesis that adult myelination is 
context and experience dependent), there is little known about the molecular mechanisms reg-
ulating adult OPC activation. The best way to understand adult stem cell activation signals is 
to look to other better characterised stem cell niches. Unsurprisingly, many of the same protein 
signals that govern embryonic development also regulate adult stem cell activation. The Notch, 
Hedgehog, BMP, Wnt, and Fgf proteins have been implicated in the activation and differenti-
ation of a number of stem cell niches—each niche requires its own dose of signalling for acti-
vation from each of these signalling pathways (Kroon et al., 2008). Across tissues, high levels 
of Notch protein maintains adult stem cell quiescence, and losing Notch leads to the loss of the 
tissue stem cell pool as the stem cell pool differentiates (Bjornson et al., 2012; Chapouton et 
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al., 2010).  In the intestinal villi, Wnt signalling protein activates the intestinal crypt progenitor 
cells, and the inhibition of Wnt is required for intenstinal stem cells to exit the cell cycle and 
terminally differentiate into Paneth cells (van Es et al., 2005). Whether these classical stem 
cell activation pathways play a role in homeostatic adult adaptive myelination remains to be 
determined. 
Diseases of the myelin
As oligodendrocytes’ myelin maintains axonal integrity, diseases of the myelin can be devas-
tating. The term leukodystrophies describes any disease which causes disruption to the myelin 
sheath. There are a number of rare congenital leukodystrophies that cause the impromper for-
mation of the myelin sheath. One of the best understood of the diseases that directly affects 
oligodendrocytes themselves is Pelizaeus–Merzbacher disease  (PMD), a recessive, x-linked 
disease which is caused by the point-mutation or duplication of the myelin component gene 
Plp1. While patients with PMD appear normal at birth, the symptoms become increasingly pro-
nounced with development. PMD varies in severity, depending on the dosage of the Plp1 gene, 
but at its most severe, PMD severely limits cognition, mobility, and can cause early childhood 
mortality (Garbern et al., 1999). Leukodystrophies such as PMD highlight the need for myelin 
in post-natal cognitive development: embryonic development proceeds as normal, but myelin-
ation is required for post-natal cognitive development. 
As oligodendrocytes lineage cells compose ~50% of total cells of the cortex, it would follow 
that most diseases of the CNS involve oligodendrocytes in one way or another (Pelvig et al., 
2008). Indeed, the focus of research for neurodegenerative diseases has largely been on neurons 
and their degeneration, but an emerging field of research is pitting the oligodendrocyte as a cen-
tral player in major neurological disorders. In Alzheimer’s disease, there is a marked decrease 
in the amount of myelinating oligodendrocytes across the human brain (Sjöbeck et al., 2005). 
In spinal cord injury, myelin loss is now being considered a central factor implicated in the 
loss of function (Papastefanaki and Matsas, 2015). While most of this work is correlative  (e.g. 
identifying a loss of myelin in various pathologies), a surprising recent paper identified a link 
between schizophrenia and oligodendrocytes (Windrem et al., 2017). In this paper, the authors 
transplant oligodendrocyte progenitor cells from patients with schizophrenia into the CNS of 
shiverer mice, a congenitally hypomyelinated mouse model. They find that only with OPCs 
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derived from patients with schizophrenia do they observe that the mouse-human chimeric CNS 
is hypomyelinated and that the mice behave abnormally. This paper provides preliminary evi-
dence in support of the hypothesis that the oligodendrocyte plays a central role in the etiology 
of many complex neurological diseases. 
The best studied disease of myelin is multiple sclerosis  (MS). In patients with multiple sclero-
sis, immune cells destroy the central nervous systems’ oligodendrocytes. It is this death of oli-
godendrocytes that causes demyelination and ultimately axonal cell death (Hauser and Oksen-
berg, 2006). MS begins 85% of the time in patients between the ages of 20 and 30, and, for most 
patients, the disease is first marked by a phase of relapses and remissions as the immune system 
attacks and destroys the myelinating oligodendrocytes. Like many auto-immune disorders such 
as type I diabetes, the cause of the initial immune attack on the myelin sheath is unclear, though 
it is assumed to be caused by a combination of genetics and environment. Similarly, the exact 
cause of each subsequent relapse is unknown and can vary from person to person; however, 
relapse has been correlated with immune adjuvants such as the flu and other forms of infections 
(Andersen et al., 1993).
Following each relapse in this early phase of MS, there is a period of remission in which the 
clinical symptoms improve. The cause of this improvement in symptoms has been correlated 
with the remyelination of the demyelinated lesioned tissue (Kornek et al., 2000). Remyelin-
ation is the process by which new OPCs are recruited to the lesioned tissue site and differen-
tiate into new myelinating oligodendrocytes to replace the immune-destroyed ones. Indeed, 
remyelination can occur quite efficiently in this first part of the relapse-remitting phase of the 
disease (Albert et al., 2007), restoring efficient signal transduction in the axon (Smith et al., 
1979) However, as the disease progresses, remyelination becomes highly inefficient, leaving 
chronically demyelinated lesions (Compston and Coles, 2002). In the end, these chronically de-
mylinated axons undergo Wallerian degeneration in which the demyelinated axon irreversibly 
deteriorates (Dziedzic et al., 2010). 
Of patients with relapse-remitting multiple sclerosis, 50% ultimately develop secondary pro-
gressive MS, a phase of the disease marked by the progressive worsening of symptoms. Re-
gardless of the variant of MS, after just 15 years following diagnosis, 75% of patients with 
MS are unemployed, and almost 60% of patients need help moving (Confavreux and Vukusic, 
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2006). Cognitive deficits as well as depression are also common amongst patients with MS. 
Most available therapeutics for patients with MS seek to mitigate the effects of immune-medi-
ated demyelination using immune-modulatory drugs. The most common classes of drugs used 
are interferon ß and glatiramer acetate  (Ebers, 1998; Farina et al., 2005), both of which are 
believed to slow MS disease progression by stimulating anti-inflammatory cytokines from T 
cells and anti-inflammatory macrophages. A recent report showed that the two most effective 
approved drugs that reduce the number of relapses are Alemtuzumab and Natalizumab  (Tice 
et al., 2016). While Alemtuzumab is a blocking antibody that binds all lymphocytes and there-
by globally dampens immune funtion, Natalizumab binds and blocks the integrin that allows 
T cells to cross the blood brain barrier. Whilst highly effective short term, these therapeutics 
fall short: symptoms of most patients still worsen over time. Immune-modulation may reduce 
the number of immune-mediated relapses, but it does not address the primary de-myelination 
events, and the de-myelinated axons still undergo Wallerian degeneration (Franklin and Gold-
man, 2015). The lack of therapeutics able to address the central issue of demyelination  in MS 
highlights the importance of researching the mechanisms of remyelination and the reasons for 
remyelination failure. 
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Experimental models of remyelination 
To best understand advances in the field’s understanding of remyelination, it is first import-
ant to review the animal models that provide the basis for these findings. A number of animal 
models have been developed to study the process of remyelination.  Each model, naturally, has 
its advantages and its limitations. There are three categories of animal models that are widely 
used to study remyelination: immune-mediated demyelination, toxin-induced demyelination, 
and genetically-targeted demyelination. 
Immune-mediated demyelination has been used for almost half a century (Yasuda et al., 1975). 
One method for causing demyelination known as experimental autoimmune encephalomyeli-
tis  (EAE) involves the co-injection of myelin component proteins such as MBP and MOG 
and the immune stimulant Freund’s adjuvant. Together, these components cause the rodent to 
initiate an auto-immune attack on CNS myelin, causing widespread CNS demyelination. The 
immune-mediated destruction of myelin echoes the process by which patients with MS develop 
demyelinating lesions. While this model has led to the discovery of a number of immune-modu-
latory therapies to treat MS, it has largely failed to identify remyelination therapies (Ransohoff, 
2012).  As an uncontrolled immune-driven animal model, the lesions occur sporadically and 
randomly throughout limited parts of the CNS. This makes studying the molecular and cellu-
lar orchestration of remyelination difficult as the timing and speed of remyelination is hard to 
determine. 
To study the process of remyelination itself, isolated from the variables of autoimmunity, a 
number of toxin induced models have been developed. Cuprizone is a copper-chelator that is 
specifically toxic for oligodendrocytes (Matsushima and Morell, 2001). As such, providing 
cuprizone in the diet of rodents causes demyelination events to appear sporadically throughout 
the CNS. In this model, demyelination and remyelination happen repeatedly within the lesion, 
which mirrors the pathology of multiple sclerosis lesions. Like the EAE model, however, the 
lesions develop sporadically over the course of cuprizone administration, making it difficult to 
characterise the state of the lesion. 
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The focal-demyelination toxin model escapes many of the limitations of the cuprizome model. 
This model involves the focal injection of a toxin such as lysophosphatidylcholine or ethidium 
bromide into white matter tracts (Blakemore and Franklin, 2008; Blakemore et al., 1977). The 
benefits of this model are that the time and location of demyelination are known. As such, the 
lesion site can be directly administered with cell transplants, small pharmaceutical compounds, 
or viral constructs, allowing for experiments that screen for factors relevant for re-myelination. 
As mentioned, MS is a disease of immune-mediated demyelination and OPC-mediated remye-
lination. In the toxin-model, the immunological element of the disease is purposefully ignored 
in order to focus on the biology of remyelination. 
The final and most recently developed model of remyelination is the genetic ablation model. 
Mice were generated that carry the tamoxifen-dependent cre recombinase gene under the pro-
moter of the myelin-specific gene Plp1 and a floxed diphtheria toxin gene (Pohl et al., 2011); 
in other words, following the injection of tamoxifen, Plp1 expressing oligodendrocytes across 
the CNS expressed the gene encoding diphtheria toxin, leading to widespread demyelination. 
Surprisingly, oligodendrocyte death did not lead immediately to axon death. Moreover, for un-
known reasons, remyelination was highly inefficient in these mouse models. It is believed that 
this could be due to the expression of Plp1 in a high proportion of the progenitor cells them-
selves, thus depleting both the progenitor and the oligodendrocyte cell pools. While  genetic ab-
lation models hold much potential in terms of their experimental power, until the orchestration 
of cellular events in remyelination in the genetic ablation models is more fully established, the 
toxin model remains the best model for researching CNS remyelination. 
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Lessons from Remyelination Studies  
The vast majority of new oligodendrocytes in these focal-induced demyelination studies are 
derived from the OPCs, though there is some evidence that neural stem cells give rise to a small 
proportion of oligodendrocytes (Menn et al., 2006). In one report, small numbers of labelled 
neural stem cells migrate from the subventricular zone following a toxin-induced lesion in the 
corpus callosum. It is unclear, though, the extent to which this occurs in lesions in other regions 
of the brain more distal to the subventricular zone. As such, the vast majority of work has gone 
into studying the migration, proliferation, and differentiation of OPCs.
As the toxin-lesion model provides the exact timestamp of the demyelinating insult, the or-
chestration of cells that contribute to remyelination in the days following the lesion is now 
well characterised. Almost every cell-type of the CNS plays a role in remyelination: Astrocytes 
surround the lesion site and secrete growth factors such as Pdgf and Fgf, regulating OPC num-
bers around the lesion (Woodruff et al., 2004). Semaphorins presumed to be secreted by axons 
stimulate the migration of the OPCs to the lesion site (Piaton et al., 2011). Pro-inflammatory 
microglia and peripheral macrophages phagocyte the myelin and secrete signals such as Activ-
in-A, acting directly on OPCs to stimulate their differentiation  (Kotter et al., 2006; Miron et 
al., 2013). 
Following the activation of the astrocytes and microglia, OPCs are recruited to the lesion site 
where they activate and differentiate into new ensheathing oligodendrocytes. Following re-
cruitment to the lesion site by mitogenic growth factors, OPCs begin upregulating many genes 
that are associated with OPC development such as their expression of Olig2, Sox2, and Nkx2.2 
along the lesion border (Fancy et al., 2004). To remyelinate the lesion site, the differentiating 
oligodendrocytes first make contact with the denuded axon, express myelin genes, and finally 
wrap the axon, restoring efficient conduction down the axon. The exact molecular steps that 
direct this process of remyelination remain unclear. However, developmental signals such as 
retinoid signalling and the loss of Fgf signalling have been shown to accelerate remyelination 
(Armstrong et al., 2002; Huang et al., 2011). 
There are some surprising differences between developmental myelination and these focal de-
myelination studies. The gold standard quantification for identifying and assessing the remy-
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elination of the lesion is known as the g-ratio—the ratio of myelin thickness to axon diameter 
(Blakemore, 1974). Importantly, during the process of remyelination, axon myelin is restored 
but is always thinner than developmental myelin, making it easy to identify the remyelinated 
lesion area. The reason for this difference remains unknown. 
 
There are some clear mechanistic differences as well that distinguish remyelination and  de-
velopmental myelination; the transcription factor Olig1, while dispensable for developmental 
remyelination, is required for remyelination  (Arnett, 2004). Conversely, the deletion of the 
canonical receptor Notch1 in development negatively impacts myelination, while its deletion 
in the adult has almost no effect on remyelination  (Hu et al., 2003; Stidworthy et al., 2004). To-
gether these results emphasize that adult remyelination echoes but does not exactly replicate de-
velopmental myelination, a fact that is likely important for developing remyelination therapies. 
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Ageing, regeneration, and OPCs 
Like all regenerative processes, the process of remyelination becomes inefficient with ageing 
(Shields et al., 1999). Even in the absence of additional inflammation, remyelination efficiency 
is impaired, and this finding is critical for better understanding the aetiology of diseases such as 
multiple sclerosis. If remyelination efficiency is age-related and, at least in part, independent of 
the adaptive immune response, then immune-modulators cannot alone be used to treat diseases 
such as secondary progressive MS. To understand the reasons for the loss of remyelination effi-
ciency with age, it is important to explore the prevailing theories of the ageing field. 
Interest in the ageing field has grown in recent decades as it has become clear that ageing is the 
confounding factor for most adult-onset pathologies  (López-Otín et al., 2013); Type ii diabetes, 
cardiovascular disease, neurodegenerative diseases such as Alzheimer’s disease, and cancer all 
have increased incidence in aged populations. Moreover, developed countries are experiencing 
a demographic challenge with increased numbers of aged people and are investing heavily in 
research to mitigate the growing health care burden of age-related disease  (Mahishale, 2015). 
As such, there is a socioeconomic imperative to better understand the ageing process. 
The activity-mediated ageing hypothesis
Experimental biologists began seeking biological explanations for longevity and ageing in the 
early 20th century. Studies of longevity began by looking at the regulators of lifespan in dro-
sophila and rats  (Economos and Lints, 1985; Osborne et al., 1917). Quickly, these researchers 
identified mating and food intake as two key regulators of longevity. Female rats that were 
house without males lived significantly longer than rats housed with males. Drosophila that 
were given minimal food intake during their days of development lived significantly longer 
than those given excess amounts of food. This early work was continued in the 1950s with a 
hallmark study showing that drosophila exposed to brief bursts of high heat in early develop-
ment lived longer than drosophila in normal temperature conditions  (Smith, 1958).  This idea 
that reproduction, stress, growth, and longevity were somehow linked, however, is not new: 
Early thinkers such as Aristotle and Galen proposed that longevity could be enhanced from 
sexual abstinence and minimal calorie intake  (Jeune, 2013).
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With the advent of modern day molecular biology, research in the ageing field began by reca-
pitulating these early findings with the new understanding of genomics. This work began in 
the early 1990s with the finding that mutant C. Elegans could live twice as long as wild types 
(Kenyon et al., 1993).  These mutant C. Elegans had a mutation in the C. Elegans daf2 gene, 
the drosophila paralogue of the mammalian insulin-like growth factor  (Igf1) gene. Follow 
up studies showed that juvenile C. Elegans that were daf2 mutants entered prematurely into a 
semi-dauer state, a state of low metabolism and low reproduction  (Gems et al., 1998). These 
studies were recapitulated again in mice with an Igf1 mutation  (Holzenberger et al., 2003). 
Finally, when the hormone Klotho, a hormone antagonist of Igf1 signalling, was given to mice, 
they had an increased lifespan of up to 30%  (Kurosu et al., 2005). 
As Igf1 signalling is tightly linked to insulin hormone—the hormone secreted in response to 
elevated blood glucose levels—this trajectory of study further intensified research into the link 
between calorie intake, cell metabolism, and ageing. To lower insulin and insulin growth factor 
signalling, much work has gone into better understanding whether calorie restriction itself has 
an effect on ageing. Perhaps the strongest evidence to date of the importance of metabolism 
on longevity and health span is the decade-spanning study showing that calorie restriction in 
Rhesus monkeys prolongs both lifespan and healthspan  (Colman et al., 2009).  After 30 years, 
only 25% of the monkeys fed a normal diet were without disease while almost 75% of calorie 
restricted monkeys were without disease. 
Together, these experiments coalesce around the Darwinian “disposable soma” theory of ageing 
(Rando, 2006). Well accepted in the ageing field, this theory suggests that the body’s energy 
resources are optimised for growth and reproduction at the expense of somatic self-preserva-
tion. After a prolonged period of growth and activation, cells ultimately accumulate too much 
‘damage’ to function properly. According to this theory, calorie restriction works by disrupting 
the flow of resources to reproductive fitness, forcing the cells into a ‘self-preservation’ mode at 
the expense of reproductive fitness. This is the prevailing theory of the ageing field whereby the 
stress of development into adulthood ultimately drives somatic ageing. 
Intracellular age-related signalling pathways
The question of how calorie restriction via insulin signalling prolongs life and healthspan re-
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mains an area of active research. Two opposing signalling pathways are important downstream 
targets of food intake: mTor and Ampk (Fig. 4). Under levels of high glucose, insulin signalling 
activates mTor signalling via PI3K and AKT. mTor in turn upregulates the ribosomal translation 
machinery, inhibits autophagy, and prepares the cell for cell division and growth  (Russell et al., 
2011). Under conditions of low glucose, AMPK signalling drives cells into  the quiescent G0 
phase of cell cycle, activating DNA damage repair, mitochondrial biogenesis, autophagy, and 
reactive oxygen species degradation  (Mihaylova and Shaw, 2011). Together these two path-
ways counterbalance one another: mTOR promoting growth and AMPK promoting quiescence. 
Mouse lifespan can be increased by up to 20% in vivo by simply inhibiting mTor pathway with 
the small molecule rapamycin  (Harrison et al., 2009) or by activating the AMPK pathway with 
the small molecule metformin  (Martin-Montalvo et al., 2013). 
The explanations linking mTor pathway to ageing are complicated and often times conflicting. 
The prevailing theory is that upon activation of mTor, cells, especially stem cells, become 
primed for growth. Under these growth conditions,  autophagy is inhibited, DNA repair stalls, 
and mitochondria begin producing energy via oxidative phosphorylation. Ultimately, the down-
stream effects of genomic instability, the loss of autophagy, and changes in cell metabolism 
are seen as the main three components driving intracellular ageing. Each of these downstream 
underpinnings of ageing require investigation in order to create therapeutic interventions for 
age related disease. 
Age related genomic instability 
Genomic instability describes DNA damage, the loss of epigenetic marks, and three-dimen-
sional topographical chromatin disorganization. As DNA is the underlying instruction book for 
cell biology,  damage to the DNA itself has long been postulated as the ultimate driving factor 
in the ageing process  (Szilard, 1959). With ageing, there is indeed an increase in the number 
of DNA mutations  (Moskalev et al., 2013). Without functioning DNA repair master-regulator 
Sirt6, mice have accelerated ageing phenotypes and shortened lifespans  (Mostoslavsky et al., 
2006). Conversely, mice with the overexpression of Sirt6 have increased longevity  (Kanfi et 
al., 2012). 



































Figure 4.  Growth versus cellular preservation signaling pathways. With pro-growth signaling path-
ways there is a hyper activation of mTOR signalling, a loss of mitochondria biogenesis, autophagy, 
and DNA integrity. Under low nutrient conditions, cells enter a self-preservation state; they degrade 
junk proteins, generate new mitochondria, and repair DNA. The ageing field largely has focused on 
reconciling these two cell states with the hope of promoting cellular self-preservation over cell growth 
and cellular ageing.    
Growth/Exhaustion
Quiescence/Preservation
Early work in the ageing field also focused on the length of the telomeres on the ends of chro-
mosomes. Telomeres are repeat nucleotide sequences that act as a buffer, protecting coding 
regions of chromosomes from damage during DNA replication. Mice without the enzyme re-
sponsible for telomere deposition—telomerase—exhibited an accelerated ageing phenotype 
(Rudolph et al., 1999). 
Unpublished studies have shown that DNA damage in the adult alone can cause an accelerat-
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ed ageing phenotype (Sinclair et al., 2016). This work, presented at a conference, described a 
transgenic mouse model that expresses a restriction enzyme only following exogenous dosage 
of doxycycline. This rare restriction enzyme was chosen only to cause double strand breaks 
in 100 non-coding and non-regulatory regions of the genome  (Kim et al., 2016). The authors 
observed short-term transcriptional stability, but overtime the animals exhibited a rapidly accel-
erated ageing phenotype. This is perhaps the strongest work to date showing that DNA damage 
itself, independent of DNA mutations in coding or regulatory regions, triggers an ageing phe-
notype. 
This reduced epigenetic stability has also been implicated in the ageing process. The epig-
enome generally refers to the methylation of DNA and core protein histones around which 
the DNA is wrapped. In ageing, both the methylation of DNA and the histone remodelling of 
DNA is significantly changed. DNA methylation is the tagging of DNA base pair cytosine with 
a methyl group and is classically associated with the silencing of DNA. With ageing, overall 
DNA methylation is lost in somatic cells  (Wilson and Jones, 1983). While there is an overall 
loss in methylation with age, many promoter regions that are involved in regulating stem cell 
proliferation and differentiation become hyper-methylated with ageing  (Day et al., 2013). In 
drosophila—the overexpression of Dnmt1—the methyl transferase enzyme partly responsible 
for DNA methylation, increases longevity  (Lin et al., 2005). 
The gene expression of core  histones is lost progressively with ageing  (Liu et al., 2013). Like 
DNA methylation, this loss in histone gene expression is complicated by the fact that certain 
kinds of chromatin remodelling actually increase with ageing. Previously considered synony-
mous, the histone modifications H3K27Me3 and H3K9Me3 are both histone marks that identify 
silenced chromatin. H3K27Me3 increases with age, a finding that corroborates the theory that 
quiescent aged cells have lower levels of transcription. Surprisingly, H3K9Me3 is progressively 
lost with ageing  (Zhang et al., 2015), suggesting a divergent role for these chromatin marks. 
Histone deactylase enzymes classically remove acetyl groups from the core histone complexes. 
This causes tighter binding of the chromatin to the histones, thereby reducing transcriptional 
activity of the tightly-wound chromatin. With ageing, the expression of these chromatin remod-
elling enzymes is lost. In one study, experimental overexpression of the histone deactylase Sirt6 
genes in mice increased their longevity by 15% (Kanfi et al., 2012).  
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Recent work has shown that the three-dimensional topographical arrangement of chromatin is 
crucial for proper gene expression  (Dixon et al., 2012). Genes that are brought to the nucle-
ar periphery are primed for gene expression, and clusters of genes that require co-expression 
are often arranged together  (Peric-Hupkes et al., 2010). While no direct link has of yet been 
made between chromatin domain re-arrangements and ageing, there are a number of hints that 
changes in chromatin topography may be another driving force behind the ageing phenotype. In 
Hutchinson Gilford Progeroid syndrome there is a mutation of the nuclear lamina gene Lmna. 
Patients with this disease have an accelerated ageing phenotype and suffer from age-related 
diseases at a young age. The nuclear lamina describes the protein network that lines the inside 
of the nuclear membrane and plays a major role in shaping the chromatin into topographical do-
mains  (Guelen et al., 2008). Unsurprisingly, the cells of patients with this mutation have large 
amounts of chromatin disorganization  (McCord et al., 2013). Similarly, in patients with another 
accelerated ageing disease called Werner syndrome, there are large scale topographical changes 
in chromatin positioning  (Zhang et al., 2015). Together, these two rare diseases shed light on 
the importance of three-dimensional chromatin organization on the rate of ageing. 
Proteostasis and ageing
 
Proteostasis is the process by which damaged proteins or organelles are degraded by the cell in 
order to preserve cellular homeostasis. There are two main mechanisms by which cells degrade 
proteins: autophagy and ubiquitin-mediated proteolysis. In autophagy, damaged organelles and 
proteins are targeted by the autophagasome and are delivered to the lysosome where they are 
degraded. In ubiquitin-mediated proteolysis, proteins that are typically tagged with the small 
protein ubiquitin are targeted by the proteasome for destruction. Both of these independent pro-
tein degradation processes are severely impaired with ageing. 
In drosophila, there is a 3-4 fold increase in ubiquitinated proteins in the CNS with ageing  (Si-
monsen et al., 2014). This suggests that proteins targeted for degradation are not being properly 
processed and thus accumulate within the CNS. In C. Elegans, when key components of the 
proteasome machinery were over-expressed, animals lived as long as those that were on calorie 
restriction. Conversely, when this machinery was knocked out, the animal’s life was significant-
ly shortened, even under conditions of calorie restriction  (Carrano et al., 2009). 
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Autophagy similarly regulates the age-state of an animal. In drosophila ageing, there is a pro-
gressive loss of the autophagy genes expressed, suggesting a loss of activity of the autophagy 
machinery. When key components of the autophagy machinery are overexpressed, drosophila 
live significantly longer; without this machinery, the animals exhibit an accelerated ageing 
phenotype  (Simonsen et al., 2014). In mice, the loss of key autophagy genes specifically in the 
CNS contributed to widespread neurodegeneration  (Komatsu et al., 2006). Recent work has 
shown that hyper-activation of autophagy machinery in neural stem cells of aged animals via 
the autophagy regulating transcription factor TFEB  rejuvenates the cells both functionally and 
transcriptomically  (Leeman et al., 2018). 
Mitochondria, cellular metabolism, and ageing
 
The first molecular explanation of ageing suggested that reactive oxygen species produced by 
mitochondria progressively impair normal cell function  (Harman, 1956). In the past decades, 
there has been little proof validating this theory of ageing. Mitochondria, however, do lie at the 
heart of the ageing process. In human ageing, mitochondria morphologically become rounded 
and are less efficient at generating ATP via the electron transport chain  (Short et al., 2005). 
Mice that have excessive DNA mutations in the mitochondrial DNA genome have a shortened 
lifespan and a severely accelerated ageing phenotype  (Kujoth et al., 2005). 
There are two main methods by which cells generate ATP: oxidative phosphorylation and 
glycolysis. Differentiating cells prefer oxidative phosphorylation over glycolysis  (Cho et al., 
2006). In adults, quiescent adult stem cells produce ATP using glycolysis  (Folmes et al., 2012; 
Suda et al., 2011). Under conditions of calorie restriction, however, aged cells across multiple 
tissues begin increasing their number of mitochondria and increasing levels of oxidative phos-
phorylation  (Nisoli et al., 2005). Moreover, in conditional mouse knockouts that prevent this 
mitochondrial biogenesis and increased oxidative phosphorylation, the effects of calorie restric-
tion and its extension on lifespan are attenuated. 
 
The reasons for the loss of efficient oxidative phosphorylation with ageing remain unclear. One 
theory is that with development and insulin-signalling there is a down regulation of AMPK 
signalling. AMPK via Sirtuin 1 is a master regulator of mitochondrial biogenesis transcription 
factor Pgc1a  (Cantó et al., 2010). Without de novo mitochondrial biogenesis, mitochondria 
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become damaged and thereby less efficient at producing ATP via oxidative phosphorylation. By 
just overexpressing Sirtuin 1 or by increasing the global level of the Sirtuin 1 cofactor, NAD+, 
mice have increased mitochondrial longevity, oxidative phosphorylation, and increased longev-
ity  (Satoh et al., 2013; Zhang et al., 2016). 
The exact reasons for increased longevity following increased ATP synthesis via oxidative 
phosphorylation remain unclear and wholly speculative. Intuitively, increased cellular energy 
would seem to suggest a more plastic and resilient cell. Another, exciting possibility is a newly 
identified role for ATP other than its classical role as the cell’s energy source. It has been recent-
ly identified that ATP acts as a biological surfactant for proteins and prevents their aggregation 
(Patel et al., 2017). With increased ATP, it is possible there is a decreased aggregation of dam-
aged cellular proteins. 
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Activity and Ageing: a conundrum
 
Across a number of tissues, the capacity of adult specific stem cells to differentiate into new 
tissue is significantly impaired in the context of injury (Goodell and Rando, 2015). The loss 
of stem cell function across a number of tissues is hypothesized to be the underlying driver of 
the ageing process (Oh et al., 2014). Without functional adult stem cells, tissues are unable to 
regenerate both in the context of disease and in homeostasis. Again, the field’s consensus view 
for this loss of function is the underlying strain placed on the stem cell niche following postna-
tal development. During this period of growth there is a loss of autophagy, changes in cellular 
metabolism, and, most importantly, DNA damage. Despite the wealth of evidence supporting 
this theory, there is a growing amount of work which suggests that the ageing process is more 
nuanced. 
Recent lessons from induced pluripotent stem cells  (iPS cells) present the biggest challenge to 
the activity-drives-ageing hypothesis. The finding that four transcription factors, Oct4, Sox2, 
Klf4, and Myc, can reprogram any adult somatic cell into a pluripotent embryonic stem cell has 
revolutionised the field of stem cell biology  (Takahashi et al., 2006). The authors showed that 
iPS cells, converted from adult mouse cells, could give rise to animal chimeras when injected 
into mouse blastocysts, differentiating into all the germ layers of development. Ultimately, 
these chimeric mice mature and are then able to produce viable offspring from gametes derived 
originally from the iPS cells  (Okita et al., 2007). 
A number of follow up studies confirmed that this process of reprogramming could be done in 
a cell from any age of donor. Surprisingly, many known age-related hallmarks disappear fol-
lowing reprogramming, even in iPS cells generated from aged persons. Upon reprogramming, 
telomere length extends, there is increased mitochondrial biogenesis, and even DNA repair 
mechanisms activate (Bhutani et al., 2010; Marión et al., 2009; Miller et al., 2013; Prigione et 
al., 2011). This process of de facto rejuvenation, however, requires this reprogramming step. 
One study examined fibroblasts directly converted into neurons and then compared them to 
fibroblasts that were first reprogrammed into iPS cells before differentiated into neurons. Di-
rectly converted neurons retained their age-state in terms of DNA methylation level and their 
expression of a panel of age-related genes, while the iPS cell derived neurons were rejuvenated, 
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losing many cellular traces of their age  (Mertens et al., 2015). It is arguable that some unknown 
factor in the reprogramming process contains the answer to the ageing process. 
If ageing is activity-driven, then the generation of highly proliferative iPS cells should only 
further drive an ageing phenotype, at least in the cells that are successfully reprogrammed. 
Recent work has considered the opposite hypothesis—that inactivity accelerates ageing. One 
study created a mouse in which all p16ink4a expressing senescent cells could be inducibly 
killed  (Baker et al., 2011). Mice without senescent cells lived longer and had a lower incidence 
of age-related diseases.  
In the most impressive study to date purporting this loss-of-activity hypothesis, the authors 
generated a mouse model that inducibly overexpressed the factors, Oct4, Sox2, Klf4, and Myc 
in transient bursts throughout the adult life of a mouse  (Ocampo et al., 2016). The authors hy-
pothesized that incomplete and ‘partial’ reprogramming of adult cells would reset cellular age-
state but not their cellular identity. Doing so, the authors observed a 33% increase in remaining 
lifespan and a global loss of the cellular hallmarks of ageing. The authors of this study, howev-
er, neither examined nor considered the effects of the reprogramming factors on the ageing of 
OPCs. 
The reasons for this activity-driven rejuvenation remain unknown. One possibility is that, as 
in the generation of iPS cells, a cell forced to re-enter cell cycle must fix damaged DNA and 
upregulate mitochondrial biogenesis pathways. Similarly, by undergoing mitosis, stem cells are 
able to dilute any damaged organelles in their daughter cells. One paper showed that healthy 
stem cells undergoing cell cycle regularly donate older mitochondria to the daughter cell  (Kata-
jisto et al., 2015). When the researchers inhibited this process of asymmetric organelle portion-
ing, the mother stem cell lost plasticity. As such, without cell cycle, stem cells may accumulate 
damaged organelles and are thus unable to maintain homeostasis. 
Insulin signalling and organismic growth drive DNA damage, the loss of autophagy, and im-
paired mitochondrial biogenesis. At the same time, activity and growth rejuvenates cells. In-
deed, both theories have convincing substantiating evidence. While superficially opposing, 
both of these two theories could be accommodated within a new third theory: Certain types 
of activity are good for cell and tissue homeostasis while other types of activity are not. From 
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the studies examined, the types of cell states that promote healthy ageing are cell cycle and 
AMPK-mediated quiescence and repair. With normal ageing, however, cells get stuck in the 
mTOR mediated G1 phase of cell cycle growth. Whether or not this hypothesis proves true in 
the context of OPC ageing remains unknown. 
Ageing and the Environment 
To understand exactly what arrests aged stem cells in an activated G1 state is to understand the 
ageing process itself. The two cellular solutions to this problem of stem cell G1 arrest are: 1.  To 
progress through cell cycle, or 2. to enter into quiescence. In aged and damaged tissue, entering 
into a state of self-repair and quiescence may indeed rejuvenate a stem cell, but ultimately the 
stem cell will need to activate and progress through the cell cycle to regenerate the aged tissue. 
Whether or not the aged environment is permissive to cell division in the first place is largely 
unknown. 
Early transplant studies shed some light on this question. When healthy embryonic cells are 
transplanted into normal aged CNS, the cells engraft and survive but do not multiply  (Hallas 
et al., 1980). Embryonic CNS cells transplanted into young adult animal CNS survive and do 
grow. These crude early studies reveal that even embryonic CNS cells at their most generative 
cannot progress through cell cycle in an aged environment. As such, the key to understanding 
the ageing process is identifying the factor that makes the aged environment so refractory to 
stem cell proliferation and differentiation. 
Young blood and its effect on ageing 
Throughout young adult development, the development of tissues is synchronised with circu-
lating hormones until sexual maturity  (Lee et al., 1975). At the end of post-natal adolescent 
development, pro-growth circulating hormones are gradually lost. To determine whether some 
unknown blood-derived hormone from young adult mice can rejuvenate an aged animal, re-
searchers surgically linked the circulatory system of young and old mice in a process called 
heterochronic parabiosis. Doing so, researchers have found that a wide range of stem cells at 
least partially rejuvenate following exposure to a young circulatory system. Muscle stem cells 
repair tissue damage more efficiently, hepatocytes proliferate more, and even remyelination by 
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OPCs in the CNS is more efficient  (Conboy et al., 2005; Ruckh et al., 2012). 
Following the exposure of aged cells to young serum in vitro, the cells rejuvenated, further 
suggesting that the unknown factor is not cellular but hormonal  (Conboy et al., 2005). A pro-
teomics array showed that one circulating hormone, Gdf11, is reduced with ageing, but is in-
creased in aged mice that have undergone the parabiosis procedure. Despite many conflicting 
reports, this hormone, Gdf11, has been reported to alone increase neurogenesis, cardiovascular 
function, and muscle regeneration  (Katsimpardi et al., 2014; Loffredo et al., 2013; Sinha et 
al., 2014). Further studies are required to validate these reports, but the parabiosis studies em-
phasise the importance of non-cell autonomous factors in organismic ageing. Moreover, they 
suggest that the metabolic deficits implicated in cellular ageing may be symptoms, rather than 
causative instigators of the ageing process.  
Even within a young systemic environment, however, regeneration remains limited. There have 
even been reports that while transient exposure to young factors transiently rejuvenates aged 
adults, the effect is  not long-term  (Shytikov et al., 2014). In mice, long term follow-up stud-
ies show that lifespan remains unchanged, as does the incidence of age-related pathologies. If 
young hormones alone cannot rejuvenate aged animals, then some undiscovered factor remains 
to explain the process of ageing. 
Stem cell niche and ageing
It has long been appreciated that local environmental signals mediate the local stem cell pop-
ulation’s activation in the case of wound healing. As previously covered, following a demye-
linating insult in the CNS, neurons, astrocytes, and microglia all signal to OPCs to regenerate 
the damaged tissue. However, with ageing, these signalling cascades are significantly impaired. 
Following a demyelinating insult in the aged brain, microglia fail to exit a pro-inflammatory 
state and thereby do not signal to OPCs to differentiate into new oligodendrocytes  (Miron 
et al., 2013). By promoting anti-inflammatory microglia in the CNS with the TGFB receptor 
agonist Activin A, OPCs can more efficiently differentiate within the lesion. Similarly, in the 
aged brain, astrocytes do not produce the same level of growth factors, further impairing the 
regenerative capacity of OPCs  (Hinks and Franklin, 2000). 
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In addition to growth factors and intercellular signalling cascades, there are alternative mecha-
nisms by which the niche microenvironment effects stem cell function; the stem cell niche mi-
croenvironment also includes signals from the extracellular matrix (ECM) and from the chang-
ing physical material properties of the tissue itself. 
Extra cellular matrix and CNS ageing 
In the central nervous system, the extracellular matrix consists of a multi-molecule structure 
known as the peri-neuronal net. Largely consisting of big linear Hyaluronans, di-sacharide car-
tilage-like molecules, and smaller chondroitin sulfate proteoglycans, the perineuronal net plays 
an instructive role in neural development and CNS homeostasis  (Kwok et al., 2011). In early 
post-natal development, the perineuronal net ensheaths neuronal synapses, in an activity de-
pendent manner  (McRae et al., 2007). If the perineuronal net is degraded enzymatically, there 
are an increased numbers of neuronal synapses, but neurons themselves become less sensitive 
to the neurotransmitter glutamate  (Pyka et al., 2011). As such, the perineuronal net is hypothe-
sised to stabilise neuronal connections in development and in memory formation.
In spinal cord injury in rodents, the enzymatic degradation of the perineuronal net using chon-
droitinase enhances cellular and  functional recovery from the injury. Following injection of 
chondroitinase into the injury site, axonal projections sprout across the contusion site and ani-
mals are able to regain a degree of mobility  (Alilain et al., 2011; Bradbury et al., 2002). Young 
adult OPCs themselves become more active and are able to more completely remyelinate a 
demyelinating insult following treatment with a chondroitinase enzyme  (Keough et al., 2016). 
Together, these results begin to identify the molecules underlying the regeneration-adverse con-
ditions of the adult CNS. Moreover, these studies reveal the non-permissive role that the ECM 
has on cellular activity and regeneration—further complicating the reasons for OPC dysfunc-
tion in ageing. 
Across the body, there is a collapse of the extracellular matrix environment homeostasis with 
ageing. In the hair follicle niche, there is a loss of expression of the extra cellular matrix com-
ponent, Col17a1, with ageing.  The authors show that following substantial hair follicle DNA 
damage, Col17a1 protein production stops, and the hair follicle stem cells themselves sponta-
neously differentiate. Without a resident stem cell population, the hair follicle ultimately dies, 
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and there is widespread age-related hair-loss  (Matsumura et al., 2016). When the cells of the 
hair follicle niche over-express Col17a1, however, the hair follicle stem cells are able to main-
tain their stem cell identity, and the hair follicle niche does not age. A similar study in muscle 
finds that there is a loss of fibronectin with ageing, and that this loss underlies the loss of muscle 
stem cell identity and activity  (Lukjanenko et al., 2016). Exogenously provided fibronectin 
enhances regeneration of the muscle niche following injury. These studies highlight the in-
structive role of the extra cellular matrix on the activity of stem cells, and that if the matrix is 
perturbed—as it is with ageing—then the resident tissue stem cells cannot properly function.  
So far, no work has directly examined the impact of the ageing ECM on OPC function. One 
study found that the brain, as a whole, has a progressive accumulation of the regeneration-ad-
verse chondroitin sulfate proteoglycan molecules  (Végh et al., 2014). If these molecules under-
lie the lack of regeneration in the aged brain, then their compositional imbalance with ageing 
may well cause remyelination failure. 
The exact cellular mechanism by which adult stem cells respond to changes in the extracellular 
matrix environment remains unclear. In the context of spinal cord injury, the protein Ptpσ has 
been identified as the receptor for chondroitin sulfate proteoglycans  (Lang et al., 2015). If the 
binding of this receptor to chondroitin sulfate proteoglycans is impaired with a small molecule, 
axons ignore their environment and can regenerate following spinal cord injury. Whether this 
signalling pathway is relevant for other tissues or stem cell niches remains unknown.  
Biophysics, stem cells, and CNS ageing 
The relationship between tissue form and stem cell function is highly relevant to the biology of 
adult stem cells. In one of the first hallmark studies to explore the relationship between biophys-
ics and adult stem cells, researchers seeded adult bone marrow-derived mesenchymal stem cells 
(MSCs) on synthetic hydrogels of different stiffness  (Engler et al., 2006). The mammalian 
body is composed of tissues of varying stiffness  (e.g.  brain is soft and bone is stiff). As such, 
the authors hypothesised that adult MSCs would behave differently when put into environments 
of different stiffness. The authors found that on softer hydrogels, these MSCs differentiate 
preferentially into muscle, while on stiffer hydrogels they differentiate preferentially into bone. 
Modulating matrix stiffness alone changed the fate choice of the cell. 
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This finding that cell fate choices are impacted by extracellular matrix rigidity has implications 
for the field of stem cell biology. In order to expand adult muscle stem cells in vitro, researchers 
found that cells required an environment with the extra cellular matrix conditions that mim-
icked the in vivo muscle  (Gilbert et al., 2010). In the intestine, a combination of extracellular 
matrix molecules and stiffness tuned hydrogels were required for the expansion of intestinal 
stem cells  (Jung et al., 2011). Neonatal OPCs have been shown to exhibit increased self-re-
newal and differentiation capacity on soft hydrogels compared to stiff hydrogels, and have an 
increased propensity to differentiate into astrocytes on stiff hydrogels (Urbanski et al., 2016). 
It is difficult to disentangle the effects of extracellular signalling pathways—such as the Chon-
droitin-Ptpσ pathway—from the effects of mechanical signalling. Matrix signalling is mediated 
by the composition of the extracellular matrix environment, whereas mechanical signalling is 
mediated by the physical stiffness of extracellular matrix proteins. Likely, both mechanical and 
extracellular matrix signalling are involved in parallel and interconnecting signalling pathways 
which communicate the exact type of environment that the stem cell is in and thus how it should 
behave. 
Focal adhesion kinase 1  (Fak1) is one of the key proteins at this intersection of extracellular 
matrix signalling and mechanical signalling. When transmembrane integrins bind an extracel-
lular matrix protein, Fak1—which is indirectly bound to the intracellular domain of the integrin 
via the protein paxillin—becomes activated  (Mitra et al., 2005). Fak1 subsequently activates 
the pro-growth protein c-Jun and Erk1 which in turn activates the actin polymerising proteins 
Rho kinase and Myosin II. Under conditions of increased matrix stiffness, the integrins cluster 
together, and thereby amplify Fak signal transduction  (Butcher et al., 2009). When this sig-
nalling pathway is inhibited, mesenchymal cells grown on different stiffness substrates can no 
longer respond to matrix  stiffness and differentiate as if they were on a soft matrix  (Engler et 
al., 2006).
Further factors mediate mechanotransduction to signal mechanical changes to the cell nucleus 
so that the cell can respond appropriately. Under conditions of low strain, the protein Yap1 
remains bound to the intracellular domain of the transmembrane E-cadherin  (Benham-Pyle et 
al., 2015). Under high mechanical strain, however, Yap1 is released from the cell membrane, 
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shuttles into the nucleus, and activates pro-growth signals. In the liver, when Yap1 is constitu-
tively active, the liver grows by as much as 4-fold, regardless of the mechanical strains of the 
chest cavity environment  (Camargo et al., 2007). In the CNS, neurons with re-activated Yap 
expression dedifferentiate and become expandable neural stem cells (Panciera et al., 2016). 
The nuclear lamina are similarly part of this mechano-transduction signalling cascade. There 
are two main components of the nuclear lamina: nuclear lamin A/C and nuclear lamin B. With 
increasing tissue stiffness, there is a concurrent increase in nuclear lamin A/C  (Swift et al., 
2013).  It is hypothesised that this increase is a protective measure, defending the nuclear DNA 
from shearing under high mechanical strain. Moreover, the authors show that nuclear lamin A/C 
acts as a tethering molecule that nucleates Yap1. Without this increase in nuclear lamin A/C, 
Yap1 cannot efficiently enter into the nucleus. 
Despite the field’s increased understanding of these mechanosensing signalling pathways, it 
remains difficult to wholly uncouple mechanical signaling from extracellular matrix protein 
signalling; all of these signalling cascades are highly dependent on both signalling mecha-
nisms.  The transmembrane gated ion channel Piezo1, however, is one of the only purely mech-
ano-sensing proteins that has been described. Only recently discovered  (Coste et al., 2010), 
Piezo1 and its homologues are highly conserved protein sequences that are present in the ge-
nomes of most multi-cellular organisms. No homologues have yet been discovered in bacteria. 
It is hypothesised that once multicellular organisms evolved, cells required a new method for 
sensing the 3-dimensional mechanical strain that uniquely occurs in multicellular organisms in 
order to coordinate growth and movement in the X, Y, and Z dimensions  (Soattin et al., 2016). 
The channel Piezo1 is embedded in the cell membrane, and upon mechanical strain is pulled 
apart to allow for an influx of ions. There, the ions act as secondary messengers communicat-
ing to the cell the mechanical strain of its environment. In developing zebrafish embryos, the 
loss of Piezo1 inhibits cell migration, induces cell crowding, and loses control of cell num-
bers  (Eisenhoffer et al., 2012). In mice, the double knock-out of Piezo1 is embryonic lethal 
(Li et al., 2014). With a homozygous knockout of Piezo1, the blood vasculature cannot form 
properly as blood endothelial cells do not spread out. Instead, they grow on top of one another 
without self-repulsion. In mammalian adult epithelial cells, Piezo1 similarly controls cell num-
bers  (Gudipaty et al., 2017). With epithelial wounding experiments, endothelial cells around 
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the wound site downregulate Piezo1. Once normal cell density is re-established, Piezo1 levels 
return to normal.  Additional mechanistic work has found that Piezo1 mediates the influx of 
calcium. This increased intracellular calcium activates calpain  (McHugh et al., 2010). Calpain 
subsequently activates integrin signalling, the phosphorylation of Fak1, and the activaction of 
Erk.  
Figure 5.  Canonical mechanosensing pathways. Cadherins are directly associated with Beta-catenin 
and Yap1. Under conditions of high strain,Yap1 and catenin are released from the nuclear membrane 
and enter the nucleus. Piezo1, under conditions of high strain opens, allowing for ions to enter the 
cytoplasm. There, they activate Fak which in turn activates Erk, Jun, and actin polymerisation. 
Increased actin polymerisation causes heightened strain on the nucleus, causing an increase in the 
protein nuclear Lmna. With increased Lmna, Yap1 enters the nucleus, there is increased heterochroma-




















Chapter 1: Introduction 45
The role of Piezo1 signalling in OPCs is unknown. Moreover, there is scant evidence that 
mechanics and mechano-transduction play any role in the ageing process. One recent paper 
shows that muscle matrix environment progressively stiffens with ageing and that aged muscle 
stem-cells cultured on hydrogels that mimic the stiffness of young muscle, re-activate aged 
stem cells (Lacraz et al., 2015). It is intuitive that matrix stiffness would change and affect 
stem cell function  in tissues such as skin, vasculature, muscle, or gut as these tissues undergo 
physical mechanical strain. The CNS, however, does not undergo such obvious physiological 
strains throughout adult life. As such, it remains unknown what role, if any, mechanosensing and/
or Piezo1 has on OPC function and regeneration. 
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Molecular interventions to ageing: genomic engineering in the adult
We are beginning to understand the ageing process of adult stem cells and its impact on over-
all organismic health. Until recently however, it has not been possible to modify the genome 
of an adult mammal to prolong life and healthspan. As such, most therapeutic strategies for 
age related-disease in humans have involved using small molecule drugs to target the relevant 
protein pathways.  In rodents, genome engineering has allowed for the generation of transgen-
ic animals, allowing for single specific genes to be silenced or overexpressed in a controlled 
manner in an adult. In order to understand whether genome engineering could ever be used as 
a molecular intervention for modifying the adult human, it is important to first understand the 
techniques that underlie the generation of transgenic animals. 
Upon DNA damage, a cell repairs the damaged DNA using one of two mechanisms: homolo-
gous recombination or the error-prone non homologous end joining  (NHEJ). Capitalising on 
this endogenous repair machinery, researchers generating transgenic animals would inject mod-
ified gene sequences flanked by tens of kilobases of site-specific homologous DNA sequences 
into embryonic stem cells (Capecchi, 1989). Cells with randomly damaged DNA at the exact 
loci of interest would undergo homologous recombination with the recombinant modified DNA 
fragment. This modified embryonic stem cell would then be selected for with a selection gene 
such as neomycin and injected into a blastocyst. If the blastocyst formed a chimera with the 
modified stem cells, then the postnatal mouse would have some gametes that contained the 
transgenes. In the second generation of mouse breeding, mice could be generated in which ev-
ery cell contained the modified DNA fragment. This process of genome engineering transgenic 
animals, however, was highly inefficient.
The reason for this inefficiency is largely due to the fact that a cell would have to undergo spon-
taneous DNA damage at the exact locus being targeted for DNA repair. Moreover, in the ma-
jority of cases, and except for when the cell is progressing through S phase of mitosis, ES cells 
repair DNA using NHEJ, not homologous recombination. To overcome these limitations, com-
plex genome modifying technologies, such as zinc finger nucleases and Tal-effector nucleases, 
were invented. Both technologies work by generating site-specific DNA breaks in order to force 
DNA repair at the sites. This way, cells more readily underwent homologous recombination at 
the exact site of interest, thereby incorporating the modified recombinant DNA fragment  (Ding 
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et al., 2013). However, this process which is involved in generating complex sequence-specific 
protein fragments to target DNA breaks at the location of interest and remained inefficient; only 
2% of transfected stem cells incorporated the recombinant DNA fragment at the correct loci. 
The development of CRISPR (clustered regularly interspaced palindromic repeat)/Cas9 tech-
nology has allowed for the rapid and efficient manipulation of the genome (Doudna and Char-
pentier, 2014) . The CRISPR/Cas9 system relies on two main components: the Cas9 protein and 
a small ≤100 base pair  (bp) guide RNA  (gRNA) (Fig. 6). The gRNA sequence is designed to 
bind, using Watson-Crick base-pairing, to any specific 20 bp region of the genome that is fol-
lowed on the 3’ side of the sequence by the three base pairs XGG  (AGG, TGG, CGG, or GGG) 
(Cong et al., 2013). The gRNA and Cas9 complex together and scan the genome until they find 
the complementary sequence to the gRNA target sequence. Part helicase and part nuclease, 
Cas9 unwinds the DNA as it scans for the gRNA target sequence and, upon binding, generates 
a double DNA strand break 3 base pairs upstream of the XGG site  (Mali et al., 2013). Using 
this approach, any sequence that is followed by an XGG sequence can be specifically targeted 
for DNA double stranded break. 
The CRISPR/Cas9 approach relies on the simple Watson-Crick base-pairing of only the 20 base 
pairs of the gRNA sequence, making it highly modular and easy-to-use for biologists. To gener-
ate gene knock outs, the Cas9/gRNA complex repeatedly cuts the target sequence site until the 
NHEJ machinery creates a gene knockout mutation. This mutagenesis technique is so efficient 
that, following one transfection of the Cas9/gRNA complex, almost 50% of the target gene 
sequences incur a gene-loss of function mutation  (Ran et al., 2013).  To insert a recombinant 
DNA sequence into a locus, the approach is similar to that of the original random integration 
techniques—recombinant DNA fragments are flanked by kilobases of DNA fragments that are 
homologous to the Cas9 targeted cut site. Upon a double stranded DNA cut by Cas9, the cell’s 
endogenous machinery incorporates the recombinant DNA fragment. In the first uses of this 
technology, almost 10% of the embryonic stem cells contained the recombinant DNA fragment 
(Mali et al., 2013). Follow up work using a small molecule that inhibits NHEJ machinery, 
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Figure 6.  Methods for modifying the genome using CRISPR/Cas9. CRISPR machinery is composed of 
Cas9 protein and a‘guide RNA’which binds to a region of interest in genomic DNA using Watson-Crick 
base pairing. Following binding to genomic DNA, Cas9 creates a double stranded break and the DNA can 
obtain insertions or deletions (Indels) following the non-homologous end joining (NHEJ) of the DNA. 
Harnessing cell’s endogenous DNA repair machinery, researchers can insert pieces into the DNA. Genom-
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forced cells to undergo homologous recombination, allowing for a sequence-specific, recombi-
nant gene knock-in efficiency of ~60%  (Maruyama et al., 2015). 
While the CRISPR/Cas9 system has allowed for efficient genome manipulation in fast-cycling 
ES cells, little work has gone into editing primary cells in vitro or in editing adult cells in vivo. 
One recent paper systemically delivered an adeno-associated virus (AAV) containing the Cas9 
gene and gRNA sequences to a mouse containing a frame-shift gene mutation in the gene 
dystrophin (Tabebordbar et al., 2016). This mutation, which occurs naturally in patients with 
Duschenne muscular dystrophy, causes widespread muscle wastage and shortened lifespan. 
Using two gRNA sequences that flank the mutation site, the researchers were able to excise the 
mutated DNA site, restoring proper protein synthesis and proper muscle physiology.
Only one paper has shown the ability to create systemic gene knock-ins in adult non-dividing 
cells using the CRISPR/Cas9 system  (Suzuki et al., 2016). In this work, the researchers gener-
ated gRNAs targeting the neuron-specific Tubb3 gene.  Simultaneously, the authors flanked a 
GFP gene with synthetic Tubb3 gRNA targeted sequences. At the same time that Cas9 cut the 
genomic Tubb3 site, Cas9 also cut either side of the GFP sequence, thus releasing the linear-
ized GFP sequence from the supplied plasmid DNA. Then, instead of relying on homologous 
recombination, which occurs in actively mitotic cells, the authors relied on NHEJ, the DNA 
repair method used in most adult mitotic cells. Doing so, they were able to knock-in the GFP 
sequence into the Tubb3 sequence in non-dividing neurons. Finally, the authors packaged this 
system into an adeno-associated virus and injected it systemically into an animal, showing, for 
the first time, site-specific genome corrections and knock-ins in the adult. 
Only one paper has used the CRISPR/Cas9 system in primary oligodendrocyte progenitor cells 
(Petersen et al., 2017). In this work, the authors use the system to partially knock down a 
specific gene in vitro. Whether or not the CRISPR/Cas9 system can be used for more compli-
cated genomic manipulations such as knock-ins, both in vitro and in vivo, in OPCs remains un-
known. Finally, whether in vivo CRISPR could efficiently target significant numbers of OPCs 
and thereby age-related pathways also remains unknown. To date, no group has proven that 
CRISPR can be used to target adult stem cells in vivo. Finally, due to the blood brain barrier, it 
remains unclear whether in vivo CRISPR of the adult/aged CNS is a feasible goal for the field 
of regenerative neuroscience. Such a technology would allow for the rapid dissection of genetic 
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pathways in the CNS, leading to the development of novel therapeutics targetting age related 
disease.   
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Aims and Objectives of this dissertation 
This literature review highlights a number of gaps in our understanding of oligodendrocyte 
progenitor cells in the adult and aged animal: The niche of the OPC, the signals that activate the 
OPC in homeostasis, the biophysical properties of the aged OPC niche, and finally, the under-
lying cause of OPC ageing all remain unknown. 
For these reasons, in this dissertation I set out to: 
1. Define the niche of the adult OPC and the signaling pathways that govern OPC activation. 
2. Characterize the regenerative capacity of aged OPCs following genomic reprogramming. 
3. Better understand the effect of the ageing OPC niche on OPC activity and function.
4. Develop a systemically administered CRISPR/Cas9 system that specifically targets OPCs 




Sprague Dawley rats, C57/B6 mice, and transgenic mice were bred in the Innes Building and the 
Stem Cell Institute Animal Facilities at the University of Cambridge. The transgenic Lgr5-CreERT2/
Td-tomato and the Confetti 2.0 mice were provided by Meritxell Huch of the Gurdon Institute (Huch 
et al., 2013; Livet et al., 2007). The Pdgfra-H2B animals were provided by Jenny Nichols of the Stem 
Cell Institute (Hamilton et al., 2003). The Sox10-Cre animals were originally provided by William 
Richardson lab of the University College London (Matsuoka et al., 2005). All animals were fed a 
standard choke diet, unless otherwise indicated, and were kept under a 12h dark 12h light cycle. All 
procedures were performed in accordance with the requirements and regulations of the United King-
dom Home Office.
Oligodendrocyte progenitor cell isolation protocol isolation protocol 
Neonate and adult OPCs were dissected from wild-type Sprague-Dawley rats or C57/Bl6 mice and 
sacrificed using overdose of pentobarbital; dissected whole brains were placed immediately in Hiber-
nate A Low Fluorescence media (HALF; prepared in-house) and placed on ice. The meninges were 
removed and the dissected brains were chopped using a scalpel. The HALF containing the tissue was 
placed into a 15mL falcon tube and spun for 2 minutes at 150g. The HALF media was aspirated, and 
the pelleted brain tissue was re-suspended in activated filtered dissociation media, added in equal vol-
ume to the volume of the pelleted tissue.  The brains were then placed on a 55 RPM orbital shaker at 
35˚ C for 30 minutes. The tissue was then centrifuged at 200g for 5 minutes, the papain was removed, 
and the brains were re-suspended in HALF media containing 2mM sodium pyruvate (Thermo Fisher; 
11360070), and 2% B27 (Thermo Fisher; 17504-001). Using a 5mL pipette, the dissected brains were 
gently titurated 10 times. Using fire polished pipettes of decreasing diameter, the brains continued to 
be titurated until appearing as a single cell suspension. The cell suspension was then passed through 
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70µM filter (Corning; 352350) to remove any remaining clumps of cells. To further remove debris 
from the cell suspension, 1 part 90% Percoll (GE; 17-0891-01), diluted in 10x PBS was added to 
3 parts cell suspension. The cell suspension was then spun at 800g for 20 minutes, re-suspended in 
Miltenyi washing buffer (MWB; prepared in-house), and counted. After being spun again for 7 min-
utes at 250g, the pelleted cells were re-suspended in 500µL MWB buffer and 2.5µL A2B5 antibody 
(Millipore; MAB312) per 1x107 cells. After a 30-minute incubation on a gentle rocker at 4˚ C, 5 times 
the volume of the cell suspension of MWB was added, and the cell suspension was spun at 250g for 7 
minutes. The pelleted cells were then re-suspended in 80µL MWB and 20µL MACs beads (Miltenyi; 
130-047-302). After a 30-minute incubation on a gentle rocker at 4˚ C, the cell suspension was centri-
fuged at 250g for 7 minutes and re-suspended in 1mL MWB. The cell suspension (max 5x108 cells) 
was placed in a MS column (Miltenyi; 130-042-201) on a MiniMACS Separator (Miltenyi; 130-042-
102), and washed 3 times with 500µL MWB buffer, waiting each time for the liquid to pass completely 
through the column. In one swift move, 1mL of MWB buffer was added to the column, the column 
was removed from the stand and placed atop a new collection tube, and the liquid was plunged through 
the column. The purified population of OPCs was then diluted and counted.
Maintenance and Differentiation of OPCs 
OPCs were plated at a density of 10,000 cells per 96-well (scaling linearly according to plate format) 
and fed on alternate days with OPC media (see media section) supplementing with 30ng/mL bFGF 
(Peprotech; 100-18b) and 30ng/mL PDGF (Peprotech; 100-13a). The cells were kept in an incubator 
at 37˚ C and 5% O2. 
To differentiate the cells, media was aspirated off the cells, and replaced with OPC media supplement-
ed with 40ng/mL Triiodo-L-Thyronine (Sigma, T2877). Media was replaced on alternate days for 7-10 
days. 
Media used for OPC isolation and maintenance are composed of the following: 
100mL of OPC Media: 100mL of DMEM/F12 (Thermo Fisher; 11039-021), 2mL sodium pyruvate 
(Thermo Fisher; 11360-070), 5mg apo-transferrin (Sigma; T2036), 1.35mL 10% D(+) glucose (Sig-
ma; G8644), 1mL SATO Stock Solution (see section below on SATO), 250µL insulin (Thermo Fisher; 
12585-014). 
50mL of SATO Stock Solution: 50mL DMEM/F12, 33mg/mL BSA fraction V (Sigma; A4919), 4µg/
mL Selenite (Sigma; S5261), 1.61 mg/mL Putrescine (Sigma; P7505), 4µg/mL Progesterone (Sigma; 
P0130). 
5L HALF Isolation Medium: 150.1mg Glycine (Sigma; G6201), 9.8MG L-ALANINE (SIGMA; 
A7627), 420.7MG L-Arginine hydrochloride (Sigma; A92600), 4.12mg L-Asparagine-H2O (Sig-
ma; A0884), 12.06mg L-Cysteine hydrochloride-H2O (Sigma; C7880), 209.6mg L-Histidine hydro-
chloride-H2O (Sigma; H8125), 526.1mg L-Isoleucine (Sigma; I2752), 526.1mg L-Leucine (Sigma; 
L8000), 583.3mg L-Lysine hydrochloride (Sigma; L5626), 149.9mg L-Methionine (Sigma; M9625), 
330.4mg L-Phenylalanine (Sigma; P2126), 38.569 L-Proline (Sigma; P0380), 210mg L-Serine (Sig-
ma; S4500), 474.8mg L-Threonine (Sigma; T8625), 79.6mg L-Tryptophan (Sigma; T0254), 360.6mg 
L-Tyrosine disodium salt dihydrate (Sigma; T1145), 470.6mg L-Valine (Sigma; V0500), 19.55mg 
Choline Chloride (Sigma; 26980), 9.53mg D-Calcium pantothenate (Sigma; C8731), 18.3mg Nia-
cinamide (Sigma; 1462006), 20.6mg Pyridoxine hydrochloride (Sigma; P9755), 16.9mg Thiamine 
hydrochloride (Sigma; T4625), 36mg i-Inositol (Sigma; I5125), .5mg Ferric Nitrate (Sigma; 254223), 
1997.9MG Potassium Chloride (Sigma; P3911), 369.9 Sodium Bicarbonate (Sigma; S5761), 25810mg 
Sodium Chloride (Sigma; S9888), 543.6mg Sodium Phosphate dibasic anhydrous (Sigma; 71640), 
.9633mg Zinc Sulfate (Sigma; Z4750), 22525mg D-Glucose (Sigma; g8270), 124.9 Sodium Pyruvate 
(Sigma; P2256), and 13465mg MOPS (Sigma M1254). Media was pH adjusted to 7.30 and filtered 
sterilized (Millipore; SCVPU02RE). 
MWB Washing Buffer: 10x PBS (Thermo Fisher; 70011-044), 2mM Sodium Pyruvate, 2mM EDTA 
(Thermo Fisher; 15575-020), 10µg/mL Insulin. 
Generation of varying stiffness polyacrylamide gels
Glass coverslips were washed sequentially in dH2O, 70% EtOH (Sigma; 459836), and .2M NaOH. 
Bottom cover slips were air-dried and pre-coated in 1.2% bind silane (Sigma; GE17-1330-01) in 95% 
EtOH and 5% glacial acetic acid (Fisher Scientific; 64-19-7), air dried, and subsequently polished 
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with lint free cloths. Top coverslips were submerged in 15% Sigmacote (Sigma; SL2-25ML) diluted 
in chloroform (Sigma; 288306) and incubated for 1 hour. Top coverslips were removed from the Sig-
macote solution and polished with a lint free cloth. To make a soft hydrogel 7% acrylamide (Sigma; 
A4058), 6% bis-acrylamide (Sigma; 146072), and 48 mM 6-Acrylamidohexanoic acid were combined 
in dH2O. To make stiff hydrogels, 14% acrylamide and 12% bis-acrylamide were combined with 48 
mM 6-Acrylamidohexanoic acid. The gels were formed by adding a final concentration of .004 g/mL 
TEMED (Sigma; T9281) and of .001 g/mL ammonium persulfate (Sigma; A3678) to the acrylamide 
solution. Acrylamide solution was rapidly pipetted onto the bottom glass coverslips and the hydro-
phobic top coverslip was placed on top. After 5 minutes, the top coverslip was removed with a scalpel 
and the bottom coverslip with the now polymerized hydrogel was washed 2 times in methanol. The 
hydrogels were rehydrated in PBS. 
To activate the hydrogels, they were incubated in 10mM MES hydrate (Sigma; M5287) with 500mM 
NaCl (Sigma; S9888) in dH2O (pH 6.1) for 10 minutes. To activate the functional group in the hydro-
gels, the gels were incubated for 30 minutes in 480mM N-Hydroxysuccinimide (Sigma; 130672) com-
bined with 200mM N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (Sigma; E7750) 
added to the Mes Hydrate solution. The gels were washed 1x in 60% MeOH in PBS and then covered 
overnight in 50µg/mL laminin (Sigma; L2020) diluted in pH 8.2 HEPES (Sigma; H3375). 
Atomic force microscopy 
Rats of different ages were anesthetized with 5% isoflurane and sacrificed by intraperitoneal (i.p.) 
injection of a lethal dose of pentobarbitone sodium (Euthatal). The brain was dissected out and placed 
into cold slicing artificial cerebrospinal fluid(Koser, Moeendarbary, Hanne, Kuerten, & Franze, 2015) 
(s-aCSF). One half of the brain was then glued onto a vibratome platform (VT1000 S; Leica Microsys-
tems) using superglue. 500 µm thick coronal sections of the brain were cut in cold s-aCSF bubbled 
with 95% O2 and 5% CO2 using one half of a Gillette 7 O’ Clock double edged razor blade. The 
frequency was set to 75 Hz and the forward speed to ~50 µm/s. Brain sections were transferred to a 
Cell-Tak-coated (Corning; 354240) 35 mm glass-bottom petri dish and covered with cold measuring 
artificial cerebrospinal fluid (m-aCSF). Subsequently, the samples were mounted on an inverted mi-
croscope (Zeiss; Axio Observer.A1) and constantly perfused with fresh m-aCSF bubbled with 95% 
O2 and 5% CO2.
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For blebbistatin treated AFM brains, fresh aged CNS was vibratomed as described and transferred 
into a 24-well plate containing m-aCSF and either DMSO or 5µM blebbistatin. The slices were then 
transferred into an incubator for 30 minutes and subsequently measured. 
AFM indentation measurements were performed as previously described. In brief, force distance 
curves were recorded using a JPK Nanowizard Cellhesion 200 (JPK Instruments AG) in a raster scan 
(stepsize = 100-200 µm) using tipless silicon cantilevers (rat brains: Arrow-TL1, spring constant = 
0.03 – 0.05 N/m; hydrogels: Sicon-TL, spring constant = 0.2-0.3 N/m; both from NanoWorld) with 
polystyrene beads (d = 37 µm; microParticles GmbH) glued to them. The maximum force was set to 
7 nN for brain measurements and 15nN for hydrogels, and the approach speed to 10 µm/s. Images 
were taken using a sCMOS camera (Zyla 4.2, Andor) mounted on a Zeiss Axio Zoom.V16 on top of 
the AFM setup. Using a custom algorithm (Christ et al., 2010) data was analyzed for maximum inden-
tation by fitting the force-distance curves to the Hertz model (Franze et al., 2011; Hertz, 1882; Koser 
et al., 2016).
with F = applied force, E = Young’s modulus, ν = Poisson’s ratio, r = radius of the probe, δ = inden-
tation depth, and apparent elastic modulus K=E/(1-ν^2). Intact brain and decellularized brain curves 
were analyzed for the full indentation depth at F = 7 nN, and curves from hydrogel measurements 
for 0.5µm indentation depth. The shear modulus G of the polyacrylamide gels was calculated using 
(Moshayedi et al., 2010) 
assuming  ν_PAA  ~ 0.5 (Boudou et al., 2006).
Sequencing and analysis of RNA
RNA was extracted according to the Directzol RNA MicroPrep Kit (Zymo Research; R2061) with the 
optional DNase treatment. RNA quality was assessed with a Bioanalyzer to ensure all samples had a 
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RIN value of ≥ 8.  DNA libraries were constructed using the SMARTer® Stranded Total RNA-Seq 
Kit - Pico Input Mammalian kit with multiplexed barcodes (Takara; 635005). 150 bp paired-end direc-
tional sequencing was performed on an Illumina HiSeq 4000.
Multiplexed samples were filtered, aligned to the rat UCSC rn6 assembly, normalized, and quantified 
using  Trimmomatic, Hisat2, Stringtie, and Ballgown using a previously pubished protocol (Pertea et 
al., 2016). Dendrogram clustering, t-distributed stochastic neighbor embedding, gene set enrichment 
analysis, and heatmaps were generated in ipython notebook using the libraries pandas, matplotlib, 
numpy, seaborn, gseapy, and scikit-learn.    
EdU incorporation assay, immunofluorescence, and imaging 
For the EdU incorporation assay, 10µM EdU was added into the cell culture medium for five hours, 
followed by the protocol provided by the Click-iT Plus EdU Alexa Fluor 647 Imaging Kit (Thermo 
Fisher; C10640). Otherwise, in vitro tissue culture cells were fixed in 4% Paraformaldehyde (Ther-
mo Fisher; 10131580) for 20 minutes at room temperature. The cells were then washed once in PBS 
(Thermo Fisher; BP3994) and then blocked in PBS with 0.1% Triton X-100 (Sigma; T8787) and 5% 
Donkey Serum (Sigma; D9663) for 30 minutes at room temperature. 
Fixed in vivo tissue sections were cryo-protected overnight in 20% sucrose (Sigma; S0389), embedded 
in OCT (VWR; 361603E), flash frozen in dry ice and cut in 12µM sections on a cryostat. Tissue was 
allowed to dry on a SuperFrost Plus slide (VWR; 48311-703). Slides were either stored at – 80˚ C until 
use. To stain, slides were brought to room temperature and  were placed in a slide chamber containing 
1x Citrate buffer (Sigma; C9999). The slide chamber was brought to 100˚ C for 30 minutes for antigen 
retrieval. Slides were then allowed to cool to room temperature and they were washed once in PBS. 
Fixed tissue for clearing was processed and stained as previously described(Susaki et al., 2015). Fol-
lowing perfusion and post-fixation, animal brains were sectioned using a matrix into 2mm thick sec-
tions and cleared using the CUBIC protocol. If additional immunostaining was required, tissue was 
stained according to the methods previously described using application-specific antibodies.  
For cryosections and immunofluorescence, primary antibodies diluted appropriately (see table of an-
tibodies) in PBS with 0.1% Triton X-100 and 5% Donkey Serum were then added to each well or 
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slide and they were stained overnight at 4˚ C. For most proliferation and differentiation assays, the 
antibodies for Olig2 and MBP were used. In cases when antibody species clashed, the Olig2-activated 
transcription factor Sox10 was used the identify oligodendrocyte lineage cells. 
The cells or slides were then washed twice for 10 minutes in PBS with .1% Triton X-100. For one 
hour, cells or slides were incubated in fluorescent secondary antibodies diluted appropriately in PBS 
with 0.1% Triton X-100 and 5% Donkey Serum. Cells or slides were again washed twice for 10 
minutes in PBS with 0.1% Triton X-100. For 10 minutes, cells were incubated with Hoechst 33342 
(Thermo Fisher; H1399) diluted 1:10000 in PBS. Slides were then mounted in mounting media with 
DAPI (Vectashield; H-1500). Cells and slides were stored in PBS at 4˚ C. 
Fixed, fluorescent cells or slides were imaged using the Zeiss Axio Observer or the Leica TCS SP5 
confocal microscope. As indicated, quantifications were performed either by eye or using high-con-
tent imaging and quantification, where appropriate. To perform high content analysis, 96 well plates 
were imaged using the GE InCell 2000. Fluorescence intensity thresholds for each stain were set from 
control samples and 42 images were randomly captured from each well. To process the images, pre-
set protocols from the open source software Cell Profiler were calibrated so that the software would 
not identify false positives. Quantifications were averaged across triplicate technical replicates. Au-
tomated quantifications were further validated and corroborated by manual quantifications of subsets 
of images.
Flow cytometry analysis of primary isolated OPCs was performed by fixing OPCs in suspension for 
20 minutes in 4% PFA. Following fixation, cell suspension was spun at 800g for 5 minutes, and the 
PFA was aspirated. The cell pellet was re-suspended in 0.1% Triton X-100 and 5% donkey serum 
in PBS and placed for 30 minutes on ice. The suspension was spun again and incubated in primary 
antibody diluted 1:300 overnight at 4˚ C. The cell suspension was washed twice by spinning the cell 
suspension, incubating it in 0.1% Triton X-100 in PBS for 10 minutes, and spinning again. After the 
second wash-spin, the cell pellet was re-suspended in secondary antibodies diluted 1:500 in 0.1% Tri-
ton X-100 and 5% donkey serum diluted in PBS and incubated on ice for 2 hours. The cell suspension 
was wash twice again for 10 minutes each and re-suspended in PBS. Flow cytometry was performed 
on the Attune NxT Flow Cytometer (Thermo Fisher).  
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qPCR and Western Blots 
Immediately following OPC isolation protocol, RNA was isolated from purified OPCs according to 
the Directzol RNA MicroPrep Kit (Zymo Research; R2061). RNA was stored at -80˚ C. cDNA was 
generated from the RNA according to the QuantiTect Reverse Transcription Kit’s instructions (Qia-
gen; 205310). For the RT-qPCR data, pre-designed primers (see table of primers used) were used at 
a concentration of 400µM and an efficiency of greater than ~98% were determined for each primer 
pair using serial dilutions of OPC cDNA. cDNA, primers, and the Syber Green Master Mix (Qiagen; 
204141) were combined according to the kit’s instructions, and RT-qPCR and melting curve analysis 
were performed on Life Technologies’ Quantstudio 6 Flex Real-Time PCR System.  
Immediately following OPC isolation protocol, protein was isolated from purified OPCs using Cel-
Lytic M (Sigma; C2978) protein extraction solution and a protease inhibitor (Sigma; P8340). Isolated 
whole protein content was measured using a BSA gradient kit (Bio-Rad; 500-0206), and gradient in-
tensity was quantified using Tecan’s Infinite 200 Pro Microplate Reader. 10µg of isolated protein was 
combined with 4X Bolt® LDS Sample Buffer (Thermo Fisher; B0007), brought to 95˚ C for 10 min-
utes and with the SeeBlue Protein Ladder (Thermo Fisher; LC5925) was run on Bolt 4-12% Bis-Tris 
Plus Gels (Thermo Fisher; NW04120BOX) in MES buffer (Thermo Fisher; B0002) for 35 minutes at 
165 V. Protein was transferred for 90 minutes at 100 V to a PDVF membrane (Millipore; IPSN07852) 
in transfer buffer (Bio-Rad; 161-0732) with 20% methanol (Sigma; 322415). PDVF membranes were 
blocked for 30 minutes with 50% Odyssey blocking buffer (Licor; 927-40100) in TBS (Thermo Fish-
er; BP24711) and 0.1% TWEEN 20 (Sigma; P2287). Primary antibodies were added at the proper 
dilution (see table of antibodies) to the blocking buffer, and membranes were left overnight in primary 
antibodies and blocking buffer at 4˚ C. Membranes were washed twice in TBS with TWEEN 20 for ten 
minutes each wash and near infrared species-appropriate secondary antibodies were added (see table 
of antibodies). Membranes were stained for two hours, washed twice in TBS with 0.1% TWEEN 20, 
and imaged on the Licor Odyssey Fc. 
Transplantation of labelled OPCs into Neonate
Neonatal and Aged OPCs were isolated in parallel using previously described MACs isolation proto-
col. Immediately following cell isolation, cells were labelled with Bacmam 2.0 CMV-GFP (Thermo 
Fisher; B10383) as per the manufacturer guidelines, and 300,000 cells were transplanted into the pre-
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frontal cortex of p1-p3 neonate pups using previously published coordinates(Khazipov et al., 2015). 
For proliferation analysis, 75 µg/g EdU (Abcam; ab146186) was injected I.P. 14-16 hours prior to 
perfusion fixation. 
Creating demyelinating focal lesions in vivo and delivery of small molecules 
Bilateral focal demyelinating white matter lesions were created by injecting 4µL of .01% ethidium 
bromide into the caudal cerebral peduncles of aged female rats (≥15 months) as described previous-
ly(Woodruff & Franklin, 1999). After 7 days post lesion, 4µL of 50 U/mL chABC (Sigma; C3667), 
50 U/mL of penicillinase (Sigma; P0389), or 5µM blebbistatin was injected into the lesion site using 
animal-specific injection-site coordinates. For proliferation analysis, 75 µg/g EdU was injected I.P. 
14-16 hours prior to perfusion fixation. Dr. Myfanwy Hill performed the lesions. 
For histological cryosections, animals were perfusion fixed with 4% paraformaldehyde at 21-days post 
lesion. For Toluidine blue stain and electron microscopy sections, animals were perfusion fixed with 
4% glutaraldehyde (Sigma; 340855), and sectioned into 1.5mm thick coronal sections. The sections 
were post-fixed in 1% osmium tetroxide (Sigma; 201030), dehydrated in graded concentrations of 
ethanol, and subsequently embedded in TAAB resin. The brains were sectioned into 1µM sections 
using a microtome and stained with Toluidine Blue O (Sigma; T3260) according to the manufacturer’s 
instructions.          
       
siRNAs, modified mRNA synthesis and transfection 
From cDNA, primers were generated containing the T7 promoter on the 5’ end of the target transcript. 
Immediately downstream of the T7 promoter we inserted a Kozak sequence consisting of GCCACC 
followed by the start codon ATG, and performed a standard 35 cycle polymerase chain reaction ac-
cording to the Phusion Polymerase kit (Thermo Fisher; F530S).  Using the PCR product, we then syn-
thesized the RNA using the synthesized DNA and HiScribe T7 ARCA mRNA Kit with Tailing (NEB; 
E2060S) with the addition of 5-Methylcytidine (Trilink; N-1014) and Pseudouridine (NEB; 1019). To 
determine fragment size of the synthesis product, we used the Quantitect Reverse Transcription Kit 
and ran the cDNA on a 1% Agarose gel (Thermo Fisher; 16500) at 100 volts for 30 minutes.
For a transfection of 1 well of a 96-plate-wells, each plated with 10,000 cells, .5 pmol of siRNA (GE; 
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D-001960-01-05) was combined with 1.5µL of Opti-MEM media (Thermo Fisher; 31985062). In a 
separate tube, 1.5µL of Opti-MEM media was combined with .15µL of Lipofectamine RNAiMAX re-
agent (Thermo Fisher; 13778030). The diluted RNAiMAX was then combined with the diluted RNA 
and incubated at room temperature for 20 minutes. Following the incubation, 3µL of the transfection 
combination was added to each well. 
For the transfection of modified mRNA a transfection of 1 well of a 96-plate-well plate, each plated 
with 10,000 cells per well, 25 ng per well of modified RNA was combined with 1.25µL of Opti-MEM 
media (Thermo Fisher; 31985062). In a separate tube, 1.25µL of Opti-MEM media was combined 
with .0375µL of Lipofectamine Messenger Max reagent (Thermo Fisher; 13778030). The diluted lipo-
fectamine was then combined with the diluted RNA and incubated at room temperature for 5 minutes. 
Following the incubation, 2.5µL of the transfection combination was added to each well. 
Generation of decellularized CNS scaffold 
CNS tissue of young and aged rats was dissected and immediately vibratomed in 500µM coronal 
sections in HALF medium on ice. Brains were decellularized using an adapted from .  Sections were 
immediately flash frozen at -80˚ C in dH2O. Sections were rapidly thawed at 37 ˚ C. Individual sec-
tions were transferred to a 24 well plate with 4% sodium deoxycholate (Sigma; D7650) for 2 hours and 
placed on an orbital shaker at 105 RPM. Sections were washed in 1x PBS with 1% penstrep (Sigma; 
P4333) for fifteen minutes on the orbital shaker. PBS was removed and 3% Triton X-100 in PBS was 
added onto the sections, again shaking for 1 hour on the orbital shaker at 105 RPM. Triton X-100 was 
then removed and replaced with PBS. These steps of sodium deoxycholate to PBS to Triton X to PBS 
were repeated 3 times. Finally, the sections were transferred into a 8µM pore cell culture insert (Corn-
ing; 353097) coated in Poly-D-Lysine (Sigma; P6407) and were incubated overnight in PBS with 1% 
penstrep with DNAse I (Sigma; 11284932001). The following day, the sections were washed 3 times 
more with PBS with 1% penstrep and finally the sections were incubated in OPC media with growth 
factors. Freshly isolated OPCs were pipetted into the insert. 
Calcium Imaging
Cells were loaded with 1µm Rhod2-am (ab142780) as per the manufacturers guidelines for 30 min-
utes. Cells were washed 2x in PBS, supplied with fresh media with growth factors and equilibrated in 
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the incubator for an additional 20 minutes.  Images were acquired every 20 seconds for the duration of 
ten minutes of spontaneous calcium flux. 
Generation and transfection of plasmids and/or minicircle vectors with Cas9, and transplantation into 
aged CNS 
Competent minicircle bacteria strain were generated from ZYCY10P3S2T minicircle bacteria (Sys-
tem Biosciences; MN900A-1). For non-minicircle vectors, competent DH5 alpha cells were used 
(NEB; c2987). Using Phusion polymerase (Thermo Fisher; F530S), PCR fragments with 20 basepair 
overlaps using the primers below and the pSpCas9(BB)-2A-GFP and pAi14-GFPNLS-MC plasmids 
were assembled using NEBBuilder HiFi DNA Assembly (NEB; E2621S) and gel extracted (Qiagen; 
28704).  pSpCas9(BB)-2A-GFP (PX458) was a gift from Feng Zhang (Addgene plasmid # 48138). 
pAi14-GFPNLS-MC was a gift from Juan Belmonte (Addgene plasmid # 87114). AAV-CMVc-Cas9 
was a gift from Juan Belmonte (Addgene plasmid # 106431). pCAG-Cre-IRES2-GFP was a gift from 
Anjen Chenn (Addgene plasmid # 26646). pUCmini-iCAP-PHP.eB was a gift from Viviana Gradi-
naru (Addgene plasmid # 103005). pHelper was a gift from CRUK.  All other non-plasmid derived 
sequences were ordered from Integrated DNA technologies and are included in the primers table. 
Minicircles were generated using previously described methods(Kay, He, & Chen, 2010) and plasmids 
were isolated with a Midi kit (Machery-Nagel; 740410.10). Plasmid sequences were confirmed using 
sanger sequencing. 
Capped Cas9 mRNA with modified base pairs (TriLink; L-7206), Tubb3 targetting crRNA:tracrR-
NA  (Dharmacon), and minicircle constructs containing reverse-strand Tubb3 target sequence were 
transfected into MACs sorted neonatal OPCs 24 hours after isolation using Lipofectamine LTX with 
plus reagent (Thermo Fisher; 15338100).  To test whether vector was successfully knocked-in, a U6 
forward primer along with 5’ flanking Tubb3 forward primer and a 3’ flanking Tubb3 reverse primer 
were mixed with genomic DNA isolated using QIAamp DNA Mini Kit (Qiagen; 51304) and fragments 
were assessed using gel electrophoresis. 
OPCs were dissociated from PDL plastic 96 hours following transfection using TrypLE Express 
(Thermo Fisher; 12604013), re-suspended in HBSS, and 400,000 cells were slowly injected into 14 
month-old females into grey matter in the prefrontal cortex using a Hamilton syringe and a stereotactic 
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frame. 13.5 days following transplantation, animals were injected with I.P. with 75µg/g body weight 
of EdU and on day 14 were perfusion fixed. 
Generation of Nested CRISPR Plasmids
AAV-CMVc-Cas9 was a gift from Juan Belmonte (Addgene plasmid # 106431). pCAG-Cre-IRES2-
GFP was a gift from Anjen Chenn (Addgene plasmid # 26646). pUCmini-iCAP-PHP.eB was a gift 
from Viviana Gradinaru (Addgene plasmid # 103005). pHelper plasmid was a gift from the Cancer 
Research United Kingdom viral core facility. 
Using the AAV-CMVc-Cas9 plasmid backbone and AAV2 ITR sequences, we cloned in the nested 
CRISPR system using NEBBuilder HiFi DNA Assembly. U6, gRNA, and Ribozyme containing se-
quences were ordered from Integrated DNA Technologies (see Sequence table), and cloned as previ-
ously described. 
Myc sequence was cloned from iPS cells (Gift of the Rowitch lab) and reverse transcribed with Pro-
toscript II (NEB; M0368S). 
Virus production protocol and in vitro, in vivo transfection, and spinal cord lesions. 
AAV production and purification followed the previously described protocol(Challis et al., 2018). 
In brief, HEK293 cells were grown in 15mm plastic dishes and triple transfected with the pHelper 
plasmid, the PHP-EB capsid plasmid, and the transgene plasmid. Five days later cells were lysed and 
virus was isolated using Optiprep density gradient medium (Sigma; D1556) and ultra-centrifuged at 
350000g. Viral layer was isolated and concentrated using Amicon Ultra-15 Centrifugal Filter Units 
(Sigma; Z648043-24EA). AAV titer was determined using SYBR green qPCR. For in vitro studies, 
mixed glia cells grown in 10% FBS in DMEM/F12 were infected with 100,000 viral genomes per cell 
per viral particle. Media was changed 24 hours later and cells were left for 96 additional hours with 
media changes every 48 hours. For in vivo administration of the virus, mice were restrained and 5E11 
viral genomes per virus were injected into the tail vein of 8 week old or 18 month-old C57/Bl6 mice. 
Spinal cord lesions were created by injecting 1% lysolecithin in PBS into the ventral white matter tract 
of the spinal cord.  21 days following tail-vein injection, mice were perfusion fixed. 
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For DNA/RNA extraction of CRISPR modified cells, DNA/RNA was isolated using TRIzol phase 
separation (Thermo Fisher; 15596026). All PCRs were performed using Phusion polymerase and In-
del analysis was peformed using Tide using the default parameters(Brinkman, Chen, Amendola, & van 
Steensel, 2014). 
Tissue Clearing, cleared staining, Light-sheet microscopy, and image analysis
Tissue clearing was performed using the CUBIC protocol, as previously described(Susaki et al., 2015). 
In brief, animals were perfused in 4% PFA and CNS was subsequently cut into 2 mm coronal slices 
using a brain matrix. Samples placed in a 48-well plate and were cleared for 3 days in the reagent 1 
solution of the CUBIC tissue clearing protocol. Following the reagent 1, samples were stained in 0.5% 
Triton with 0.5% BSA in PBS with the laminin antibody (see antibody table) at a concentration of 
1:300 for three days rotating on an orbital shaker at 37˚ C. Primary antibody was washed twice with 
0.5% Triton in PBS for two hours each rotating on an orbital shaker at 37˚ C. Slices were then incu-
bated in secondary antibody in 0.5% Triton with 0.5% BSA at a concentration of 1:300 for three days 
on an orbital shaker at 37˚ C. Finally, samples were again wash twice for two hours each, and placed 
into Reagent 2 of the CUBIC tissue clearing protocol. 
Samples were placed in 50% silicone oil (Sigma; 85409) and 50% mineral oil (Sigma; M8410), and 
mounted on a custom-built light sheet microscope. The microscope was built by Ruth Sims at Cancer 
Research United Kingdom and all images were acquired using a 20x objective. Image processing was 
performed using OpenSPIM and Clear Volume, both open source programmes and used in FIJI. 
Comet assay
For comet assays of freshly isolated OPCs approximately 5000 OPCs were resuspended in 100μl 
PBS and mixed with 300μl 1% low melting point agarose (37C). Cells were detached using TrypLE 
1x Select (Thermo Fisher; 12563011) for 8min at 37°C. The comet assay was then performed as de-
scribed31. Briefly, OPCs were centrifuged at 300g for 5 min. at room temperature and the cell pellet 
was resuspended with 100μl PBS and then mixed with 300μl molten low-melting point agarose (Ther-
mo Fisher; 16520-050) pre-incubated at 37°C. The cell-agarose suspension was then applied gently 
onto polysine slides that were pretreated with 1% agarose and allowed to solidify at 4°C. The slides 
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were submersed in alkaline cell lysis buffer (0.3M NaOH, 100mM EDTA, 0.1% (w/v) N-Lauroylsar-
cosine (Sigma; 61745), 1.2M NaCl in ddH2O) for 16 hours at 4°C in the dark. The slides were then 
electrophoresed in alkaline electrophoresis buffer (0.03M NaOH, 2mM EDTA, pH > 12.3, pre-chilled 
at 4°C) for 25min at RT with 1V/cm, whereby the cm were measured as the distance between the elec-
trodes. Finally, electrophoresed and propidium iodide (Thermo Fisher; P3566) stained DNA was im-
aged and 50-100 nuclei per animal were visually scored according to published protocols. Statistical 
significance was determined comparing respective damage categories between experimental groups 
by a two-tailed unpaired t-test. A significant result was assumed for p<0.05.
Animal models and Tamoxifen administration 
Confetti animals were oral-gavaged for 4 days with 40 mg/day of tamoxifen (Sigma; T5648). To 
induce long-term labelling of Lgr5-Cre animals, food pellets were replaced with colored tamoxifen 
food pellets (Envigo; 130856). For pre-weaned pups, tamoxifen pellets were given to the mother and 
tamoxifen was given to the pups via the mothers’ milk. 
Table of small molecules
Small Molecule/Re-
combinant Protein











Wnt 3a 50 ng/mL Peprotech 315-20
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Table of  antibodies
Antibody Dilution Provider Product Number
Rabbit α Olig2 IHC: 1:1000 Millipore ab9610
Rabbit α Ng2 IHC: 1:100 Millipore MAB5384
Rat α MBP IHC: 1:100 AbD Serotec MCA409S
Rabbit α Lmnb1 IHC: 1:1000 WB: 
1:5000
Abcam ab16048
Goat α Lmna/c IHC: 1:100 
WB:1:7500
Santa Cruz sc-20681
Mouse α Actin WB: 1:20000 Sigma 556321
Mouse α CC1 IHC: 1:300 Millipore MABC200
Goat α Sox10 IHC: 1:100 Santa Cruz sc-17342





IHC: 1:100 Sigma C8035
Rabbit α GFP IHC: 1:300 Abcam ab290
Rabbit α H3K9Me3 IHC:1:500 Abcam ab8898
Rabbit α Laminin LSFM: 1:300 Sigma L9393
Goat α Td-tomato IHC: 1:300 Scigen Ab8181
Alexa Fluor 594 Goat 
α Mouse IgM
IHC: 1:500 Thermo Fisher A-21044 
Alexa Fluor 488 
Donkey α Rabbit
IHC: 1:500 Millpore A21206
Alexa Fluor 594 
Donkey α Rabbit
IHC: 1:400 Molecular Probes A21207
Alexa Fluor 594 
Donkey α Goat
IHC: 1:500 Thermo Fisher A-11058
Alexa Fluor 647 
Donkey α Mouse
IHC: 1:500 Thermo Fisher A-31571
IRDye800CW D 
anti-Goat
WB: 1:10000 Li-Cor 926_32214
IRDye800CW D 
anti-Mouse
WB: 1:10000 Li-Cor 926_32212
IRDye600CW D 
anti-Rabbit
WB: 1:10000 Li-Cor 926_38073
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Table of  Primers








Lmna 5’ – ctacagcaaacactaag-
gaac – 
3’ 
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Pdgfra
gRNA 
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Table of  gBlock Fragments (IDT)
Descriptionn Sequence Provider 




































Dynamics between OPCs, niche, and progeny in the 
CNS
Oligodendrocyte progenitor cells (OPCs) continuously myelinate the central nervous system (CNS) 
throughout adulthood. Unlike other stem cells, however, the OPC in the adult has no defined niche. 
Moreover, the signals that underlie the OPC activation in CNS homeostasis remain unknown. Pre-
vious reports have found that in development, OPCs migrate along the blood vessels and spread out 
across the CNS (Tsai et al., 2016). Here, we find that OPCs remain on the blood vessels throughout 
adulthood, while their progeny, the oligodendrocyte, are localized to the brain parenchyma.  Using 
single cell sequencing and lineage tracing, we have identified Lgr5 as a marker for activated OPCs 
whose progeny delaminate from the blood vessel and differentiate into oligodendrocytes. Finally, we 
have identified Wnt3a and R-spondin to activate adult OPCs in vitro. 
Stem cells underlie homeostasis and repair in the adult. Most tissue-specific stem cells reside in a 
niche, an environment which protects and defines their stem cell identity (Spradling et al., 2008). It 
is thought that without a definite niche, stem cells would spontaneously differentiate causing wide-
spread stem cell depletion. Upon activation, the stem cells often exit their niche, and differentiate 
into committed post-mitotic cells (Hsu et al., 2011). For each stem cell population, the signals for 
the switch from stem cell quiescence to activation are unique, but Wnt, Notch, BMP, and Hedgehog 
signaling make an appearance in this activation process for many tissue-specific stem cells. 
In the central nervous system (CNS), there are two dominant stem cell populations: neural stem cells 
(NSCs) and oligodendrocyte progenitor cells (OPCs).  While NSCs are spatially confined within dis-
crete regions of the brain, OPCs are spread relatively  evenly across the CNS and make up 5-10% of 
the total number of cells in the brain (Barres et al., 1992). OPCs differentiate into oligodendrocytes 
well into adult rodent and human life, albeit in an age dependent manner (Hill et al., 2018; Yeung et 
al., 2014). In multiple sclerosis, this loss of OPC activity with ageing may well underlie the clinical 
phenotype of chronically demyelinated lesions (Goldschmidt et al., 2009). Moreover, it is increasing-
ly accepted that OPCs play a major role in normal cognitive functions and are the cell type underlying 
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complex psychiatric illness (McKenzie et al., 2014; Windrem et al., 2017). 
Despite their clinical relevance, little is known about the OPC niche or about the factors that cause 
OPCs to activate and differentiate into oligodendrocytes in the homeostatic CNS. In development, 
OPCs migrate along the blood vessels of the CNS (Tsai et al., 2016). Endothelial cells expressing the 
chemokine ligand Sdf1 bind OPCs via the chemokine receptor Cxcr4 and promote their migration. 
In the adult, however, the precise niche of OPCs remains unknown. While NSCs are known to have 
a niche on the blood vessel in the adult (Shen et al., 2008), it is widely believed that OPCs are evenly 
scattered throughout the parenchyma of the brain (Vanlandewijck et al., 2018). 
Here, using multiple lines of transgenic mice, brain clearing and light sheet microscopy, we take a 
macroscopic view of the CNS and find a vascular niche for OPCs across white and grey matter of 
the CNS. Using toxin-induced lesions and single cell sequencing, we identify the canonical stem cell 
marker Lgr5 to be significantly upregulated in activated adult OPCs. With lineage tracing of Lgr5 in 
adult mice we show that Lgr5 expressing cells live on the blood vessels while their oligodendrocyte 
progeny are in the parenchyma, thus establishing a spatially-defined stem cell lineage in the CNS. 
Finally, as Lgr5 is part of the Wnt signaling cascade, we find that Lgr5-agonist R-spondin and Wnt 3a 
can activate adult OPCs in vitro.  
While NSCs have been found to have a vasculature niche, OPCs have been reported as in the CNS 
parenchyma. Unlike NSCs which are regionally defined and differentiate in an uni-directional man-
ner, OPCs are spread throughout the entirety of the CNS, proliferating, differentiating, and migrating 
in the X, Y, and Z dimension. As such, to determine whether the OPC has a niche, we hypothesized 
that a macroscopic, multi-dimensional view of the CNS was required. To achieve this, we used thick 
2mm tissue, the CUBIC clearing protocol, and light-sheet microscopy of aged (≥14 months) Pdgfra-
H2B-GFP animals. We suspected OPCs may too have a vascular niche, so we began by optimizing the 
CUBIC clearing protocol using wild-type aged animals and subsequent immuno-staining blood vascu-
lature with laminin (Fig. 1a). We used aged animals because of previous reports that the GFP-histone 
fusion protein lingers in newly differentiated oligodendrocytes. As aged animals have low rates of de 
novo myelination, we hypothesized most GFP labeling would occur in OPCs themselves.
In 2-dimensional 12.5µM cryo-sections, we observed no immediate pattern in the GFP labelled cells 
(Fig. 1b). However, following tissue clearing, light-sheet microscopy, and 3-dimensional reconstruc-
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Figure 1. Adult OPCs have a vascular niche. a Tiled maximum projections across 2mm of CNS of 
laminin staining acquired from a custom-built light sheet microscope. Scale bar represents 50µm. b, 
Representative image of Pdgfra-H2B-GFP mouse cortex from a 12.5µm cryosection. Scale bar rep-
resents 100µM. c, Representative image acquired using light-sheet microscopy on Pdgfra-H2B-GFP 
cortex that had been cleared using the CUBIC protocol. Scale bar represents 100µM. d, Representa-
tive image acquired using light-sheet microscopy on Pdgfra-H2B-GFP cortex co-stained with laminin. 
Scale bar represents 50µM. e, Representative images of CUBIC cleared Pdgfra-H2B-GFP cortex that 
had been co-stained with Olig2 and Laminin. Scale bar represents 20µm. f, Histogram of the proportion 
of GFP-labelled cells within specific distances from laminin stained vasculature across multiple im-
aging planes. Averages represent the mean proportion of cells in given category from N = 3 biological 
replicates. Here, and throughout chapter, means represent quantifications of ≥200 cells quantified per 
replicate across ≥3 fields of view and  **** indicates a one-way ANOVA significance value of ≤.001. 
Images were acquired by Dr. Ruth Sims of Cancer Research UK.
tion we observed GFP cells clustering around vessel like structures across the CNS (Fig. 1c). With 
immunostaining of laminin, we confirmed that OPCs across the CNS cluster on laminin stained blood 
vessels (Fig. 1d). All cells were of the oligodendrocyte lineage as confirmed by Olig2 protein co-stain-
ing (Fig 1e). More than 80% of the labelled GFP cells were within 5µM of a given blood vessel, as 
measured from the center of the labeled nucleus to the blood vessel (Fig. 1f). For the first time, these 
results show that adult Pdgfra expressing OPCs associate with the CNS vasculature.  
A factor which confounds these observations is that the clearing process eliminates cells more distal 
to the blood vessel. To rule out this possibility, we did short term labelling (21 days post tamoxifen) 
of Sox10-CreER animals (Fig. 2a). Sox10 is a marker of the entire oligodendrocyte lineage, so we 
expected labelling of both oligodendrocytes and OPCs. Doing so, we observed bipolar, labelled OPC-
like cells clustering to the blood vessel while more complex structured oligodendrocyte-like cells were 
distal to the blood vessel (Fig. 2b-d). Quantifying the distance of the cells to the vessel, we found that 
of the entire Sox10 oligodendrocyte lineage, only ~20% of cells were on the vessel (Fig. 2e). These 
results bolster our claim that OPCs cluster on blood vessels while the differentiated cells are away 
from the vessel (Fig. 2f). 
We hypothesized that OPCs on the vessel upon activation in the homeostatic adult CNS would de-lam-
inate and subsequently differentiate into the myelinating oligodendrocyte. Unlike the stem cells of the 
intestine and the skin,  adult OPC activation in the homeostatic adult brain is a spatially and temporally 
rare event, making it a difficult process to study (Psachoulia et al., 2009). To understand the signaling 
pathways that underlie OPC activation, we re-purposed previous single cell sequencing data from our 
group performed by PhD student Natalia Deja. Her work, originally executed to discover the origin of 
Schwann cells in the CNS, experimentally activated OPCs by creating a focal area of demyelination 
in the adult rat caudal cerebellar peduncle using 0.1% ethidium bromide (Woodruff and Franklin, 
1999). This demyelinating injury model kills all oligodendrocytes and is followed by a period of 
remyelination, whereby OPCs migrate to the lesion, proliferate, and differentiate into new myelinat-
ing oligodendrocytes. Ten days following the lesion, the lesion site was vibratomed from fresh CNS 
tissue, dissociated, and FACs sorted for the OPC marker A2B5. Cells were subsequently single-cell 
sequenced. Using t-distributed stochastic neighbour embedding on sequenced single cells from both 
lesioned and un-lesioned brain, 3 populations of OPCs emerged: homeostatic OPCs, activated cycling 
OPCs, and committed differentiating OPCs (Data not shown). 
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Figure 2. Adult oligodendrocytes do not have a vascular niche.  a, Diagram outlining experimental strat-
egy for labelling oligodendrocyte lineage cells in Sox10-CreErt2/Confetti adult mice. b, Maximum pro-
jection of lightsheet microscope image across 500µm of laminin and GFP labelled cells 21 days following 
tamoxifen induction of the Sox10 driven cre-recombinase. c, Representative image of multi-processed 
Sox10 labelled oligodendrocytes (indicated by arrow) and laminin. d, Representative image of bipolar 
Sox10 labelled OPC closely associating with laminin stained vasculature. e, Histogram of the propor-
tion of GFP-labelled cells within specific distances from laminin stained vasculature across multiple 
imaging planes. Averages represent the mean proportion of cells in given category from N = 3 biological 
replicates. f, Cartoon diagram illustrating that undifferentiated OPCs remain closely affiliated with the 
vasculature while their differentiated progeny, the multi-processed oligodendrocyte, do not. Scale bars 
throughout the figure represent 50µm. Images were acquired by Dr. Ruth Sims of Cancer Research UK. 
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To determine the signalling pathways that underlie the activation of adult quiescent OPCs, we looked 
at the molecular signalling pathways most differentially upregulated in the activated lesion OPCs 
compared to the control un-lesioned tissue OPCs. Using KEGG pathway analysis, and found in Ms. 
Deja’s work, that the modulation in ß-catenin signalling is the most upregulated pathway involved in 
OPC cell activation. This KEGG analysis corroborates the finding that the canonical Wnt-pathway 
regulating transcription factor Tcf7l2 is the most upregulated gene in the activated lesion OPC cells. 
As Wnt signalling is the most enriched for pathway in activated OPCs, we hypothesised that adult 
OPC activation is mediated by Wnt signalling, and a Wnt pathway related cell-surface receptor may 
initiate the Wnt signalling cascade, ultimately leading to activation. From the gene set pathway analy-
sis, we identified the canonical stem cell activation gene Lgr5 to be amongst the most highly expressed 
of Wnt pathway genes in the activated lesion OPC population. The data is not shown in this thesis as 
the work forms the basis of Ms. Deja’s own PhD thesis.  
Lgr5 is a marker of stem cell activation in a number of stem cell niches, including the skin and the 
intestine (Buczacki et al., 2013; Jaks et al., 2008). The Lgr family of receptors regulate Wnt signalling 
strength by inhibiting molecular programmes that dampen  Wnt signal strength (Hao et al., 2012). Pre-
vious studies in postnatal development found Lgr5 expressing neurons in the developing cerebellum, 
but no follow up work has looked for a role of Lgr5 in the adult CNS (Miller et al., 2014). As Wnt 
signalling genes and Lgr5 are enriched for in activated adult OPC populations, we hypothesised that 
Lgr5 would be a marker for activating OPCs in the adult. To test this, we crossed mice that expressed 
the Cre-ER gene under the promoter of Lgr5 with Rosa26-stop-Td-tomato mice. At 3 months of age, 
we dosed the animals with tamoxifen 4 times. As OPC cycling can be up to 30 days in the adult brain, 
we hypothesised that we would need to lineage-trace for 30 days in order to label an activated OPC 
expressing Lgr5 (Fig. 3a). Following 30 days, we found a significant proportion of Olig2 expressing 
cells that were co-labelled with Td-tomato and a smaller proportion of cells co-labelled with Td-To-
mato, Olig2, and the oligodendrocyte intracellular marker CC1 (Fig. 3b-c). As such, we conclude that 
activated adult OPCs express Lgr5 and that oligodendrocytes generated in the adult derived from an 
Lgr5 expressing activated OPC. Finally, to confirm that Lgr5 expressing OPCs themselves remain on 
the blood vessel, we stained Lgr5 lineage traced tissue sections with laminin and found Lgr5+ OPCs 
to remain largely within 5µM of the blood vessel (Fig. 3d-e). Additional work is ongiong to confirm 
the role of Lgr5 as a marker of activated OPCs (see Discussion).  
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Figure 3. Activated homeostatic OPCs in the adult CNS express Lgr5. a, Diagram outlining strategy for 
Lgr5 lineage tracing in the adult mouse CNS. Lgr5 Cre-recombinase animals with floxed-stop Td-to-
mato were oral gavaged tamoxifen 4 times at 3 months of age. 4 weeks later the animals were perfusion 
fixed.  b-c, Representative images and quantifications of the proportion of Td-tomato, Olig2, and CC1 
co-staining across the cerebellum and the cortex. Scale bars represent 50µm. d-e, Representative im-
ages and distance quantifications between Td-tomato/Olig2 cells from the laminin vasculature. Scale 
bars represent 100µm. f-h, In vitro images of MACs sorted OPCs from adult Lgr5-eGFP animals show 
that after 24 and 96 hours of in vitro in growth factors, adult OPCs express Lgr5, as indicated by the ex-
pression of GFP. Scale bars represent 100µm. All quantifications represent mean proportion from N=3 
biological replicates. Animals were fed Tamoxifen by Dr. Björn Franklin of Robin Franklin’s group. 
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If Lgr5 expression is indeed a marker of OPC activation, we hypothesised that isolated adult OPCs 
in vitro would express Lgr5 after exposure to growth factors. To test this, we sorted adult OPCs using 
magnetic associated cell sorting (MACs) using the marker A2B5 from adult Lgr5-eGFP transgenic 
animals in which all Lgr5 expressing cells also express GFP. We observed that after 24 and 96 hours 
in vitro, most of the isolated OPCs were co-labelled with GFP and Olig2 (Fig. 3f-g). However, oligo-
dendrocytes, MACs sorted using the antibody MOG, were not GFP positive (Fig. 3h). These in vitro 
findings confirm our in vivo lineage tracing that Lgr5 expression is specific to activated OPCs, but not 
their progeny, the oligodendrocyte.   
If the activity of OPCs is indeed regulated by Lgr5-mediated Wnt signal strength, then agonists of the 
Lgr5/Wnt signalling pathways should activate adult OPC, causing them to both proliferate, delaminate 
from the blood vessel, and differentiate into de novo oligodendrocytes. Using publically available 
single cell sequencing databases of the adult human and mouse cortex, we identified multiple Wnts 
and R-spondins that are expressed across the CNS (Lake et al., 2018; Zeisel et al., 2015). We found 
most secretors of Wnt agonists to be Rbfox3 (Neun) expressing neurons. We identified Wnt 3a and 
R-Spondin-3 to be the most widely  expressed by neurons and oligodendrocytes across the adult CNS 
(Fig. 4a). R-Spondin-3 directly associates with and activates Lgr5 (de Lau et al., 2011). To understand 
whether these Wnt signals can modulate the activation state of OPCs, we MACs isolated 3 month-
old adult mouse OPCs with the OPC specific antibody A2B5. We then treated the OPCs with various 
concentrations of the Wnt agonists for 5 days in vitro (Fig. 4b). In low levels of growth factors Pdgf 
and Fgf, very low levels of adult OPCs proliferated as marked by EdU incorporation or differentiated 
into MBP expressing oligodendrocytes (Fig. 4c-f). Following treatment with R-Spondin-3 or Wnt3a, 
however, >15% of cells were proliferating as marked by EdU incorporation and >20% of cells spon-
taneously differentiated into MBP expressing multi-processed oligodendrocytes. We thus identify the 
Wnt pathway and its modulation by R-Spondin-3 or Wnt3a as a significant signalling pathway under-
lying adult OPC re-activation, proliferation, and differentiation.  
Discussion 
Here we report the finding that adult OPCs live on the blood vessels across the CNS, but their progeny, 
the oligodendrocyte, live off the vessel. To identify the signal that underlies the activation of the adult 
OPC, we performed single cell sequencing 14 days following a demyelinating lesion and found Wnt 
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Figure 4. Wnt agonists activate adult OPCs. a, R-Spondins and Wnts regulate activity state of adult 
OPCs. a, Re-analysed tSNE plots from previously published single cell sequencing dataset from adult 
mouse cortex (Zeisel et al., 2015). tSNE charts show that Wnt3a and R-Spondin-3 are the dominant 
Wnt pathway agonists in the adult CNS. Moreover, the charts show that Rbfox3 expressing neurons 
are the dominant cell type secreting these proteins. b,  A schematic outlining the experimental strategy 
for testing the effects of Wnt agonists on adult OPCs. Mouse OPCs were MACs sorted with the anti-
body A2B5 and plated in growth factors Fgf and Pdgf. Numerous Wnts and R-Spondins at varying 
concentrations were added in addition to the growth factors. c-f, Representative images and quan-
tifications of the effects of R-Spondin-3 (RSPO3) and Wnt3a on OPC proliferation, as indicated by 
the labelling of EdU, and on spontaneous differentiation of oligodendrocytes as indicated by co-ex-
pression of myelin basic protein (MBP) and transcription factor Olig2. Scale bars represent 50µm 
and  **** indicate a one-way ANOVA significance value of ≤.001. g, A schematic with the proposed 
model for the OPC niche in the adult brain. OPCs reside on the blood vessel. Upon activation with 
Wnt agonists such as R-Spondin-3 from the local niche, OPCs activate Lgr5, delaminate, and differ-
entiate into oligodendrocytes in the parenchyma. 
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signalling to be the most enriched for signalling pathway amongst activating OPCs. Specifically, we 
found the Wnt regulating receptor Lgr5 to be enriched for within this population. Using long term in 
vivo lineage tracing of Lgr5 we found that Lgr5 marks OPCs across the CNS and that the progeny of 
the Lgr5 expressing OPC is the oligodendrocyte. Finally, we found that the agonist R-Spondin-3 and 
Wnt3, proteins expressed by cells of the neuronal lineage, are sufficient to both proliferate OPCs and 
cause them to spontaneously differentiate into myelin expressing oligodendrocytes (Fig. 4g). Taken 
together, this work describes the niche of the adult OPC and shows Lgr5-mediated Wnt signalling as 
the activating pathway by which adult OPCs proliferate and differentiate in the CNS. 
The niche, adult stem cells, and plasticity
Previous work understanding OPC differentiation has focused largely on in vitro models using neona-
tal or embryonic-derived OPCs (Hubler et al., 2018). While these models have identified differentia-
tion signals that underlie developmental OPC differentiation programmes, it remains unclear whether 
these same pathways are relevant for adult OPC differentiation. One major difference between neo-
natal and adult differentiation pathways is that adult OPCs must first activate, exit quiescence, and 
then begin the molecular programmes that underlie differentiation; in vitro neonatal/embryonic OPCs 
already are actively progressing through the cell cycle. As such, developmental OPCs require only a 
differentiation, not an activation signal. 
We report that OPCs reside on the CNS vasculature, as they do in development (Tsai et al., 2016). Our 
study, however, does not identify the signal that causes OPCs to remain on the vasculature.  In de-
velopment, the chemokine ligand Sdf1 attracts OPCs to the endothelial cells of the brain vasculature. 
It remains unknown whether this mechanism for OPC homing to the vasculature remains relevant in 
adult OPCs. Follow up work must identify how the OPC remains on its vascular niche. 
Previous work in other tissues has revealed the role of the niche for maintaining cell ‘stemness’ and 
stem-cell identity (Cheung and Rando, 2013; Quarta et al., 2016). Without a proper niche, stem cells 
undergo cell cycle and spontaneously differentiate, thereby depleting the pool of resident stem cells. 
With ageing, the maintenance of the niche architecture is impaired thereby leading to the depletion of 
the stem cell itself (Lukjanenko et al., 2016). In previous studies, preventing OPC affiliation with the 
vasculature in neonatal development causes an accumulation of OPCs in the CNS parenchyma (Tsai 
et al., 2016). Whether or not the vascular niche maintains OPC identity throughout adulthood is an 
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area that must be actively pursued. Moreover, whether this vasculature niche changes with ageing may 
explain why OPC plasticity is lost with ageing in the context of remyelination.  
Here we also show that the main cell bodies of oligodendrocytes themselves are not on the blood 
vessel. These results suggests a oligodendrocyte lineage hierarchy wherein OPCs are on the blood 
vessel while oligodendrocytes themselves are in the parenchyma. However, it remains unknown how/
whether the OPC delaminates from the vessel to form a myelinating oligodendrocyte. It is possible 
that OPCs enter into the cell cycle on the blood vessel and that the daughter cell is then positioned 
distal to the blood vessel. Alternatively, the OPC itself may delaminate from the vasculature, activate, 
and then differentiate into an oligodendrocyte. 
A major limitation of our study is that we do not provide direct evidence that oligodendrocytes them-
selves are in the CNS parenchyma—not on the vasculature. Rather, we used a Sox10 transgenic mouse 
that labels all oligodendrocyte lineage cells to show that some oligodendrocyte-lineage cells are not 
associated with the vasculature. We then conclude, based on the evidence from the transgenic Pdgfra 
OPC-labelling mouse, that while OPCs are largely on the niche, many cells in the oligodendrocyte 
lineage are not. However, additional evidence is required to bolster the claim that oligodendrocytes 
themselves are not on the vasculature. Future work must use a transgenic oligodendrocyte-specific 
labelled mouse to that oligodendrocytes reside in the CNS parenchyma. Combined with our Pdgfra 
results, such a finding would confirm that these two cell types in the oligodendrocyte-lineage have 
spatially distinct niches.
Previous work has shown that OPCs undergo both symmetric and asymmetric division (Zhu et al., 
2011). This would suggest that OPCs can either delaminate and subsequently activate or undergo 
mitosis, producing differentiating daughter cells that are distal to the blood vessel. The only available 
studies, however, examine OPCs in postnatal development and not in the homeostatic or lesioned 
adult brain. Moreover, these previous studies assume that all Ng2, Pdgfra expressing OPCs across 
the CNS, are the bona fide stem cell population. In the intestinal crypt and the hair follicle, the long-
term stem cell can both symmetrically and asymmetrically divide  (Hsu et al., 2011; Snippert et al., 
2010). As such, OPCs likely also both symmetrically and asymmetrically divide. Current work in our 
group is looking at the clonal dynamics of Pdgfra expressing OPCs in the homeostatic CNS. Using 
Pdgfra-CreER animals crossed with animals with the Confetti 2.0 construct, we are using light sheet 
microscopy and laminin immunostaining to better understand the clonal dynamics of OPCs in relation 
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to the vascular niche. 
Wnt signalling from the niche
Here we have shown that Lgr5 mediated Wnt signalling underlies the activation of OPCs in the con-
text of the lesion, that activated OPCs express in vivo express Lgr5, and that certain R-Spondins and 
Wnt proteins drive adult OPC activation in vitro. Using previously published single cell sequencing 
databases of adult cortex, we found that Rbfox3 expressing neurons express the agonists for Lgr5 and 
Wnt signalling pathways. The gene expression data suggests a previously undescribed relationship 
between neurons and OPCs. Previous reports have documented that OPCs themselves form synapses 
with neurons and that glutamate at least in vitro can stimulate neonatal OPC activity (Bergles et al., 
2000; Lin and Bergles, 2004). This work, however, does not explore any other signalling pathways 
that may facilitate a neuron-OPC relationship. Moreover, this work does not look at the interaction 
between these cell types in the adult. 
It remains unclear whether Lgr5 itself is important for the functioning of OPCs or whether it is simply 
a marker for OPC activation. In the intestine, conditional adult knockout of Lgr5 in the crypt stem 
cell niche revealed no obvious phenotype (de Lau et al., 2011). This is likely due to the fact that Lgr 
homologues Lgr4/6 compensate for the loss of Lgr5 expression. Deletion of both Lgr4/5 in the crypt 
cell, however, leads to a loss of cell proliferation. In the CNS, Lgr5 has been found as a marker for 
gliobastoma (Nakata et al., 2013). The higher expression of Lgr5 correlates with a more adverse pa-
tient outcome. In keeping with this, we find that Lgr5 upregulated in activated OPCs; in both cases the 
expression of Lgr5 is correlated with proliferating glial cells. Future work will seek to determine the 
precise role Lgr5 plays in Wnt signal modulation and in the activation of OPCs. 
A major limitation of this study is that our in vivo Lgr5 lineage tracing is short-term, based on one 
age-group, and largely correlative. Indeed, we show that OPCs in the CNS are the dominant cell type 
labelled by Lgr5, but additional lineage tracing experiments are required to bolster our claim that 
Lgr5 is an activation marker specifically for adult OPCs. A major question is whether Lgr5 is an im-
portant marker for activating OPCs in post-natal development. To test this, we have recently begun 
an experiment in which neonatal transgenic mice have been given tamoxifen for 30 days. If Lgr5 is 
a marker for active OPCs in development, then we would expect all oligodendrocytes to stem from 
Lgr5 expressing OPCs. If we do not observe widespread oligodendrocyte labelling with RFP, then we 
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would have found a novel marker distinguishing active adult OPCs from active neonatal developmen-
tal myelination. 
In this chapter, I claim that OPCs but not differentiated oligodendrocytes express Lgr5 in the adult 
CNS. To show this, I co-stained sections from the Lgr5-Cre transgenic animal Olig2 and CC1. I found 
that the dominant cell type labelled with RFP are Olig2+ but CC1- OPCs. With lineage tracing, I 
found a small subset of differentiated oligodendrocytes labelled with RFP. I claim that these differ-
entiated oligodendrocytes must stem from a Lgr5 expressing OPC. However, I provide no evidence 
that these differentiated oligodendrocytes no longer express Lgr5. A necessary future experiment will 
be to use the Lgr5-eGFP-Cre mouse in which all Lgr5 expressing cells express GFP and RFP while 
the progeny of Lgr5 expressing cells only express RFP. With our working hypothesis, this mouse 
model would show that active OPCs themselves are both GFP and RFP, meaning that they are at the 
moment expressing Lgr5, while oligodendrocytes themselves are only RFP expressing, meaning that 
oligodendrocytes stem from an Lgr5 expressing OPC, but themselves no longer express Lgr5. Such 
experiments are required to confirm the claim that Lgr5 specifically label active OPCs, not oligoden-
drocytes, in the adult CNS.   
Throughout the chapter, I claim that Lgr5 labels active OPCs. However, I do not provide evidence 
showing that all active OPCs, rather than a subset, express Lgr5. To show that active adult OPCs ex-
press Lgr5 in the adult, experiments are currently ongoing in which we crossed Lgr5-Cre-ER mice 
with Sox10-flox-DTA animals. This way, all cells that are Lgr5, Sox10 co-expressing will be ablated 
with the diphtheria toxin (DTA) when the animal is fed tamoxifen. In these adult transgenic mice, we 
created an area of focal demyelination in adult mice and fed the mice tamoxifen. If our hypothesis is 
correct, then active Lgr5/Sox10 expressing OPCs in the lesion area will be ablated and remyelination 
will fail to occur. If this is the case, then we can confirm that all active OPCs express Lgr5 and that 
without this population of cells, adult myelination/remyelination cannot occur. 
In the intestine, the Paneth cells are one of the major cell types of the epithelium. Paneth cells secrete 
Wnt and R-spondin and thereby signal to the intestinal Lgr5-expressing crypt stem cell to self-renew 
and differentiate into new intestinal epithelium (Sato et al., 2011). By secreting Wnt agonising pro-
teins, the Paneth cell regulates the numbers and activation state of the resident stem cell population. 
It is therefore conceivable that the neuron in the CNS plays a similar role to the Paneth cell in the 
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intestine. As neurons require myelination for efficient signal transduction and for trophic support, it 
follows that the neuron itself contains the secretory proteins that signal for additional myelination. As 
such, the neuron secrete these Wnt agonising proteins, stimulating local vasculature associated OPCs 
to activate and differentiate into novel myelinating oligodendrocytes. Future work must determine the 
distribution of the various cells within the CNS; only by fully understanding the spatial distribution 
of adult CNS cells can we fully define the niche of the OPC and thereby understand the inter-cellular 
milieu of signals that may underlie the activation of adult OPCs. 
With the growing belief that adaptive myelination is a mode by which learning and memory occur in 
the adult CNS, it is now important to understand the exact signals by which this process takes place. 
Following on from this work, we hope to inhibit the secretion of Wnt agonists by the neuron in the 
adult. Doing so, we will be able to determine whether adult de novo myelination will be able to occur 
even in the absence of neuron-derived Wnt signalling. Conversely, we would hyper-activate neu-
ron-driven Wnt signalling by knocking down Wnt signalling antagonist Gsk3ß and determine whether 
adult OPCs hyper-activate, proliferating at higher numbers and hyper-myelinating the CNS. 
With this work, we have begun to elucidate the stem cell niche and activating factors that cause OPC 
activation in tissue homeostasis and in injury. We position the OPC as a bona fide stem cell population 
in its niche. Looking forward, we hope to investigate the mechanisms of other, better-characterised 
stem cell niches and apply them to the oligodendrocyte lineage. Doing so, we hope to better under-
stand the adult OPC in its niche with the goal of developing new therapies to promote myelination/
re-myelination in the adult CNS. 
 
Chapter 4
Tissue stiffness contributes to the ageing of central ner-
vous system progenitor cells
Ageing causes a decline in tissue regeneration due to a loss of function in adult stem and progen-
itor cell populations (Goodell and Rando, 2015). An important example is the deterioration of 
the regenerative capacity of the widespread and abundant population of central nervous system 
(CNS) multipotent stem cells known as oligodendrocyte progenitor cells (OPCs) (Sim et al., 
2002). A relatively overlooked potential source for this loss of function is the stem cell niche, a 
source of cell-extrinsic cues including chemical and mechanical signalling (Gopinath and Ran-
do, 2008; Swift et al., 2013). In this study, we show that the progenitor microenvironment stiff-
ens with age, and that its stiffening is sufficient to cause the age-related loss of OPC function. 
We use biological and novel synthetic scaffolds to mimic the stiffness of young brain and find 
that isolated aged OPCs cultured on these scaffolds are functionally and molecularly rejuve-
nated. When we disrupt mechanotransduction, OPC proliferation and differentiation rates were 
increased in vitro and remyelination accelerated in vivo. We identify the mechanoresponsive ion 
channel Piezo1 as a primary mediator of OPC mechanical signalling. Inhibition of Piezo1 over-
rides environmental mechanical signals in vivo and allows OPCs to maintain activity in an aged 
CNS. We demonstrate that tissue stiffness is a primary regulator of aging in OPCs, and provide 
new insights into how adult stem and progenitor cell function changes with age. 
The ageing of adult stem and progenitor cells lies at the heart of the ageing process. In the aged 
CNS, efforts to reverse progenitor cell ageing have involved restoring genomic stability by over-
expressing telomerase or promoting histone deacetylation to increase neuro- and glio-genesis 
(Jaskelioff et al., 2011; Shen et al., 2008). Cell-extrinsic factors such as exercise can stimulate 
aged CNS progenitor cell proliferation and differentiation in vivo (Yau et al., 2012), while ex-
posure to blood borne factors and cells from young adult circulation can enhance progenitor 
differentiation and CNS remyelination in vivo (Ruckh et al., 2012). Despite these advances, 
the mechanisms of OPC ageing, including the bridge between cell extrinsic and cell intrinsic 
factors, remain elusive. 
A prevailing theory is that a loss of growth factor exposure underlies progenitor cell quiescence 
in ageing (Hinks and Franklin, 2000). To test this theory, we magnetic bead-purified neonatal 
(≤P7) and aged (≥20 months) primary rat OPCs of over 88% purity using the OPC specific 
marker A2B5 (Fig. 1a) and cultured them in conditions known to enable self-renewal of iso-
lated neonatal progenitor cells on poly d-lysine (PDL) coated tissue culture plastic (Tang et 
al., 2001). Only 5% of aged OPCs proliferated even after 5 and 14 days of in vitro culture, as 
labeled by EdU incorporation (Fig. 1b). In the same conditions after 5 days in vitro, over 35% 
of neonatal OPCs proliferated under the same conditions (Fig. 1c). 
In order to first determine whether this apparent loss of proliferation in aged OPCs is reversible, 
we labelled aged OPCs (≥20 months) with GFP using a baculovirus, a virus which can infect 
cells in a matter of hours. This property of the virus allowed for cells to be isolated, infected, 
and re-transplanted in the same day. The cells were then transplanted into the prefrontal cortex 
of postnatal day 1 neonatal rats and 9 days later identified proliferating cells by EdU injection 
(Fig. 1d). After 10 days in vivo, transplanted aged OPCs regained their capacity to both prolif-
erate, as labelled by EdU incorporation, and differentiate, as labelled by coexpression with the 
oligodendrocyte differentiation marker CC1 (Fig. 1e-h). Transplanted aged OPCs proliferated 
and differentiated at rates comparable to transplanted age-matched neonate controls. Both aged 
and neonatal OPCs remained of the oligodendrocyte lineage as determined by lineage marker 
Olig2. By comparison, there were no proliferating progenitors in the CNS of the aged animal 
litter-mates (Fig. 1i), and as shown later in the chapter, neonatal OPCs transplanted into aged 
brains lose their self-renewal capacity. Therefore, aged OPCs can become activated in the neo-
natal niche but not in their native niche or in vitro even with high concentrations of FGF and 
PDGF, the growth factors sufficient for young adult OPC proliferation. 
The cell niche, the microenvironment in which OPCs reside, is a key factor in the regulation of 
OPC ageing (Gopinath and Rando, 2008; Keough et al., 2016). Given that aged OPCs regain
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Figure 1.  Dynamics of OPC activation, in vitro and in vivo. a, Flow cytometry analysis on MACs 
purified OPCs confirm that we are able to isolate a pure population of Olig2+/Ng2+ OPCs from both 
neonate and aged brains. b, EdU labelling of OPCs after 1 and 2 weeks in vitro. c, Quantifications of 
N=3 replicates of neonatal and aged OPCs in proliferation conditions on PDL coated tissue culture plas-
tic after 5 days. d, Schematic of transplantation. e-h, Representative images and quantifications of the 
proliferation and differentiation rates of transplanted neonatal and aged OPCs in the prefrontal cortex 
14 days following transplantation. Unless otherwise indicated, throughout the text proliferating cells are 
quantified as the proportion of EdU+ out of total Olig2+/GFP+ transplanted OPCs, and differentiated 
cells are quantified as a proportion given in the figure, in this case the proportion of CC1+ out of total 
GFP+/Olig2+ cells. Arrows highlight example positive cells. Averages represent N = 4 biological repli-
cates, error bars represent standard deviation throughout the text. i, Representative image of 16 month 
old female white matter and grey matter with triple labelling of Olig2, EdU, and CC1. Throughout fig-
ure,  scale bars represents 50µM. Here and in all points in the text and figures, P-value significance is 
calculated by one-way ANOVA and indicated by ***, **, and * representing < 0.001, < 0.01, and < 0.05, 
respectively. Here and throughout chapter, ≥200 cells were counted per biological replicate. 
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their proliferation and differentiation capacity in the neonatal niche, we next asked if chang-
es in the tissue microenvironment underlie the observed differences in OPC activation state. 
To address this question, we generated decellularized brain scaffolds of neonatal and aged rat 
brains with a protocol using freshly vibratomed brain slices (Fig. 2a-b)(De Waele et al., 2015). 
Immunostaining of this decellularized brain ECM confirmed significant changes in chondroi-
tin sulfate proteoglycan (CSPG) with age (Végh et al., 2014) (Fig. 2c). We then seeded aged 
OPCs on both neonatal and aged decellularized brain ECM (Fig. 2d). Aged OPCs seeded on 
neonate decellularized brain ECM showed a more than 10-fold increase in their proliferation 
rate compared to aged OPCs seeded on aged ECM (Fig. 2e-f). When placed in differentiation 
conditions with T3, aged OPCs seeded on neonate decellularized brain ECM also had a greater 
than 10-fold increase in their differentiation rate compared to that of aged OPCs seeded on aged 
decellularized brain ECM (Fig. 2g-h). Neonatal OPCs lost their proliferative capacity when 
seeded on aged ECM but not on neonate ECM (Fig. 2i-j). 
As the ageing ECM negatively effects the activity-state of OPCs, even in the presence of growth 
factors, we hypothesized that digesting the ECM of the aged CNS would activate aged OPCs. 
Previous work has shown that the glycosaminoglycan degrading enzyme chondroitinase ABC 
(chABC) efficiently digests this dominant CNS ECM molecule (Keough et al., 2016). To assess 
whether disrupting ECM mechanics with chABC in the aged CNS enhances OPC regeneration, 
we generated focal areas of demyelination in aged (≥18 months) rats using a well-established 
lesion model (Fig. 3a-b). Following injection of chABC directly into the area of demyelination 
at day 7 there was a ~3 fold increase in both EdU+ OPCs and in Olig2+/CC1+ differentiated 
oligodendrocytes at 14 days post lesion (Fig. 3c-f).  These results showed that the ECM itself 
has an inhibitory role in the function of ageing OPCs. 
Alterations in chondroitin sulfate levels in frog brain tissue cause changes in its mechanical 
properties in vivo (Koser et al., 2016), suggesting that brain mechanics may change during age-
ing.  In agreement with this hypothesis, brain tissue stiffens progressively as rats develop from 
neonates into adults (Elkin et al., 2010). We therefore asked if the CNS continues to stiffen with 
ageing. To address this, we determined the apparent elastic moduli of fresh brain sections of 
rats of different ages using atomic force microscopy (AFM) (Fig. 4a) and found that, in the pre-
frontal cortex, both white and grey matter progressively and significantly stiffened by a factor 
of ~2.5 with ageing (Fig. 4b-f, decellularized ECM in Fig. 4g). This increase in ECM stiffness 
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Figure 2.  The neonatal CNS matrix restores the function of aged OPC. a, A schematic overview of 
the decellularization protocol. b, A DAPI staining following the decellularization protocol shows no 
remaining nuclear DNA, indicating complete cell removal. Scale bar represents 200µM. c, Rat brains 
of different ages were decellularized, fixed, and stained for chondroitin sulfate proteoglycans (CSPGs) 
show that extracellular matrix remains intact following the decellularization protocol. Scale bar repre-
sents 20µM. d, A schematic of the re-cellularization protocol. OPCs are MACs purified using the OPC 
surface marker A2B5, cultured for 5 days in proliferation conditions. A subset of these brain ECM are 
fixed with PFA and the remaining brain ECM are placed into differentiation conditions for 5 days. e-j, 
Representative images and quantifications of the proliferation and differentiation rates of aged and neo-
natal OPCs seeded onto both neonate and aged (≥18 months) decellularized ECM. Scale bars represent 
50µm. Averages represent means from N=3 biological replicates.  
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Figure. 3. Chondroitinase chABC enhances activation of OPCs in aged lesions. a, A schematic overview 
of the lesioning and subsequent injection of small molecules into the lesion site. b, Representative traces 
of CCP lesions. Scale bar represents 100µM. c-f, Representative images of proliferating and differen-
tiating cells per mm2 of CCP lesion cores 14 days post lesion and 7 days post direct injection of peni-
cillinase/chABC into N=4 aged females (≥ 18 months). Scale bar represents 100µM. Here and through 


























































































































































Figure 4. Rat brain tissue stiffens with ageing. a, A schematic of the preparation of brains for AFM. 
b, Global apparent elastic moduli K (Pa) of brains at different ages determined by AFM indentation 
measurements. Shown are means of 3 sections from 3 animals each. c, Representative stiffness maps of 
a neonate (~7 days post natum) and an aged brain (~455 days post natum). Scale bar represents 50µm. 
d, Regional mean stiffness values calculated by mapping AFM measurements to brain slice. e-f, Both 
grey and white matter stiffen progressively with ageing. Mean apparent elastic modului K are reported 
across N=3 brain slices across N=3 animals. g, Atomic force microscopy mean stiffness values of N=2 
neonate and N=2 aged decellularized brain ECM confirm that decellularized brain ECM, too, stiffens 
with ageing.
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with ageing mirrors the increase in genes associated with the cytoskeleton that occurs in adult 
OPCs compared to neonatal OPCs (Moyon et al., 2015). 
Changing the stiffness of the cell niche is known to lead to alterations in the levels of pro-differ-
entiation signals in some stem cell systems(Swift et al., 2013), and the mechanical properties of 
the environment are known to modulate neonatal OPC function in vitro (Jagielska et al., 2012). 
These results led us to hypothesize that the observed increase in brain stiffness alone might be 
sufficient to cause the reduced proliferation and differentiation rates of aged CNS progenitor 
cells.
To test our hypothesis, we developed synthetic polyacrylamide hydrogels to mimic the stiff-
ening of the ECM with age. These hydrogels were specifically designed to present the same 
ECM composition and density to the cells independent of stiffness, enabling the investigation 
of cellular changes due to mechanical signals alone. Only ~5% of aged OPCs plated on stiff 
hydrogels proliferated (Fig. 5a-c); however, ~55% of aged OPCs plated on soft hydrogels un-
derwent proliferation. Moreover, under differentiation conditions, only ~5% of aged OPCs dif-
ferentiated into myelin basic protein (MBP) expressing cells on stiff gels, while more than 50% 
of aged OPCs on soft hydrogels differentiated into MBP expressing oligodendrocytes (Fig. 
5c-e).  In contrast, neonatal OPCs, similar to aged OPCs, lost their capacity to proliferate and 
differentiate on stiff substrates (Fig. 5f-i). 
The loss of proliferation was surprising given that neonatal OPCs can proliferate on poly d-ly-
sine (PDL)-coated tissue culture plastic. However, we observed that the long-term activity of 
neonatal OPCs on PDL-coated plastic was isolated to spheres that detached from the substrate, 
suggesting that PDL-coated plastic itself may not be sufficient for maintenance of OPC activity 
but relies on the instability of ECM attachment (Fig. 5j). The hydrogels, on the other hand, have 
covalently bound ECM and are therefore stable long-term, with no floating spheres observed.
  
The stiffness-mediated activation of aged progenitor cells was independent of seeding density, 
and the high levels of proliferation were lost with the progressive stiffening of the hydrogels 
(Fig. 6a-b). Moreover, no significant changes in cell survival were detected on the soft or stiff 
hydrogels (Fig. 6c-d). These results suggested that the ‘activation state’ of OPCs is predomi-
nantly regulated not by the age of the cell or ECM chemistry, but by ECM stiffness.




































































































































Figure 5. A soft environment mimicking the stiffness of neonatal CNS tissue alone can restore the func-
tion of aged OPCs. a, (Top) Schematic represents OPCs cultured on top of stiffness tuned hydrogels. 
(Bottom) Representative images of aged OPCs seeded on the substrates with b, quantification of pro-
liferation rates. c,d, Representatative images and quantifications of differentiation rates of aged OPCs 
seeded on soft and stiff substrates. e, Mean shear moduli determined by AFM of our fabricated ‘soft’ and 
‘stiff’ hydrogels. a-d, Scale bars represent 40µm. f-g, MACs purified neonatal OPCs cultured on stiff 
hydrogels lose their ability to proliferate following 5 days in proliferation conditions. Neonatal OPCs 
cultured on soft hydrogels, however, continue to proliferate. h-i, Similarly, neonatal OPCs cultured 
on stiff hydrogels inefficiently differentiate into oligodendrocytes following 5 days in differentiation 
conditions. Conversely, neonatal OPCs differentiated on soft hydrogels efficiently differentiate into oli-
godendrocytes. f-i, Scale bars represent 100µm. j, Representative brightfield images of neonatal OPCs 
over-time in vitro on PDL tissue culture plastic cultured with growth factors. Throughout figure, means 
represent quantifications from N=3 biological replicates or in the case of the AFM, from N=3 independ-
ent hydrogel fabrications.   
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Figure 6. Cell density and cell death do not significantly confound observed effects of mechanical en-
vironment. a-b, Representative images and quantifications of N=3 replicates of EdU labelled OPCs 
seeded at .5x, 1x, and 2x cell seeding densities on increasingly stiff hydrogels after 120 hours in culture 
show cell-density independent, stiffness-dependent OPC activation. c-d, Labelling and quantifications 
of N=3 assays of OPC viability of both neonatal and aged progenitor cells on soft and stiff hydrogels 
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To further investigate if the soft environment pushes the identity of aged OPCs closer to that 
of neonatal OPCs, we performed RNA sequencing on acutely isolated aged and neonatal OPCs 
and compared them to both cell types seeded on stiff and soft hydrogels in vitro. We found using 
principal component analysis and hierarchical clustering that OPCs isolated from both neona-
tal and aged rats and cultured on soft hydrogels transcriptomically resembled freshly isolated 
neonatal OPCs more closely than aged and neonatal OPCs cultured on stiff hydrogels (Fig. 
7a-b). However, OPCs cultured on stiff hydrogels did not cluster closely with acutely isolated 
aged OPCs, revealing both the effect of growth factors and in vitro conditions on OPC gene 
expression profile and the inability of the stiff niche environment to fully recapitulate the ageing 
process. From the transcriptomics analysis, softness is the variable that allows aged OPCs to 
more closely resemble neonatal OPCs; to understand the reasons for this, we next looked at the 
differential gene expression data between aged OPCs cultured on stiff and on soft hydrogels. 
Over 1300 genes were significantly (p-value ≤.05) differentially expressed between OPCs cul-
tured on soft and cultured on stiff hydrogels and 21% of these upregulated genes were similarly 
upregulated in neonatal OPCs compared to aged OPCs (Fig. 7c-d). Matrix related genes such 
as Dab1, Acan, and Plxnd1 were upregulated in aged OPCs cultured on stiff hydrogels while 
cell-cycle and DNA repair genes such as Cdk1na and Sirt7, OPC activation genes such as Etv1, 
and hippo pathway genes such as Rassf2 were amongst the most upregulated genes in aged 
OPCs cultured on soft hydrogels.
Next we asked if enriched pathways overlap with pathways known to be involved in ageing 
such as metabolism, cell cycle, inflammation, and DNA stability (Goodell and Rando, 2015). 
Using gene set enrichment analysis, we found that the gene sets most significantly increased in 
expression in OPCs seeded on soft over stiff hydrogels were involved in the same age-related 
pathways such as proteostasis, metabolism, DNA replication, and DNA repair (Fig. 7e). Finally, 
expression of genes associated with many of these enriched gene sets such as Pdgfra, Ascl1, 
and Lmnb1 were also increased in expression in both neonatal OPCs and in OPCs grown on 
soft hydrogels (Fig. 7f). These results indicate that a soft environment holistically reinstates 
transcriptional programs associated with the reversal of the ageing process. Together with the 
increase in proliferation and differentiation on soft hydrogels, our results suggested that a soft 
environment rejuvenates aged OPCs. 
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Figure 7. A soft environment mimicking the stiffness of neonatal CNS tissue transcriptomically reju-
venates aged OPCs. a,  Principal component analysis (PCA) and included legend on RNA sequencing 
differential gene expression analysis. The PCA was performed on the FPKM values for each of the six 
biological conditions. Legend is provided b, Hierarchical clustering with Pearson correlation and Ward’s 
linkage shows that aged OPCs on soft hydrogels more closely resemble neonatal OPCs than do OPCs 
on stiff hydrogels.  c, Volcano plot of differential expressed genes between aged OPCs cultured on soft 
versus stiff hydrogels. Red dots show  significantly upregulated expressed genes (p < .05). d, Heatmap 
showing the log2 FPKM expression of the 25 genes with highest fold increase in expression between 
aged OPCs cultured on stiff versus soft hydrogels and the top 25 genes with the highest fold increase in 
expression between aged OPCs cultured on soft versus stiff hydrogels. All genes shown are significantly 
differentially expressed with a p-value of ≤.05. e, Gene set enrichment analysis reveals a number of 
pathways differentially expressed in aged OPCs grown on soft hydrogels versus aged OPCs grown on 
stiff hydrogels. f,  Enrichment analysis for genes involved in OPC and stem cell activation, proteostasis, 
and genetic and epigenetic stability as shown by mean FKPM log2 fold change of individual genes.  
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In order to gain a better understanding of the mechanism by which a soft microenvironment 
rejuvenates aged OPCs, we probed specific potential factors known to be involved in the trans-
duction of mechanical signals into an intracellular response. We first investigated mechano-
transduction via actin contractility by asking if small molecule inhibitors of actin contractility 
could phenocopy the effects of a soft environment.  To do this, we treated aged OPCs on stiff 
substrates with blebbistatin, a non-muscle myosin II inhibitor, which is known to affect neona-
tal OPC function (Baer et al., 2009; Wang et al., 2012). We found that the inhibitor increased 
the proliferation and differentiation rates by 5 fold when applied to aged OPCs on stiff sub-
strates (Fig. 8a-d). There was no corresponding increase in proliferation of aged OPCs on soft 
substrates treated with blebbistatin, indicating that the increase in proliferation is specific to the 
inhibition of mechanotransduction upon actomyosin relaxation (Fig. 8e-f). 
To determine the effect of actin contractility on the adult CNS in vivo, we first injected blebbi-
statin into un-lesioned grey matter of N=3 14 month old female rats. In the homeostatic aged 
CNS, there are almost no cells proliferating 10 days following a control delivery of DMSO, 
while in the blebbistatin injected brain, a small but significant proportion of cells were labelled 
with EdU (Fig. 8g-h). To determine the effect of blebbistatin in a lesion context, we injected 
5µM blebbistatin into the lesion to perturb OPC contractility (Fig. 8i). At 14 days post-lesion, 
we observed more than 3 times the number of Olig2+, CC1+ differentiated oligodendrocytes 
in lesions treated with blebbistatin than in controls in each aged animal (n=4) (Fig. 8j-k). We 
confirmed these results by analysing the extent of remyelination detectable on sections of res-
in-embedded lesions counter stained with toluidine blue. By blind lesion-ranking analysis, we 
found significantly improved remyelination in blebbistatin-injected lesions compared to the 
DMSO controls (Fig. 8l-m). Taken together with the in vitro data of blebbistatin-treated OPCs, 
these data suggest that inhibiting actomyosin contractility-mediated mechanotransduction has a 
positive effect on the activation and subsequent differentiation of aged OPCs. 
Having established actomyosin contractility as a major contributor to ageing in OPCs, we next 
sought more specific factors that may play a role in the mechanically-induced ageing response. 
First, we probed the mechanotransduction factor Lamin A/C, a ‘mechanostat’ that is known to 
mediate actin contractility (Swift et al., 2013). Our sequencing data showed an age-correlated 
increase in expression of the nuclear lamina component Lmna with ageing as well in OPCs 
cultured on stiff hydrogels. As such we confirmed the sequencing results with qPCR, Western 
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Figure 8. Targeting mechanical signalling factors to overcome environmental stiffness. a-d, Represen-
tative images and quantifications of the effects of Blebbistatin targeting actomyosin activity on the pro-
liferation and differentiation rates of aged OPCs in vitro. e-f, Representative images and quantifications 
of N=3 adult OPCs on soft hydrogels treated with Blebbistatin or DMSO show no change in rates of pro-
liferation. Scale bar represents 50µM. g-h, Representative images and quantifications of EdU labelled 
Olig2+CC1- OPCs 7 days following the injection of 5µM blebbistatin into the grey matter of N=3 14 
month-old females.  i-k, Schematic, representative images, and quantifications of the differentiation 
rates of aged OPCs following the injection of 5µM of blebbistatin at 14 days post lesion in in vivo-tox-
in-induced lesions. The data represents N=4 15 month-old age male rats. Differentiated oligodendro-
cytes are quantified as the proportion of CC1+ Olig2+ co-positive cells per mm2 of lesioned area. Scale 
bars represent 50µM. l-m, Toluidine blue staining on transverse sections of lesions of N=3 16 month old 
female rats show that remyelination at 28 days post lesion is accelerated. Blind rank analysis is based on 
average ranking for N=3 images per lesion with a higher ranking indicating better remyelination.  Dr. My-
fanwy Hill performed the lesion experiments in this figure. 
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Blots, and immunohistochemistry (Fig. 9a-g). 
As nuclear Lmna increases with ageing and with stiffness, we hypothesised that its increase 
underlies the in vitro ageing phenotype. We knocked down Lmna in aged OPCs on stiff hydro-
gels, which had no statistically significant effect on the activation state of aged progenitor cells 
(Fig. 10a-d). However, mRNA overexpression of Lamin C, the dominant Lmna splice variant 
in OPCs, in neonatal OPCs on soft hydrogels led to a significant loss of OPC activation (Fig. 
10e-i), suggesting that Lamin A/C plays at least some role in mediating mechanically induced 
ageing in OPCs. 
Other potential mechanotransducers include mechanosensitive ion channels such as Piezo1. 
Piezo1 regulates cell density and stem cell activation by responding directly to external me-
chanical signals such as substrate stiffness by tuning the influx of the second messenger calcium 
(Eisenhoffer et al., 2012; He et al., 2018; Li et al., 2014). Our sequencing data, verified by West-
ern blot, showed that Piezo1 is one of the most highly expressed proteins potentially involved 
in mechanical signalling in OPCs (Fig 11a-d). Reanalysing previous single cell sequencing da-
tabases in both human and mouse, we identified Piezo1 to be uniquely specifically expressed in 
Sox10 positive, Cspg4 positive, but MBP negative cells (Fig. 11e-h) (Lake et al., 2018; Zeisel et 
al., 2015). Finally, using immunohistochemistry on rat brains of various ages, we found Piezo1 
to be both peri-nuclear and  in the processes of Olig2+, but CC1- labelled OPCs in the adult and 
aged rat grey matter (Fig. 11i-j). 
To test the role of Piezo1, we transfected a Piezo1 siRNA into aged OPCs cultured on stiff hy-
drogels. Following knockdown, we observed that aged progenitor cells proliferated and differ-
entiated 3 to 5 fold more than the non-targeting siRNA control on stiff hydrogels (Fig. 12a-d). 
Piezo1 knock-down on soft hydrogels showed no additive effect on proliferation (Fig. 12e-f). 
As Piezo1 is a non-selective cation channel that gives rise to calcium transients, we next used 
calcium imaging to investigate if substrate mechanics impacted intracellular calcium dynam-
ics. Aged OPCs regularly demonstrated calcium transients on stiff hydrogels with ~20% of 
cells fluxing calcium over a 10 minute period of time. OPCs on soft hydrogels had virtually no 
calcium fluxes; moreover, transfection with Piezo1 siRNA abolished these calcium transients 
in aged OPCs on stiff hydrogels (Fig. 12g-i). Given the central role of calcium in controlling 
integrin signalling via Calpain 1 (McHugh et al., 2010), we hypothesised that stably knocking 
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Figure 9. The nuclear lamina composition of OPCs changes both with ageing and in response to niche stiff-
ness.  a, qPCR on OPCs reveal a loss of Lmnb1 and gain of Lmna with ageing. Values represent averages 
of OPCs from N=3 animals for each time point and are the Log2 ∆∆CT values normalized to Tbp. b, Repre-
sentative images of in vivo cerebellar grey matter cryo-sections confirm nuclear lamina changes that occur 
withageing. Scale bar represents 50µm. c, Western blot of Lamin B1 and Lamin C from freshly isolated 
OPCs of different ages confirms qPCR data. d, RNA-sequencing data of nuclear Lmnb2 in neonatal and 
aged OPCs show low levels of expression in both age groups. e-f, Western blot quantifications of aged OPCs 
grown on soft and stiff hydrogels. g, Representative images of nuclear lamina changes in OPCs on different 
stiffness hydrogels. Scale bar represents 50µM.  
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Figure 10. Role of nuclear Lmna in OPC self-renewal. a, Representative image of RFP-conjugated 
non-targeting siRNA shows high efficiency siRNA transfection. Bright-field shows high proportion of 
transfected to untransfected cells. b, qPCR on adult OPCs 48 hours following transfection with siRNAs. 
Values represent averages of OPCs from N=3 animals and are the Log2 ∆∆CT values normalized to Tbp. 
c-d, Representative images and quantifications of the proliferation of N=3 aged OPCs in growth factors 
on stiff hydrogels following transfection with siRNAs. Scale bar represents 50µm. e, Representative im-
age of GFP encoding mRNA in neonatal OPCs shows high efficiency transfection. Scale bar represents 
100µM. f, Representative images showing efficient transfection, high translation, and proper protein 
localization of Lamin C in aged OPCS. Scale bar represents 25µM. g, qPCR data 5 days post-transfec-
tion from RNA isolated from transfected OPCs. Means represent log ∆∆CT means across N=3 technical 
replicates from N=2 biological replicates. h-i, Representative images and quantifications of N=3 repli-
cates in neonatal OPCs on soft hydrogels show loss of proliferative capacity 120 hours following Lmnc 
mRNA overexpression. Scale bar represents 100µM. 
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Figure 11.  Piezo1 is widely expressed by OPCs. a, Representative images and sequencing data of aged 
progenitor cells on soft and stiff hydrogels and sequencing data of Piezo1. Scale bar represents 100µm. 
c, Western blot for Piezo1 in acutely isolated OPCs show modest increase in protein expression from 
neonates to adults. d, Mean FPKM values across 3 biological replicates of Piezo1 in neonatal and aged 
acutely isolated OPCs. e-h tSNE plots of human single cell-sequencing studies showing Piezo1 (green) 
cells co-expressing Sox10 and Cspg4 (red) in adult grey matter. Cells expressing both Piezo1 and the 
respective lineage-specific marker appear as yellow. Relevant cell populations, based on their marker 
expression, are labeled with a light blue circle. Expression legend is provided. i-j, Representative images 
and quantifications of the proportion of Piezo expressing OPCs (as labelled by Olig2+CC1-) and oligo-
dendrocytes (as labelled by Olig2+CC1-) in the CNS grey matter in the rat of N=3 P7, N=3 3 month-
olds, and N=3 14-month old animal. Scale bars represent 25µm.
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Figure 12. Piezo1 knockdown activates adult and aged OPCs. a-d, Representative images and quantifi-
cations of the proliferation and differentiation rates of N=3 biological replicates aged OPCs cultured on 
stiff hydrogels transfected with siScramble or siPiezo1. Scale bar represents 25µm. e-f Representative 
images and quantifications of N=3 biological replicates of aged OPCs transfected with a control siRNA 
or with a Piezo1 siRNA on soft hydrogels. Scale bar represents 50µm.  g, Representative Rhod-2am-
stained live cell images of aged progenitor cells on soft and stiff hydrogels transfected with siScramble 
or siPiezo1. h, Example traces of individual cells fluxing with calcium (∆F) over 270 seconds. Fluo-
rescence was normalized to the maximum fluorescence intensity per cell over the acquisition time. i, 
Quantifications of the proportion of cells that fluxed calcium ≥1 time throughout the 540 second image 
acquisition period from N=3 biological replicates. 
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down Piezo1 would allow OPCs to maintain self-renewal capacity, even in an aged stiff envi-
ronment. 
To test this hypothesis, we first needed to develop a means to stably silence Piezo1 in neonatal 
OPCs. There are numerous technical difficulties in transfecting and genetically perturbing pri-
mary OPCs. OPCs are primary cells that cannot grow clonally, are slowly dividing, do not read-
ily undergo homologous recombination (data not shown), and have a small cytoplasm to nucle-
us ratio, making them hard to transfect; as such, common-use genetic and viral approaches are 
inefficient in OPCs. Therefore, we generated a system using Cas9 mRNA, transcribed gRNAs, 
and HITI-mediated minicircle vectors to efficiently knock in a Piezo1 shRNA-GFP overexpres-
sion cassette into the unused Tubb3 locus (Fig. 13a)(Suzuki et al., 2016). This Cas9-mediated 
knock-in of shRNA-GFP has the benefit of having a characterizable monotonic knock-down 
across the pool of cells expressing the GFP. Neonatal OPCs transfected with this construct 
showed high transfection efficiency and a knock down of Piezo1 by ~80%  (Fig. 13b-e). When 
this construct was knocked-into aged OPCs on stiff hydrogels, the aged OPCs demonstrated a 
nearly tenfold increase in proliferation (Fig. 13f-g).  
We next transfected Piezo1-targeting and non-targeting control constructs into neonatal OPCs, 
and transplanted them into the aged prefrontal cortex (Fig. 13h). Fourteen days after trans-
plantation, both control and Piezo1 knock-down cells engrafted. Piezo1 knock-down cells did 
not migrate, remaining as proliferating cells at the transplantation site, whereas control cells 
extended processes, and were distributed across the grey matter. Almost none of the control 
neonatal OPCs proliferated in the aged cortex, losing their proliferative capacity (Fig. 13i-j). 
However, OPCs expressing the knockdown of Piezo1 continued to proliferate, with ~20% of 
neonatal OPCs remaining Edu positive, indicating a high level of maintained OPC activity 
despite the adverse aged microenvironment. This result represents the first time, to our knowl-
edge, that neonatal OPCs have been injected into undamaged aged CNS and maintained their 
ability to proliferate, and it clearly demonstrates the importance of mechanical signalling in the 
age-related loss of function in OPCs.
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Figure 13. Piezo1 mitigates the cell response to the stiffening CNS niche. a Schematic for Cas9-medi-
ated genomic manipulation using in vitro transcribed (IVT) gRNA, Cas9 mRNA, and in-house-made 
minicircle vectors overexpressing Piezo1-targetting shRNAs. b, Representative images show high rates 
of co-transfection of minicircle with Cas9 mRNA and IVT gRNA. Scale bar represents 25µM. c-d 
PCR design and appropriate fragment length of correctly knocked-in Minicircle fragment construct. e, 
qPCR data 48 hours post-transfection of adult OPCs with Piezo1 siRNA and Piezo1 shRNA construct 
from RNA isolated from transfected OPCs. Means represent log ∆∆CT means from N=3 biological 
replicates. f-g, Representative images and quantifications show Cas9 knock-in of shPiezo1 fragments 
in aged OPCs on stiff hydrogels phenocopies the effect of the siRNA Piezo1 in aged OPCs. Scale bars 
represent 100µM. h, Neonatal OPCs were transfected with Cas9-mediated knock-in shRNA construct 24 
hours following MACs sorting. i-j, Representative images and quantifications of GFP-expressing, EdU 
labelled cells in the grey matter of N=4 14 month old female rats. Quantifications are presented as a pro-
portion of EdU+ out of total GFP+ cells. Arrows represent example quantified cells. Scale bar represents 
50µM. Dr. Myfanwy Hill performed the cell transplantations shown in this figure.  
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Discussion
In this study, we showed that adult CNS progenitor cells do not undergo intrinsic irreversible 
changes with ageing. Instead, they acquire properties that reflect the age of their environment, 
specifically its mechanical features. As the CNS stiffens with age, OPCs respond by becoming 
less efficient at proliferating and differentiating both in vitro and in vivo. We found that reduc-
ing actomyosin contractility attenuated the age-related loss of OPC function, and identified the 
mechanosensitive ion channel Piezo1 as a key player in the mechanical regulation of the ageing 
response (Fig. 14). Other canonical ageing pathways such as genomic and epigenetic instabili-
ties, should now be considered in the context of how they are responding to the mechanical mi-
croenvironment. Furthermore, we conclude that ECM mechanics are an important determinant 
of the success of stem cell-based therapeutics that aim to treat age-related diseases. We found 
that young progenitors transplanted into aged lesion environments lose optimal regenerative 
properties; however, we point to a means to mitigate that response. We can attenuate the neg-
ative reaction to the aged microenvironment by decreasing the ability of the CNS progenitor 
cells to respond to mechanical signals from the CNS niche. Our findings open up the important 
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Figure 14. Working model of stiffness-mediated ageing hypothesis. With ageing, memory formation and 
normal cognitive development is associated with the deposition of ECM. The ECM in turn accumulates 
stiffening the tissue. This stiffening results in the Piezo1-mediated loss of activity of the CNS resident 
progenitor cell population the oligodendrocyte progenitor cell. The proposed model is that this compris-
es a feed forward loop which ultimately leads to prolonged OPC inactivity, and ultimately, CNS ageing.
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Cell non-autonomous ageing of OPCs  
Since previous work identified somatic cell nuclear transfer (SCNT) as a method for repro-
gramming the age state of an adult cell into an embryonic cell, it has been known that the genet-
ic material of cells, even from an adult or aged mammal, retains the capacity to de-differentiate, 
form an embryo, and give rise to a viable, sexually competent adult clone  (Wilmut et al., 1997). 
As such, even aged somatic cells must retain the intrinsic capacity to rejuvenate. Many groups 
have examined the capacity for adult cells to be reprogrammed into embryonic ones (Mertens 
et al., 2015) and have looked at cell intrinsic mechanisms to rejuvenate aged stem cells within 
their lineage. Here, we have uncoupled stem cell intrinsic ageing from environmental niche 
ageing. We have found that aged OPCs, when transplanted into a neonatal, brain environment, 
maintain the capacity to proliferate and differentiate into myelinating oligodendrocytes. 
One previous paper similarly looked at the capacity for adult human OPCs to myelinate the 
neonatal mouse brain and found that adult OPCs retain the capacity to efficiently differentiate 
into myelinating oligodendrocytes (Windrem et al., 2004). This study used adult human OPCs, 
however, and did not examine the effects of ageing on OPCs. Our results further this previous 
work by showing that OPCs maintain their generative capacity throughout ageing. However, 
in aged CNS lesions, OPCs fail to differentiate into new myelinating oligodendrocytes (Kuhl-
mann et al., 2008). As aged OPCs can indeed efficiently proliferate and differentiate as shown 
by the work presented here, remyelination failure is thus likely the failure of the niche to suffi-
ciently activate aged cells.   
A major limitation of the transplantation study shown in Figure 1 of this chapter is our use of the 
baculovirus to label neonatal and aged OPCs. Baculovirus, a non-integrating DNA virus, labels 
cells only for the first few rounds of cell replication, after which the GFP transgene and GFP 
protein is diluted and disappears. This property of the baculovirus limited our transplantation 
study in so far as we were only able to follow aged cells in the neonatal environment for a short 
period (10 days). Whether or not these aged OPCs in the neonatal environment would continue 
to proliferate and contribute to normal development myelination is unknown. An important fol-
low up experiment will be to repeat the transplantation assay, but with transgenic, constitutively 
expressing fluorescent mice or rats. This would have the advantage that the transplanted cells 
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would constitutively express the fluorophore, allowing for long term tracing of transplanted 
cell activity. Follow up studies must include both long term functional proliferation analysis 
and semi-thin resin sections to determine whether aged OPCs myelinate in the same manner as 
neonatal OPCs. Until then, it is unclear whether the observed phenotype of aged OPCs in the 
neonatal environment is stable or whether they stop proliferating after periods longer than 10 
days.
This set of hetero-chronic allografts has sparked further questions regarding the environmental 
effect on the age state of cells. If the aged environment underlies the aged state of OPCs, then 
we would hypothesise that a neonatal OPC serially transplanted into a neonate would not age—
without ever being exposed to an aged environment, a stem cell would proliferate ad infinitum. 
A similar question actively being pursued is whether a human neonatal OPC transplanted into a 
neonate rodent would adopt the age-state of the rodent. After ~14 months, remyelination of the 
rodent CNS becomes inefficient. In its native environment, a 14 month old human OPC would 
still be just an infant, and as regenerative as a neonatal mouse. Would, however, a 14 month old 
human OPC in the environment of the mouse brain assume an aged-cell like identity, contrib-
uting to inefficient remyelination? If environment alone determines age state, then the genomic 
expression and epi-genomic landscape of the transplanted human OPCs should resemble that 
of an aged mouse OPC. Such experiments are crucial to understanding cell intrinsic versus cell 
extrinsic factors which underlie ageing. 
The CNS, OPCs, and stiffness
The local and systemic environment of the neonatal CNS is dramatically different from that of 
the aged CNS. Systemic factors found in the blood, such as hormones, as well as local niche 
factors, such as locally secreting Wnts and Pdgf, likely underlie, at least in part, the re-activa-
tion of aged OPCs that are transplanted into the neonatal CNS. However, even in the presence 
of growth factors, aged OPCs in vitro cannot efficiently enter into cell cycle or differentiate into 
oligodendrocytes.  Thus, some unknown factor must underlie their re-activation. 
To better understand the changing niche of the CNS, we performed atomic force microscopy 
on the brain and found that the brain progressively stiffens with ageing. This stiffening is par-
tially due to the accumulation of matrix proteins. Additional work we have done—though not 
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presented here—shows that the degradation of matrix CSPGs with chABC can soften the aged 
CNS by nearly 1/3rd. These results indicate that the deposition of matrix in the postnatal CNS 
contributes to the stiffening of the adult brain. 
Matrix proteins in the brain are believed to be deposited as neuronal and glial scaffolding, hold-
ing together the synapses in the adult brain to preserve neural networks (Kwok et al., 2011). 
These matrix proteins are secreted in response to sensory experience—mice deprived of light 
do not deposit such proteins in the occipital lobe (McRae et al., 2007).  As such, with experi-
ence, there is more matrix, and likely an increase in tissue stiffness and a subsequent loss of 
OPC activity.  Future work must determine the exact changes in CNS matrix with ageing, their 
effects on stiffness, and on OPC function. Moreover, this proposed axis linking the develop-
ment of the adult mammalian CNS and the loss of OPC plasticity must be explored. 
When we place aged OPCs on soft neonate-brain-like hydrogels in the presence of high con-
centrations of growth factors, we see that aged OPCs reactivate and are able to both proliferate 
and differentiate into oligodendrocytes whereas aged OPCs on stiff hydrogels cannot. From 
this work, we show that niche bio-mechanics are an important factor for OPC activation. A 
number of studies in muscle and intestine similarly found that soft matrix environments pro-
mote self-renewal conditions in vitro (Gilbert et al., 2010; Jung et al., 2011). One paper found 
significant improvement in iPS cell generation when the cells were reprogrammed in very soft 
matrices (Caiazzo et al., 2016). Together with our results, it is becoming increasingly evident 
that many stem cells, both embryonic and adult, are more stem-like in soft environments. 
Despite this observation that aged OPCs on soft hydrogels functionally rejuvenate and tran-
scriptomically resemble neonatal OPCs, it is also clear that growth factors and the in vitro 
environment play a major role in determining the age state of OPCs. From the PCA data and 
the hierarchical clustering, aged OPCs cultured on stiff hydrogels cluster more similarly to 
neonatal OPCs than they do acutely isolated aged OPCs. Clearly, exposure of growth factors 
has a ‘rejuvenating’ effect on aged OPCs in vitro and that niche stiffness alone does not fully 
recapitulate the effects of OPC ageing. However, aged OPCs cultured on stiff hydrogels do not 
cluster as closely to neonatal OPCs as do aged OPCs cultured on soft hydrogels. These results 
show that the niche mechanics further rejuvenates cells but alone is likely insufficient to drive 
rejuvenation. While we show that mechanics plays a dominant role in OPC activity, we do not 
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disentangle in vitro these confounding effects of growth factors and mechanical environment. 
Future work must examine the role of mechanics in the absence of exogenous growth factors 
and whether even then, a soft mechanical environment can transcriptomically rejuvenate aged 
OPCs. 
The evolutionary underpinnings for the effects of a soft niche remain unexplored. One possi-
bility is that stem cell activation requires the physical space for the cell to undergo division and 
differentiation. Softness may act as a proxy, signalling to the stem cell that there is the physical 
space to activate. There is biological precedent for this hypothesis in the planaria and hydra 
(Florea, 2017; Watanabe et al., 2009).  Before the mother organism is too damaged/aged, a new 
organism buds off, forming a new organism. Rather than repair the damaged tissue, the stem 
cell buds off, finds new space and creates an effective clone of the mother organism. Similarly, 
recent work trying to generate iPS cells in the adult rodent in vivo found that the cells largely 
become senescent and cannot gain pluripotency in the in vivo environment (Mosteiro et al., 
2016). Like the hydra and planaria, immortality of humans—the capacity of the human cell to 
self-propagate ad infinitum—requires the reprogrammed cell to be removed from the endog-
enous niche environment. Perhaps again this highlights the stem cell’s need for space and the 
absence of matrix protein. Future work will aim to examine this relationship between physical 
space and stem cell activity in order to better understand the role of space on stem cell function. 
Piezo1 and OPCs  
We identify that OPCs probe the mechanics of their environment using the mechanosensor 
Piezo1. From single cell sequencing data and immunohistochemistry of the cortex, we find that 
Piezo1 expression is limited to the astrocytes and OPC population within the brain. We also 
show that without Piezo1 protein, OPCs both in vitro and in vivo retain the capacity to prolifer-
ate, even in a mechanically stiff/aged environment.
In this chapter, I show that transplanting neonatal OPCs that have a knockdown of Piezo1 
maintain their proliferative capacity, even in an aged CNS. This experiment, however, does not 
address the role of Piezo1 in the homeostatic undamaged aged brain. The transplantation assay 
effectively creates a micro-injury in the brain at the transplantation site. While control OPCs 
transplanted lost their proliferative capacity, the fact that Piezo1 knock-down OPCs maintain at 
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least some of their proliferation capacity does not mean that Piezo1 alone dictates cellular acti-
vation state. Rather, it is an equally likely possibility that signals from the local injury site from 
the transplantation in conjunction with lost Piezo1 expression allow cells to proliferate, even in 
the aged CNS. In order to conclusively determine the role of Piezo1 in OPCs, future work must 
use Piezo1 conditional knockout mice to study the role of Piezo1 in OPCs throughout CNS 
development, in homeostasis, and in the context of a demyelinating insult.
Piezo1 is a transmembrane ion channel protein. Under conditions of high strain, the Piezo1 
channel opens, allowing for the flow of ions into the cell (Coste et al., 2010). These ions act as 
secondary messengers to convey to cytoplasmic proteins that the cell is in a stiff environment. 
Yet, the evolutionary underpinnings of why OPCs uniquely express Piezo1 remain unclear as 
the brain is not an obviously mechanically strained organ. One hypothesis is that Piezo1 itself 
senses cell density. In homeostatic skin epithelium, Piezo1 is expressed within the processes of 
cells (Gudipaty et al., 2017). In cases of injury, however, Piezo1 dissociates from the cell cy-
toplasm, becoming perinuclear. Once the epithelium re-establishes normal cell density, Piezo1 
re-localises to the cytoplasm. Upon knocking down Piezo1, the epithelium over proliferates, 
creating blebs of hyper-proliferating cells. These findings complicate the previously established 
hypothesis that Piezo1 is a pure-mechanostat. The authors argue, instead, that Piezo1 is a mon-
itor of normal homeostatic cell density. 
In work shown in this paper, we have found Piezo1 to be perinuclear in neonatal OPCs and 
within the OPC processes during adulthood. Additionally, in unpresented work we have found 
Piezo1 to  be perinuclear in OPCs when in a young adult lesion  and within the processes in 
aged lesions when OPCs appear stuck at the periphery of the lesion. This bolsters the previous 
publication’s claim that Piezo1 is a counter of normal cell density rather than a pure mechanos-
tat. Within the lesion OPCs re-localise Piezo1 to be peri-nuclear as the cells undergo mitosis 
and differentiate. These findings complicate our work’s overarching claim that OPC age state 
is described by mechanics alone. Perhaps cross-linking density of matrix protein would be a 
more appropriate description of this phenomena. It is possible that a soft hydrogel environment 
mimics the environment of a low density matrix environment thus tricking the OPC to re-enter 
cell cycle and differentiate into an oligodendrocyte.   
With these revelations, we now hypothesise that OPC ageing begins at the end of overall brain 
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growth. Once the brain reaches maximal size, matrix, and cell density, OPCs via Piezo1 cannot 
activate as there is contact-inhibition that negatively regulates cell-cycle. Piezo1 is the protein 
within the cell that senses overall organ growth termination and signals to the OPC to slow cell 
cycle. Once this occurs, OPCs enter a prolonged phase of G1, thus intrinsically ageing in the 
manner described in the introduction. If OPC ageing begins once the CNS stops growing, then 
the true underlying cause of CNS ageing is the overall regulator of organ size. 
Recent work suggests that overall brain size and development is tethered to bone growth (Oury 
et al., 2013). As bones grow they secrete the circulatory hormone osteocalcin. This hormone 
has a direct effect on the growth and development of the CNS (Obri et al., 2018). When devel-
opment finishes, however, the bones stop its secretion. If the termination of organ growth co-
incides with the beginning of physiological ageing, then identifying the biological parameters 
that govern overall organismic and organ size is the key to understanding the ageing of stem 
cells. Future work must determine what these organismic size determinants are to truly under-
stand the basis for physiological ageing. 
Chapter 5
Cell-type specific, systemically administered Nested 
CRISPR in wild type aged mice reveals a role for Piezo1 
in the stem cells of the CNS
In chapter 4, I show that Piezo1 activity has a major role in modulating the activity state of oligo-
dendrocyte progenitor cells (OPCs), the dominant stem cell population in the adult central nervous 
system (CNS). To rapidly dissect the role of Piezo1 in the OPCs of the adult and aged CNS in both 
homeostasis and in regeneration, we have built a dual adeno-associated virus (AAV) nested CRIS-
PR/sp. Cas9 system which efficiently genome engineers OPCs of the adult CNS following a single 
intravenous injection of AAV particles. We have combined multiple genome engineering strategies, 
including synthetic CNS-targeting AAVs, non-homologous-end-joining (NHEJ) mediated knock-ins, 
and RNA-triple helix structures and ribozymes to efficiently manipulate the gene Piezo1, specifically 
in OPCs. Doing so in the aged CNS, we have observed an increase in OPC self-renewal in homeo-
stasis and accelerated regeneration following CNS injury. Finally, using a modified nested CRISPR 
technique, we have generated an OPC-specific, Piezo1 reporter-animal and show that OPCs across 
the CNS express Piezo1. These findings highlight the importance of Piezo1 in OPC activity and pro-
vides a new experimental approach to rapidly hypothesis-test the role of specific genes on individual 
cell populations in the adult and aged animal. 
As discussed briefly in the previous chapter, the mechano-sensing gated ion channel Piezo1 was first 
identified as a gene upregulated in the glia of Alzheimer human brains and as a negative regulator of 
Ras signalling (McHugh et al., 2010). Since then, Piezo1 has also been identified as a regulator of 
cell number in development and in epithelial wound healing (Eisenhoffer et al., 2012; Gudipaty et al., 
2017). In drosophila, gut stem cells activate in response to increased food load via Piezo1. Finally, 
Piezo1 knockout mice die embryonically partially as a result of the failure of the vasculature to de-
velop normally (Li et al., 2014). In the previous chapter, we identified Piezo1 as fundamental to the 
activation of OPCs in the adult and aged CNS. Under conditions of mechanical stress, Piezo1 inhibits 
OPC self-renewal and differentiation, and its knockdown allows cells to self-renew both in vitro and 
in vivo, even in an aged environment.  We hypothesize that Piezo1 negatively regulates OPC activa-
tion once the brain attains maximal size and cell density. 
Generating an inducible, OPC-specific Piezo1 knockout animal in aged mice is a laborious and 
time-intensive process using traditional transgenic animal models—transgenic animals must breed 
for multiple generations and ultimately the animals must age for over a year. To circumnavigate this 
process, we combined three genome engineering strategies to create an OPC specific Piezo1 knockout 
in wild type C57/Bl6 adult and aged mice. Recent work has shown that a dual AAV system delivered 
systemically can knock-in genes into precise genomic locations of adult post-mitotic cells (Suzuki 
et al., 2016). One AAV delivers a Cas9 gene under a CMV promoter while the other AAV delivers 
the sequence-specific gRNA under a U6 promoter and knock-in fragment flanked by gRNA cut sites, 
encoded in the reverse compliment orientation.  Advances in the creation of synthetic AAV capsids 
has allowed for the generation of a CNS-specific and highly-efficient integrase-deficient AAV which 
targets >80% of all neurons >60% of glia in the adult mouse CNS (Challis et al., 2018). Finally, re-
cent advances in synthetic biology have harnessed RNA-triple helical structures and self-cleaving 
ribozymes to drive the polycistronic expression of fluorescence proteins and gRNAs under RNA poly-
merase II promtoers (Nissim et al., 2014; Yoshioka et al., 2015). 
We have harnessed all three of these technologies in synthetic biology to create a widespread, in vivo, 
CNS-targeting AAV that efficiently deletes Piezo1, specifically in OPCs in an adult and aged mouse. 
Doing so, we observe that OPCs have an increased rate of self-renewal in the homeostatic aged brain 
and increased regeneration in a focal toxin model of demyelination. Finally, we have generated a novel 
multilevel nested CRISPR system which effectively acts as an in vivo, OPC specific, Piezo1 reporter, 
revealing widespread Piezo1 expression across the adult CNS. These results demonstrate widespread 
targeted cell-type specific genome modifications in the adult mammal and emphasise the importance 
of Piezo1 for regeneration and repair of the damaged CNS. 
OPCs lack a cell type described promoter sequence that could drive the expression of a transgene 
specifically in OPCs. Moreover, there are not many genes uniquely expressed by OPCs. In transgen-
ic animals, the endogenous Pdgfra gene has been targeted  to drive a Cre-recombinase to activate 
OPC-specific transgene expression (Rivers et al., 2008; Zawadzka et al., 2010).  As such, we targeted 
Pdgfra to drive OPC specific transgene expression. First, we generated an PHP-EB AAV expressing 
Cas9 under a CMV promoter (Fig. 1). To target specifically OPCs, we generated a second PHP-EB 
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2. Transgenes packaged in 2 AAVs
1. Constructed transgenes
3. Constituively expressed 
4. If cell is infected by both vectors, Cas9 makes 3 cuts
5. Transgene fragment is inserted 
Using NHEJ machinery
Cas9Pdgfra gRNA
Genomic Pdgfra target sequence Transgene with two reversed target sequences
6. If transgene inserted in reverse orientation:
7. Once inserted, if Pdgfra is expressed in cell:
New Pdgfra-transgene fusion mRNA is transcribed
gRNA sequences re-appear. Locus recut until correct orientation
gRNA target sequence gRNA target sequence
Pdgfra    IRES GFP  Malat1   HH  Piezo1-gRNA  HDV 
Piezo1 gRNA is released from mRNA
Pdgfra    IRES GFP  Malat1    HH                            HDV 
8. Ribozymes self-cleave, release gRNA 
Pdgfra    IRES GFP  Malat1    
9. Pdgfra-GFP mRNA is translated
Malat1 protects newly exposed 3’ mRNA from 
degredation
10. Piezo1-gRNA complexes with Cas9  
Genomic Piezo1 locus is mutated
Cas9 KO
ITR ITRCMV Cas9 PA
PAITR ITRITRU6 Pdgfra - gRNA gRNA 2IRES GFP MALAT1 3’ HH HDV
Figure 1. A nested CRISPR system for cell-type specific gene knock outs. A schematic outlining the ap-
proach. A non-homologous end-joining mediated knock-in of a construct is inserted into a gene specific 
to a given cell type. This construct contains a ribozyme flanked second gRNA, targeting Cas9-mediated 
gene knockdown to a second locus. HH is an abbreviation for Hammerhead ribozyme, HDV for hepatitis 
delta virus ribozyme, PA for poly-adenylation sequence, and ITR for an internal terminal repeat sequence. 
Square and triangle represent gRNA target sequence. 
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AAV vector expressing a 3’ UTR targeting Pdgfra gRNA under the RNA polymerase III U6 promoter. 
Adjacent to the polymerase III termination sequence of repeat thymines, we inserted a Pdgfra gRNA 
cut sequence, antisense to the endogenous gRNA target sequence. Downstream of the cut sequence 
we placed an IRES-GFP followed by the 3’ end of the Malat1 gene, a PolyA replacement sequence 
that stabilises mRNA by forming a RNA triple helix (Wilusz et al., 2012).  Downstream of the helix 
we placed synthetic ribozyme-flanked gRNA targeting either Piezo1 or a non-targeting control gRNA. 
Finally, adjacent to the final PolyA signal, we inserted another antisense Pdgfra gRNA cut sequence. 
As described previously (Suzuki et al., 2016), when the Pdgfra gRNA sequence is expressed from the 
U6 promoter, both the endogenous genomic locus and the transgene is cut. The excised GFP-gRNA 
fusion gene is then inserted with NHEJ machinery into the endogenous Pdgfra cut locus. Once insert-
ed, the GFP-gRNA transgene is expressed only when Pdgfra is also expressed. With the transcription 
of the fusion GFP-ribozyme-flanked-gRNA transcript, the ribozymes self-cleave, releasing the Piezo1 
targeting gRNA. Moreover, the newly exposed 3’ UTR of the GFP mRNA is protected from degrada-
tion due to the 3’ UTR of the Malat1 gene. As such, when Pdgfra gene is expressed, GFP and a second-
ary gRNA sequence targeting the Piezo1 gene locus are also expressed. This technique theoretically 
makes it possible to mutate the Piezo1 locus only in Pdgfra expressing cells, creating an effective OPC 
specific Piezo1 animal knock out. 
While the PHP-EB vector efficiently infects the adult CNS, it has yet to be determined whether the 
vector can efficiently infect OPCs. To determine the efficacy of our vector in knocking in the transgene 
construct with the PHP-EB AAV, we dissociated p1 neonatal mouse pup brains and infected them 
overnight with both the Cas9 AAV and our knock-in cassette. As a control we created a transgene that 
encodes for GFP and a non-targetting gRNA. Five days after infection, we found that PHP-EB has the 
capacity to infect OPCs and that our knock-in construct is specifically expressed in Olig2 expressing 
OPCs in vitro (Fig. 2a-c). PCR of the knock-in fragment showed that the fragment is inserted into the 
correct locus (Fig. 2d). We confirmed using sanger sequencing and TIDE analysis that the Piezo1 lo-
cus contains gene mutations 5 days following infection specifically in mixed brain cells infected with 
a Piezo1 knock-out virus  (Fig. 2e).  However, with a Western blot we observed minimal reduction in 
Piezo1 protein in the mixed glia cells 5 days following infection with the knock-out virus (Fig. 2f); 
this is likely due to the low proportion of OPCs within the mixed glia population. Future work will be 
to determine whether Piezo1 protein levels are reduced with the Nested CRISPR system in a purified 
population of OPCs.
As the Nested CRISPR construct works in vitro, we next determined whether this construct would 
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Figure 2. Validating nested CRISPR system in vitro for the Piezo1 locus. a-c, Representative images 
and quantifications of infected mixed glia cells with construct. Quantifications represent positive pro-
portion of either GFP+ cells out of total Olig2 expressing cells or proportion of Olig2 expressing cells 
out of total GFP expressing cells. Averages represent means N=3 biological replicates and error bars 
represent standard deviation. Scale bars show 50µm. d, A schematic and a DNA gel of the Pdgfra locus 
following CRISPR/Cas9-mediated knock-in confirms construct knock-in in the correct position. P1 
signifies forward primer while P2 represents the reverse primer used for the PCR. e, Indel detection of 
the Piezo1 locus confirmed by Sanger sequencing and TIDE analysis. f, Western blot shows minimal 
reduction in Piezo1 protein 5 days following infection. Here and throughout chapter, ≥200 cells were 
counted per biological replicate.
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work in vivo. To test the efficacy of the vector, we tail vein injected 5 x 1011 of each of the knock-in 
vector and the Cas9 vector in 12 week-old mice (Fig. 3a). After 21 days, we perfusion fixed the an-
imals. In both the control, non-targeting gRNA  and the Piezo1 targeting knockout vector, we found 
GFP expressing cells across the CNS, including the cortical grey matter, the striatum, the corpus cal-
losum, the cerebellum, and the spinal cord  (Fig. 3b-d). We found that nearly 30% of Olig2 expressing 
oligodendroglia lineage expressing cells expressed GFP within the cerebellum and the cortical grey 
matter. In the corpus callosum we found nearly 50% of all Olig2 expressing cells also expressed GFP. 
Olig2 labels all cells of the lineage, both the OPC and its progeny, the oligodendrocyte, but the pro-
portion of Olig2 expressing cells that express GFP reflects the ratio of OPCs to oligodendrocytes. This 
suggests that the vast majority of OPCs in the CNS successfully received the transgene. Moreover, 
across the CNS, very few GFP labelled cells were Olig2 negative, suggesting the expression of the 
knock-in cassette in the Pdgfra locus is highly selective for the OPC population. To confirm correct 
integration of the transgene within the Pdgfra locus, we isolated DNA from fresh CNS tissue of in-
fected animals and performed a PCR  (see Fig. 2d). Similar to in vitro, we found correct transgene 
integration in animals infected with both the Cas9 and non-targetting or Cas9 and Piezo1 KO vectors, 
but not in animals infected with the GFP vector only (Fig. 3e). As the construct correctly integrates 
into significant numbers of adult CNS, we next determined whether the Pdgfra driven Piezo1 gRNA 
was sufficient to create insertion-deletion mutations (indels) in the Piezo1 locus in vivo. To test this, 
we homogenised adult cortex, PCR amplified the Piezo1 locus, Sanger sequenced the fragment, and 
performed TIDE analysis on the loci (Brinkman et al., 2014). We found that ~2-3% of the Piezo1 loci 
contained indels (Fig. 3f-g). In control non-targeting gRNA knock-in animals, we observed no signif-
icant indels at the Piezo1 locus. As we homogenised whole brain tissue, the exact proportion of OPCs 
with mutated Piezo1 cannot be determined with this approach. As referenced in the discussion, the 
rate of Piezo1 indels remains a main focus of future studies.  However, together with the immunohis-
tochemistry, we can confirm that GFP is expressed uniquely in the oligodendrocyte lineage. 
As Piezo1 regulates proliferation rates in vitro as shown in chapter 4, we next looked at whether 
Piezo1 enhances OPC proliferation and differentiation in the context of CNS regeneration/remyelin-
ation. To test this, we tail vein injected 18 month-old aged animals with the vector pools. After 1 week, 
we demyelinated ventral spinal cord white matter by direct injection of 1% lysolecithin (Fig. 4a). At 
13 days post lesion, we injected EdU, and one day after that, we perfusion fixed the animals. We found 
that in the GFP-only AAV infected animals, there were a high proportion of GFP expressing cells on 
the periphery of the lesion (Fig. 4b-f). These Olig2 expressing cells had a low rate of proliferation as 
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Figure 3. Widespread and targeted Nested CRISPR in the adult CNS. a, A schematic outlining the ex-
perimental strategy. Animals were tail-vein injected with 5x1011 of both the knock-out and Cas9 AAV. 
The animals were perfusion fixed 21 days later or tissue was taken for DNA analysis. b-d, Representa-
tive images and quantifications of GFP/Olig2 co-expressing cells across multiple regions of the CNS. 
Data taken from N=3 control knock-out animals. Scale bars represent 50µm. e, Schematic of modified 
genomic locus and  PCR confirms correct genomic integration of knock-in fragment from N=2 biologic-
al replicates of the non-targeting control vector (NT), the Piezo1 knock-out vector (KO), or a non-in-
fected animal (ø). f, Schematic determining Piezo1 knockout efficiency following AAV injection. DNA 
was isolated from the homogenized brains of tail-vein injected animals, the Piezo1 locus was Sanger 
sequenced, and analyzed using TIDE. g, TIDE results show INDEL efficiency following Piezo1 gene 
targeting using the nested CRISPR system. 
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134 Chapter 5: Cell-type specific, systemically administered Nested CRISPR
Figure 4. Piezo1 knockout using nested CRISPR system promotes regeneration in the aged CNS. a, 
Schematic of spinal lesioning following tail-vein injection of CRISPR system. b, Representative images 
of white matter lesion with white line indicating the lesion area. Scale bar represents 100µm. c-d, Rep-
resentative images and quantifications from N=3 mice of EdU incorporation into Olig2/GFP expressing 
cells in the lesion core. e-f, Representative images and box whisker plot quantification of white matter 
lesion stained only for Olig2 show increased OPC infiltration into the lesion site following Piezo1 
knockout. Lesion site indicated by white line. Scale bar represents 100µm. g-h, Representative images 
and quantifications of the number of CC1+/Olig2+ per mm2 of lesion area in N=3 control or Piezo1 
knockout animals. Throughout figure, *** represents p-value significance of ≤.01 as determined by a 
one-way ANOVA. Here and throughout chapter, lesions were performed by Dr. Chao Zhao, affiliated 
with Robin Franklin’s group. 
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indicated by incorporation of EdU. In the Piezo1 KO infected animals, however, Olig2 expressing 
cells migrated deep within the lesion core and had ~3.5 fold higher rates of proliferation compared to 
the control. As previously reported, remyelination occurs inefficiently in the aged adult (Sim et al., 
2002). In the control GFP aged lesion, we found the large majority of CC1+/Olig2+ oligodendrocytes 
at the periphery of the lesion, with few differentiated cells within the core of the lesion. In the aged 
Piezo1 KO animal, however, we found a two fold increase of differentiated oligodendrocytes within 
the lesion, many of them within the lesion core  (Fig. 4g-h). Together, these results show that Piezo1 
regulates the activity-state of aged OPCs; by knocking it out, specifically in OPCs, we improve the 
proliferation  and differentiation capacity of OPCs in an aged lesion. 
We next made small modifications to the AAV system to see if it would be possible to knock-in GFP 
into the Piezo1 locus, only in cells expressing Pdgfra, effectively creating an OPC-specific Piezo1 
reporter construct. To do so, we repositioned the ribozyme flanked Piezo1 gRNA such that all Pdgfra 
expressing cells express the Piezo1 gRNA (Fig. 5a). As such, all cells expressing Pdgfra would also 
express the Piezo1 gRNA. Immediately downstream of Piezo1 gRNA sequence, we put a second 
round of reverse complement Piezo1 gRNA cut sequences flanking an IRES-GFP sequence. This way, 
in Pdgfra expressing OPCs, the Piezo1 gRNA would be expressed, the IRES-GFP sequence would 
be excised and inserted into the Piezo1 locus via NHEJ. This way, all Pdgfra- Piezo1- co-expressing 
OPCs would be labelled with GFP. 
To confirm that this system works in vitro, we again over-night infected dissociated p1 mouse neonates 
with either a combination of Cas9 and the knock-in vector or with the Cas9 vector alone. We found 
significant proportions of Olig2 expressing cells expressing GFP, showing an exclusive knock-in into 
the oligodendroglial lineage (Fig. 5b). To confirm whether this system works in vivo, we infected N=3 
12 week old animals with  5 x 1011 of each of the viral particles (Fig. 5c). At 3 weeks post tail-vein in-
jection we again observed a high proportion of Olig2 expressing cells co-expressing GFP (Fig. 5d). In 
the corpus callosum there were significant numbers of Olig2/GFP co-expressing cells. Moreover, GFP 
expression was limited to Olig2 expressing cells, again confirming that the system is specific to OPCs. 
Future work must determine the extent of GFP labeling present across the CNS. Finally, to show the 
correct integration of the transgene in vivo, we performed a PCR of homogenised cortex and found 
proper integration of GFP into the Piezo1 locus, only in the animals that received the multiplexed nest-
ed CRISPR construct (Fig. 5e). In this way, we effectively created a cell-type specific, gene-specific 
reporter in the adult CNS 21 days following a single intravenous injection of AAV particles. 
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Figure 5. Multiplexed Nested CRISPR shows Piezo1 is expressed by Pdgfra+ OPCs. a, Schematic 
overview of the Nested CRISPR system. If a cell expresses Pdgfra, a Piezo1 gRNA is expressed and 
an IRES GFP DNA fragment is inserted into the Piezo1 locus. b, Mixed glia cells infected with AAV 
overnight and left for 5 days confirm that there is GFP expression and that the GFP expression is 
specific for OPCs. c-d, Schematic and representative images of young adult (12 week) mouse cortex 
21 days following a tail vein-injection of the knock-in cassette with Cas9 or the knock-in cassette 
on its own. Images show widespread GFP/Olig2 co-localization. e, Schematic and DNA gel show-
ing correct genomic integration of the IRES-GFP cassette into the Piezo1 gene locus in not in the 
non-targeting gRNA vector (NT) or in the previously reported knock out vector (KO). P1 represents 
the forward primer for the ‘positional PCR’ and P2 shows the reverse primer. Across figure, scale bars 
represent 50µm. 
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Discussion
Here, we have shown the role of the mechano-sensor Piezo1 in tissue homeostasis and in CNS re-
generation. To elucidate its role, we have developed a dual AAV-system using the synthetic serotype 
PHP-EB. We have shown the capacity for this system to efficiently engineer the nervous system’s 
dominant stem cell population, the OPC. Using synthetic biology techniques, we have created a Nest-
ed CRISPR system, in which the CRISPR-mediated knock-in of a secondary gRNA downstream of a 
cell-type specific promoter enables a cell-type specific gene knock-out. Specifically, we have applied 
this system to understanding Piezo1, and have shown that in the context of an aged demyelinating 
lesion, the knockout of Piezo1 allows for enhanced OPC proliferation and differentiation within the 
lesion environment. Finally, to better understand the expression of Piezo1 across the CNS, we generat-
ed a multi-levelled Nested CRISPR system. This system allows us to engineer an OPC-specific Piezo1 
GFP reporter in an adult mouse. The implications for these findings are manifold: we have identified 
a major role for Piezo1 in remyelination, and emphasise the importance of biophysical pathways 
for regenerating the aged CNS. Additionally, we have created an in vivo CRISPR-mediated genome 
engineering system in which specific cells of the adult can be targeted and subsequently genome en-
gineered.  This system is highly modular and these findings could have implications for the broader 
biological community.
Limitations of the Nested CRISPR System
The synthetic PHP-EB AAV serotype delivered intravenously can deliver genetic information to ~80% 
of cells in the CNS (Challis et al., 2018). This makes the PHP-EB AAV vector one of the most power-
ful tools for the neuroscience community. AAVs, however, have their limitations. AAVs have a maxi-
mum gene carrying capacity of ~5 kb, including the ~300 base pairs required for transgene packaging 
into the AAV. This size constraint limits the ability to deliver large or poly-cistronic transgenes.
A major challenge in gene therapy is delivering transgenes to specific cells within the body. This 
would minimize the off-target effects of the therapeutic and provide a competitive advantage over 
currently available broad-spectrum untargeted pharmaceuticals. Using cell-type specific promoter se-
quences, the authors in the original publication demonstrate that they are able to deliver fluorescent 
genes to specific-cells within the CNS. Fluorescent proteins are relatively short ~750 bp, and the cell-
type specific promoter sequences they use are pre-characterized, short (~500 bp), and efficiently ex-
pressed. Other cell types such as the OPC have undefined cell-type specific promoter sequences while 
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oligodendrocytes have much larger >1000bp promoter sequences (Challis et al., 2018). 
Even if a small promoter sequence has been previously described, the capacity for AAVs to deliver 
transgenes is limited. For one thing, many genes are larger than the 5000bp AAV size constraint. Here, 
we show the importance of Piezo1 on the activity of adult OPCs. However, gain of function exper-
iments, wherein Piezo1 is overexpressed, would not be feasible with the AAV system as the Piezo1 
transgene itself is >7500 bp. This size constraint is a limitation for therapeutics as well. Duchenne 
muscular dystrophy is caused by a mutation in the gene dystrophin (>11000)(Tabebordbar et al., 
2016), and, due to its size, delivery of the corrected transgene is not feasible with AAVs.     
These limitations pose major hurdles for CRISPR mediated gene editing. The CRISPR gene Cas9 
is itself large (>4000 bp). As such, combining Cas9 with a tissue-specific promoter, such as MBP, is 
not feasible. Moreover, OPC-specific targeting of Cas9 expression is not feasible due to OPCs lack 
of a defined cell-type specific promoter sequence. Finally, even with a short promoter sequence and 
a synthetic short poly-adenylation sequence, a Cas9 AAV vector is already at maximal size capacity. 
This means that multiplexing the Cas9 gene with a sequence specific gRNA already surpasses the size 
limitations of the AAV vector.    
In this chapter, I combine three different technologies to create a cell-type specific gene knock-out in 
an adult mouse brain. As referenced previously, all 3 technologies were independently developed and 
published. However, the work in this chapter is largely preliminary and a number of aspects of the 
Nested CRISPR system remain unknown. Throughout the text, I show that GFP protein expression 
co-localises largely with Olig2 expressing oligodendrocyte lineage cells and that, with PCR, the ge-
nomic fragment integrates in the right locus. However, future work must confirm that the IRES-GFP-
gRNA transgene is uniquely integrated in the correct Pdgfra locus. This problem of the specificity of 
transgene integration is compounded by the fact that we are introducing genomic fragments into aged 
animals. As shown in Chapter 6 of this thesis, there is increased DNA damage in OPCs with ageing. 
This increase in DNA damage and presumably double stranded DNA breaks means that the NHEJ 
machinery may insert the GFP-gRNA transgene into alternative loci in the genome, not just the locus 
cut by the Cas9 enzyme. Moreover, as the transgene is preceded by the IRES sequence, if the trans-
gene is inserted into a transcribed region of the genome, GFP will be translated, regardless of its site 
of genomic integration; this would significantly undermine the OPC specificity of the system as cells 
that transcribe these other loci would target Piezo1 for degredation.  One way to test the precision of 
the system would be to FACs sort GFP expressing cells from an infected aged brain and perform deep 
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DNA sequencing. Doing so, we would be able to calculate the frequency with which the transgene 
appears at the correct loci. Only then could we confirm whether the Nested CRISPR is specific enough 
to be used in the aged CNS. 
Even if the system does specifically introduce the GFP-gRNA transgene to the Pdgfra locus, it remains 
unclear whether the secondary Piezo1 targeting transgene is efficient at creating insertion-deletions in 
the Piezo1 locus. In this chapter, we homogenised whole mouse brain cortex and found low rates of 
mutations at the Piezo1 locus both in vitro and in vivo. As OPCs are only 5% of the total cells within 
the CNS and if this Nested CRISPR system is truly cell-type specific, then we would expect the mu-
tation rate at the Piezo1 locus to be at most 5%. To truly understand the rate of Piezo1 knockout in 
vivo in OPCs, Pdgfra expressing OPCs must be FACs sorted from the brain and analysed in a similar 
method as described in this chapter. While the TIDE analysis provides a simple tool for understanding 
the total number of insertion-deletions in a population of cells, the only method for understanding the 
per-cell mutation rate across both Piezo1 alleles is to perform single-cell amplicon sequencing; this 
approach would determine the proportion of cells with either a heterozygous or a homozygous loss of 
function of mutation at the Piezo1 locus, as described previously (Suzuki et al., 2016). Both approach-
es for determining the in vivo Piezo1 mutation rate are ongoing as such analysis is required to prove 
the efficacy of the Nested CRISPR system. 
Overcoming AAV limitations
To evade these size and promoter limitations, previous work has shown that Cas9 can be divided up 
into two fragments of ~2000 bp packaged into two separate AAVs and subsequently injected into ani-
mals (Yang et al., 2016). There, the two Cas9 fragments are transcribed separately but the protein frag-
ments complex with one another once translated. In this way, the authors are able to multiplex Cas9 
with a fluorescent protein and a sequence specific gRNA. With this approach, it would be possible to 
target oligodendrocyte-specific gene promoter MBP with Cas9, a fluorophore, and a sequence-specific 
gRNA, allowing for oligodendrocyte-specific genome modifications.  
Many cells, however, lack a defined cell-type specific promoter sequence.  As such, targeted, cell-
type specific transgene delivery for cell-types such as OPCs remains undescribed in the literature. To 
overcome these limitations, we used a dual CRISPR AAV system, as previously described (Suzuki et 
al., 2016). In this work the authors infect the muscle following the delivery of two AAV particles: one 
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encoding Cas9 and the other a gRNA sequence, and a knock-in cassette flanked by gRNA cut sites. 
If a cell is infected with both particles, Cas9 will complex with the gRNA, cutting the genome and 
releasing the knock-in cassette from the transgene construct. The knock-in cassette is then inserted 
into the genome using non-homologous end-joining. Doing so, the authors are able to express GFP 
from an endogenous promoter sequence. We combined this technique with a previously described 
synthetic biology technique in which gRNAs can be expressed from cell-type specific promoters using 
self-cleaving ribozymes (Nissim et al., 2014). Together, we knock-in a gRNA into a cell-type specific 
promoter, and thereby make genome modifications specifically in the OPC in the CNS. 
This system is highly modular, capable of driving multiple-levels of genome manipulation from any 
gene expressed in a given cell type. However, a simple all-in-one AAV would likely increase the effi-
ciency and simplicity of the system. With our system, this is not feasible due to size constraints of the 
well-characterized Cas9 derived from the bacterial species Streptococcus pyogenes. Recent work has 
identified Cas9 orthologues across a number of bacterial species (Kleinstiver et al., 2015). The small-
est orthologue is Cas9 derived from the bacterial species Campylobacter jejuni (cj Cas9). Due to its 
size of ~2900 bp, cjCas9 has generated excitement in the field of in vivo gene editing and has already 
been used to successfully genome edit in vivo using an AAV (Kim et al., 2017). cjCas9 is ~1100 bp 
smaller than the originally described Cas9 and provides 1100 bp extra for transgene delivery. Using 
this extra space for transgene delivery, we hope to combine our ribozyme-mediated cell-type specific 
CRISPR technology with the cjCas9 to create an all-in-one nested CRISPR system. 
A gene-specific promoter database for all coding genes would diminish the advance of this nested 
CRISPR system. If the Pdgfra locus were to have a well-established and short promoter sequence, then 
we could drive Cas9 and/or gRNA expression using this promoter; doing so, we could drive OPC-spe-
cific gene editing. This would circumnavigate the need to first knock-in a ribozyme-flanked gRNA into 
the Pdgfra locus, likely making the entire cell-type specific CRISPR system more efficient. Publically 
available epigenetic databases open up our capacity to readily identify the promoter regions of specific 
genes (Rosenbloom et al., 2012). Open chromatin domain sequencing (DNAse-seq and ATAC-seq) of 
fetal human brain reveals distinct open chromatin domains 500-2500 bp upstream of the Pdgfra locus. 
Future work will be to dissect the components of these open-chromatin domains, identifying the mini-
mal promoter components that drive Pdgfra expression in OPCs with the hopes of one day driving the 
CRISPR/Cas9 system from a minimal Pdgfra promoter sequence. By driving the CRISPR machinery 
from a cell-type specific promoter, I hope to circumnavigate many of the discussed limitations of the 
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Nested CRISPR system. 
Improving on the system
Here, we report on our ability to create multi-level CRISPR knock-ins, in which the expression of a 
single gene can drive the knock-in of a second gene at a separate locus. The design of this system is 
not without its limitations. Recently, Cas9 cutting has been shown to have a multitude of off target 
effects, including large scale insertions and deletions (Kosicki et al., 2018).  However, this paper used 
the PiggyBac transposase system combined with Cas9 to introduce genome modifications. This is an 
unusual approach for introducing the CRISPR technology into cells and the combinatorial effect of 
Cas9 with transposase remains unknown. Similarly, it remains unknown whether other methods for 
the introduction of CRISPSR machinery would have such widespread off-target effects. 
Despite the limitations of this previous study, it is highly plausible that long-term expression of Cas9 
would have adverse effects on genome integrity. As such, a ‘closed loop’ nested CRISPR system 
would help mitigate any potential off target effects. One could imagine a system in which the CRISPR 
machinery itself is shut off following indel-creating/fragment knock-in. Our multi-leveled system re-
lies on two sequence-specific gRNAs to direct the Cas9 first to the Pdgfra locus and then to the Piezo1 
locus. The Pdgfra gRNA is expressed using the constitutively active U6 promoter. Previous work in 
vitro created synthetic programmable CRISPR networks in which the expression of one gRNA shut 
off the expression of another gRNA (Nissim et al., 2014). The authors multiplexed the first gRNA us-
ing self-cleaving ribozymes with an additional sequence that was antisense to the second gRNA; doing 
so, the authors created a gRNA mop. When the first gRNA was expressed, the mop was also expressed 
and thereby inactivated the second gRNA. With only a few modifications, we could similarly include 
a mop sequence such that once the Piezo1 gRNA is integrated into the Pdgfra locus, the Pdgfra gRNA 
is mopped up and inactivated. Finally, one could imagine a system in which once the GFP fragment is 
knocked into the Piezo1 locus, a ribozyme flanked Cas9 targeting gRNA is also expressed; once nested 
gene-editing is completed, Cas9 protein would target the Cas9 transgene itself, thereby turning off the 
system. Future work will be to tinker with these modifications to create a closed loop CRISPR system, 
improving upon the efficacy of the system and avoiding any off-target effects. 
This multiplexed nested CRISPR system is highly modular and can be used to better understand the 
role of individual genes in specific cell-types. Here, we employed the system to better understand the 
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role of Piezo1 in Pdgfra expressing OPCs in the aged 18-month-old CNS. Using the nested CRISPR 
system, we were able to do this rapidly and cost-effectively. The virus took 2-3 weeks to construct, 
synthesize, and validate in vitro and an additional 3 weeks following tail-vein injection. After just 6 
weeks, we had a 19-month-old aged transgenic animal, a process that previously would have taken 
years and with high-experimental risk. Moreover, the construction of these viruses is scalable, allow-
ing us to create multiple gene-targeting vectors in the time it would take to make just one. In the future, 
we will use this technology as a platform to better understand the role of individual genes on adult 
and aged OPC activation and differentiation in vivo. We will be able to do so quickly and for multiple 
genes, allowing for rapid-hypothesis testing in animal models. Despite the power of this system to rap-
idly generate animal models, the potential off target effects of Cas9 and the imprecise nature of DNA 
repair via NHEJ means that the Nested CRISPR approach will unlikely be used as a cell-type specific 
gene knock out strategy for CRISPR-based human therapeutics.    
Piezo1 and OPCs
In chapters 4 and 5 of this thesis, we look at the effect of Piezo1 on OPCs in vitro and in vivo in the 
context of remyelination. However, it remains unknown whether Piezo1 has a role in OPCs in post-na-
tal development or in steady-state adult brain homeostasis. To test this, we are currently conducting 
experiments in which an in vivo AAV CRISPR system was injected into the tail vein of P1 mice pups. 
After 6 weeks, we will look to see if OPCs without Piezo1 have phenotypic differences in total cell 
number or in the total numbers of oligodendrocytes. As I hypothesise in Chapter 4, Piezo1 may be 
a regulator of total OPC number in the CNS and prevents cellular crowding. I expect that without 
Piezo1, there will be an increase in total OPC cell number and an increase in the proportion of pro-
liferating OPCs. Finally, while the Nested CRISPR system allows for the rapid hypothesis testing of 
individual genes in OPCs, the effects of AAV-mediated CRISPR are heterogeneous—with each cell 
infected containing different rates of mutation depending on the region of the CNS. As such, there 
is still a role for traditional animal models that rely on the Cre recombinase technology. The most 
robust method for determining the role of Piezo1 in development, homeostasis, and in remyelination 
is still to breed Piezo1-floxed animals with animals that contain an OPC-specific Cre Recombinase 
transgene. Perhaps, with continuing advances in vectors that target specific tissues and the develop-
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ment of technologies with increased genome engineering efficiency eventually traditional transgenic 
mouse models could be replaced all together.  Until then, a transgenic mouse-model would allow for 
an inducible, widespread, and uniform Piezo1 knockout in OPCs and would likely more fully address 
the role Piezo1 in the CNS. 
Chapter 6
Activity-state via the oncogene Myc describes the age 
state of CNS progenitor cells
Like many adult stem cell populations, the capacity of oligodendrocyte progenitor cells to proliferate 
and differentiate is significantly impaired with ageing. Previous in vivo work has shown that tis-
sue-wide transient expression of the reprogramming factors Oct4, Sox2, Klf4, and Myc extends lifes-
pan and enhances somatic cell function. Here we show that just one of these reprogramming factors, 
Myc, is required to rejuvenate aged OPCs as determined both by in vitro assays and by transcriptome 
profiling. Neonates that are treated with an inhibitor for Myc lose their capacity to both proliferate 
and differentiate in vitro. Finally, re-purposing the CRISPR technology described in chapter 5 of this 
thesis, we show that OPCs that have increased Myc expression in vivo both proliferate and differen-
tiate more efficiently in an aged lesion environment. Together, these results directly link Myc activity 
to cell age-state and thereby provide further insights into the biology of ageing.    
In normal development, mammalian embryonic stem cells uni-directionally differentiate into adult 
somatic cells. During this process, cells progressively commit to the various lineages of the adult 
organism. In the adult, a reserve pool of tissue-specific adult stem cells, however, do not terminal-
ly differentiate; rather, they remain undifferentiated, differentiating into tissue-specific cell-types as 
needed to maintain homeostasis or repair damaged tissue. In the CNS, the most widespread and 
abundant cell population is the OPC (Dawson et al., 2003). In adulthood, OPCs self-renew and give 
rise primarily to new myelinating oligodendrocytes. OPCs remain actively cycling and differentiat-
ing well into adulthood (Hill et al., 2018; Yeung et al., 2014). However, with ageing, the capacity for 
OPCs to both self-renew and differentiate into myelinating oligodendrocytes is significantly impaired 
(Psachoulia et al., 2009). In toxin-induced lesion models of white matter remyelination, the OPCs 
fail to remyelinate the damaged tissue (Sim et al., 2002). This loss of function is likely relevant for 
patients with demyelinating diseases such as multiple sclerosis. 
In the past decade, our understanding of the ageing process has changed dramatically. With the dis-
covery of pluripotent stem cells and subsequent work, it is now clear that cells do not undergo im-
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mutable changes with ageing. Rather, with the reprogramming factors Oct4, Sox2, Klf4, and Myc, 
aged cells, regardless of their physiological age, can be reset to their embryonic form, thereby erasing 
all the cellular hallmarks of ageing (Mertens et al., 2015; Takahashi et al., 2007). In the most im-
pressive study to date, the authors hypothesized that while long term exposure to the reprogramming 
factors reset cellular age-state entirely, short transient bursts of the reprogramming factors would only 
partially reprogram the cell to a younger more rejuvenated version (Ocampo et al., 2016).  Doing so, 
the authors observed that transient bursts of expression of these four reprogramming factors extends 
the lifespan and the regenerative capacity of aged animals. 
 
Much work has gone into restoring the regenerative capacity of aged OPCs (Shen et al., 2008). Aged 
OPC function can be enhanced by overexpressing histone deacetylases. In parabiosis studies, the aged 
OPCs can more efficiently remyelinate aged lesioned tissue when they are exposed to systemic factors 
from the young circulatory system (Ruckh et al., 2012).  Both studies show that the function of the 
aged OPC can, at least in part, be restored. Despite these original findings, little is known about the 
molecular processes underlying the ageing of OPCs. Moreover, it remains unknown what role, if any, 
the reprogramming factors have on the ageing of progenitor cells. 
Here, we use the principals of iPS cells and partial reprogramming to identify whether any of the in-
dividual or combinations of reprogramming factors have the capacity to rejuvenate aged progenitor 
cells. Using mRNA overexpressing vectors on primary isolated aged OPCs, we identify the repro-
gramming factor and oncogene Myc alone as sufficient to reverse the hallmarks of OPCs ageing. 
Conversely, inhibiting the function of Myc in neonatal OPCs using a small molecule, we inhibit the in 
vitro generative capacity of the cells. Using transcriptomics and in vitro assays to detect genetic and 
epigenetic stability we find that OPC age-state can be modulated by the presence or absence of Myc 
activity. Finally, using the novel technology of systemically administered AAVs and in vivo CRISPR 
we have found that Myc overexpression in OPCs promotes their self-renewal and differentiation ca-
pacity, even in aged animals. 
While systemic, transient overexpression of the OSKM reprogramming factors have been shown to 
extend lifespan and regenerative capacity in aged mice, the role that each of the reprogramming fac-
tors play in the observed effects of partial reprogramming remains unknown (Fig. 1a). Moreover, it is 
unclear whether all or just some of the reprogramming factors have a role in rejuvenation. We hypoth-
esized that the reprogramming factors with the largest role in regenerating aged progenitor cells would 




















































Figure 1. Reprogramming factors are expressed by primary neonatal but not aged OPCs. a, Cartoon 
diagram illustrating the underlying principle of partial reprogramming for rejuvenating aged OPCs. b, 
A heatmap of the log2 fold change FPKM values of the reprogramming factors Oct4, Sox2, Kl4, and 
Myc in neonatal versus aged rat OPCs. c-d, Mean FPKM values for Sox2 and Myc in neonatal and 
aged OPCs. Throughout figure, bar charts represent  mean from N=3 biological replicates and error 
bars represent standard deviation. 
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be the factors that are expressed in neonatal OPCs, when OPCs are at their most generative. Using se-
quencing data from primary aged (≥14 months) and neonatal (≤p7) rat OPCs isolated using magnetic 
associated cell sorting (MACs) based on the OPC marker A2B5, we observed the transcription factors 
Sox2 and Myc to be expressed in neonatal OPCs but not in aged OPCs (Fig. 1b-d). The other factors 
Klf4 and Oct4 are not expressed at any age-point in the OPC lifecycle.
As Sox2 and Myc are the only two transcription factors ever expressed by neonatal OPCs, we hypoth-
esized that over-expression of the factors individually could partially re-program primary aged OPCs 
in vitro. To accomplish this, we MACs sorted aged OPCs and plated them in high concentrations of 
growth factors. From previous work, we have found that the standard neonatal in vitro conditions of 
OPCs with the factors Pdgf and Fgf alone are insufficient to drive the proliferation of aged progenitor 
cells. One day following plating, we transfected the aged cells with synthetic modified mRNAs en-
coding eGFP, Sox2, Myc, or a combination of Sox2 and Myc.  Transfection of eGFP encoding mRNA 
into aged OPCs is highly efficient, with over 80% of OPCs expressing the gene after 48 hours (Fig. 
2a-b). We found high levels of proliferation of aged OPCs in the Sox2, Myc transfected conditions 
but a much less pronounced effect when Sox2 was transfected alone (Fig. 2c-d). However, we found 
that Myc overexpression alone recapitulated the phenotype of the combination Sox2, Myc treatment; 
4 days after 1 round of transfection of Myc, 19 month old OPCs had a ~9 fold increase in their rates 
of proliferation as labeled by EdU incorporation and co-localization with the oligodendrocyte lineage 
marker Olig2 (Fig. 2e-f). When the cells were put into differentiation condition media with the pro-dif-
ferentiation signal T3 for five days, aged OPCs transfected with GFP had low rates of differentiation 
≤5% while those transfected with Myc efficiently differentiated into oligodendrocytes as defined by 
their co-expression of Olig2 and myelin basic protein (MBP) (Fig. 2g-i). The overexpression of the 
oncogene Myc not only increased aged OPC proliferation but also their differentiation.
As Myc alone is sufficient to promote both the proliferation and differentiation of aged OPCs in vitro, 
we hypothesized that Myc activity is necessary for the self-renewal and differentiation capacity of 
neonatal OPCs. To test this, we used the low molecular weight compound 10058-F4 (Myci), which 
inhibits both Myc and n-Myc activity by blocking the dimerization of Myc and Max (Zirath et al., 
2013). As such, it is a well-established small molecule for selectively studying the role of Myc in 
neonatal OPCs (Scognamiglio et al., 2016). In this work, the authors found that ES cells treated with 
Myci become dormant, losing their proliferative capacity. Upon restoration of Myc activity, howev-
er, ES cells re-enter cell cycle. To see if Myc modulation with Myci similarly effects neonatal OPC 
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Figure 2. Myc alone reactivates aged OPCs. a-b, Representative images and quantifications of the trans-
fection efficiency of modified mRNA in aged OPCs. Control transfections were transfected with lipofec-
tamine without mRNA encoding GFP. Scale bars represent 100µm. c, Schematic overviewing in vitro 
gene over-expression assay for aged OPC activation. d,  Representative images of -1 experiment show-
ing the combinatorial effect of Sox2/Myc overexpression in aged OPCs. Scale bar represents 50µm. e-f, 
Representative images and quantifications of EdU incorporation in Olig2 stained aged OPCs transfected 
with either GFP or Myc modified mRNA. g, Schematic overview of in vitro gene over-expression assay 
for aged OPC differentiation. h-i, Representative images and quantifications of aged OPCs transfected 
with either GFP or Myc modified mRNA and placed into differentiation media conditions. e-i, Scale bars 
represent 200µm. Throughout figure averages represent means from N=3 biological replicates and *** 
signifies a one way ANOVA P-value of ≤.01. Here and throughout chapter, ≥200 cells were quantified 
per biological replicate.
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activity state, we first found the maximum non-lethal dose of the compound. We found that 16-28µM 
results in minimal cell death after culturing neonatal OPCs for 48 hours in growth factors. At 16µM 
after 5 days culturing in vitro with Fgf and Pdgf, neonatal OPCs lost virtually all of their proliferative 
capacity, while neonatal OPCs cultured in DMSO maintained their self-renewal capacity as shown by 
EdU incorporation (Fig. 3a-c). 
If cells were exiting cell cycle by the inhibition of Myc, then it is possible that the cells were just dif-
ferentiating into post-mitotic oligodendrocytes, not just transitioning to a slowly-cycling adult OPC. 
Moreover, if the neonatal OPCs were simply out of cell cycle but equally as regenerative, then with-
drawing Myci and placing them into differentiation conditions with T3 should efficiently differentiate 
the OPCs into MBP expressing oligodendrocytes; this would suggest that the OPCs were simply 
quiescent. To test these potentially confounding hypotheses, neonatal OPCs were either pre-treated 
with Myci prior to differentiation or treated with Myci during differentiation (Fig. 3d). Neonatal OPCs 
placed in differentiation conditions for 5 days following 2 days treatment with 16µM Myci in growth 
factors remain Olig2 expressing but fail to form MBP expressing oligodendrocytes. Whereas, con-
trol DMSO treated OPCs maintain their differentiation capacity (Fig. 3e-f). Similarly, neonatal OPCs 
treated with Myci in differentiation conditions also fail to differentiate into MBP expressing differen-
tiated oligodendrocytes. These results show that Myci treatment does not drive terminal differentiation 
into Oligodendrocytes or Olig2 negative astrocytes; rather, inhibition of Myc drives neonatal OPCs 
towards a quiescent state such that, at least over the course of 5 days, OPCs fail to re-activate and 
differentiate— even in the absence of Myci. 
If Myc activity alone describes the age state of an OPC, we hypothesized that the modulation of Myc 
activity would affect age-related pathways. To test this, we sequenced acutely isolated neonatal and 
aged OPCs, neonatal OPCs treated with Myci, and aged OPCs transfected with Myc. We found that 
aged and neonatal OPCs clustered separately as shown by hierarchical clustering and principal com-
ponent analysis (PCA) (Fig. 4a-b). Neonatal OPCs that were treated with Myci clustered separately 
from both aged OPCs and neonatal OPCs while OPCs treated with only DMSO were similar to acutely 
isolated neonatal OPCs. Aged OPCs transfected with Myc mRNA clustered more closely with acutely 
isolated neonatal OPCs, while aged OPCs transfected with GFP mRNA clustered less closely with 
neonatal OPCs. PCA analysis shows that while Myc overexpression in vitro drives aged OPCs to a 
more neonatal-like transcriptional state, neonatal OPCs treated with Myci do not resemble aged OPCs; 
rather, neonatal OPCs treated with Myci enter an undefined cell-state that must be further examined. 























































































































































Figure 3. Neonatal OPC loss of proliferative and differentiation capacity following inhibition of Myc. a, 
Schematic outlining experimental strategy for Myci treatment and neonatal OPCs. b-c, Representative 
images and quantifications of EdU incorporation from N=3 biological replicates showing the effects 
of varying concentrations of Myci on Olig2+ ≤P7 neonatal OPCs. d, Schematic outlining strategy for 
understanding the effects of Myci on neonatal OPC differentiation. e-f, Representative images and quan-
tifications of N=3 biological replicates of the effects of Myci on the differentiation of Olig2+ neonatal 
OPCs into MBP+ oligodendrocytes. OPCs were either treated with Myci in proliferation conditions 
(Prol) or in differentiation conditions. Scale bars represent 50µm and **** signifies a Tukey’s multiple 
comparisons test after One way ANOVA. In this figure, quantification and experimental design was 
assisted by Dr. Björn Neumann of Robin Franklin’s group. 
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To better understand the process by which Myc allows aged OPCs to more closley resemble neonatal 
OPCs in terms of their transcriptome, we looked at individual genes and gene sets that changed be-
tween aged OPCs transfected with GFP and those transfected with Myc. Amongst the most significant-
ly up-regulated genes in Myc transfected aged OPCs were proliferation-related genes such as Gas6 
and the DNA replication and RNA transcription components Med13 and Noc3l, while aged OPCs 
transfected with GFP had high levels of cytoskeletal genes such as Hax1 and pro-inflammatory genes 
such as Il1rn (Fig. 4c-d). These specific genes highlight the types of pathways enriched for in gene 
set enrichment analysis. We found that in aged OPCs transfected with Myc, there was enrichment for 
genesets involved in oxidative phosphorylation, cell cycle, and ribosome biogenesis. The enrichment 
of these specific gene sets emphasizes the importance of Myc activity on overall cell activity (Fig. 4e). 
Finally, in aged OPCs transfected with Myc, specific OPC activation genes such as Sox2 and Nkx2.2, 
and oligodendrocyte lineage genes such as Mbp and Mog, all increased in their expression (Fig. 4f). 
This would suggest that as OPCs activate with the increase of Myc, they upregulate the genes required 
for their differentiation.
Aged OPCs transfected with Myc had an increase in expression of a large number of DNA repair genes 
such as the Ercc1 and Rad50. To determine the DNA integrity following Myc activity modulation, we 
performed the comet assay under alkaline conditions, a technique developed to detect all forms of 
DNA damage. Neonatal OPCs in vitro treated with DMSO, retained their DNA integrity, with only 
~15% of OPCs having DNA damage as indicated by the proportion of tailed ‘comets’. Conversely, in 
aged OPCs transfected with only GFP, ~60% of all OPCs had DNA damage (Fig. 4g-h). Only 30% of 
comets of aged OPCs transfected with Myc had tailed comets, indicating at least half as much DNA 
damage following Myc transfection. Neonatal OPCs treated with Myci retained their DNA integrity, 
as indicated by a low proportion of tailed comets. It is likely that 5 days in vitro is insufficient time 
to cause high levels of DNA damage, even in conditions of low Myc activity. Together, these results 
show that the re-introduction of Myc in vitro can increase the transcript expression levels of DNA 
repair machinery and ultimately repair damaged DNA in aged OPCs. 
We next sought to determine the effect of Myc activity in regeneration in the aged lesion environment. 
Using a similar approach to the one explained in Chapter 5 of this thesis, we re-purposed the system-
ically administered AAV (PHP-EB) (Challis et al., 2018). In conjunction with the AAV, we used the 
CRISPR technique developed in Chapter 5 to direct the  sequence-specific integration of genomic 
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P-value ≤.05Aged +GFP
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Figure 4. Transcriptomic modulation of OPC age state with Myc activity a, Hierarchical clustering with 
Ward linkage of acutely isolated aged OPCs, neonatal OPCs, aged OPCs transfected in vitro with Myc 
or GFP, and neonatal OPCs treated with provided legend. with Myci or with DMSO. b, Principal com-
ponent analysis of each replicate with legend provided. c, Volcano plot of differentially expressed genes 
between aged OPCs transfected with GFP and those transfected with Myc. Red dots indicate genes that 
have statistically significant difference (P-value ≤.05) in fold-change expression. d, Heatmap showing 
the log2 FPKM expression of the 25 genes with highest fold increase in expression between aged OPCs 
transfected with GFP versus Myc transfected OPCs and the top 25 genes with the highest fold increase 
in expression between aged OPCs transfected with Myc versus GFP. All genes shown are significantly 
differentially expressed with a p-value of ≤.05. e, Gene set enrichment analysis of aged OPCs trans-
fected with either GFP or Myc. Highlighted gene sets are age-related pathways enriched for in the com-
pared groups. f, Selected genes from various genesets show a number of differentially expressed genes 
between Myc and control transfected aged cells. g-h, Representative images and quantifications of the 
comet assay for DNA damage. Quantifications represent the mean for each labelled cell group from N=3 
biological replicates. For each replicate 50-100 nuclei were quantified. 
156 Chapter 6: Activity-state via the oncogene c-Myc describes the age state of CNS progenitor cells
fragments into slowly-dividing/post-mitotic cells (Suzuki et al., 2016). With these two technologies, 
we developed a dual AAV system. One virus delivers the sp. Cas9 gene under the CMV promoter, 
while the other delivers a construct which contains both an overexpression sequence for 3’UTR-tar-
getting Pdgfra gRNA and a knock-in cassette containing IRES-Myc-T2A-GFP, flanked by reversed 
gRNA target sequences (Fig. 5a). This system allows for GFP and Myc to be expressed in all Pdgfra 
expressing OPCs of the CNS following a single intravenous injection of the dual-AAV system. Similar 
to the approach taken in Chapter 5, we targeted the 3’ UTR for transgene integration to avoid perturb-
ing the gene expression of Pdgfra itself. Finally, this provides for the controlled expression of Myc 
as only OPCs express Myc; once the OPC differentiates into an oligodendrocyte and downregulates 
Pdgfra, Myc expression is also lost. 
To confirm that this CRISPR AAV system works, we infected dissociated p1 neonate mouse pup CNS 
with the vectors. As a mixed cell population, GFP should only be expressed in cells also expressing 
the oligodendroglia lineage marker Olig2. Indeed, five days following infection, we found significant 
populations of Olig2 expressing cells also expressing GFP (Fig. 5b). After confirming that the system 
works in vitro, we tail vein injected both AAVs into aged 18 month old mice and then perfused the 
animals 3 weeks after that (Fig. 5c). Three weeks following the initial tail vein injection, DNA PCR 
on the homogenized cortex revealed the correct genomic integration of the control, GFP-only vector 
and of the GFP-Myc vector (Fig. 5d). qPCR on the RNA from homogenized brain revealed a 4 fold 
upregulation of Myc transcript in the animals that received the Myc-GFP AAV compared to animals 
that received the GFP only vector (Fig. 5e). Cryo-sections of un-lesioned grey and white matter in the 
spinal cord showed over 35% of Olig2 expressing cells staining positive for GFP and <10% of total 
GFP cells staining negative for Olig2 (Fig. 5f-g). These results show that the CRISPR knock-in effi-
ciently targets the CNS and that the expression locus is highly specific for OPCs. 
After confirming the knock-in efficacy of the Myc over-expression system, we tail vein injected the 
AAVs into mice, lesioned the mice one week later, and perfused the animals two weeks after that (Fig. 
6a). To determine the rate of proliferation in Myc-AAV infected animals, mice received an intraperi-
toneal injection of EdU 24 hours prior to perfusion fixation. In the lesion of the control GFP infected 
animal, we observed ~10% EdU labeled, Olig2 stained OPCs; moreover, most of these proliferating 
cells were at the periphery of the lesion site (Fig. 6b-d). In the Myc vector infected animal, however, 
~40% of the Olig2 stained cells in the lesion were labeled with EdU. Similarly, in the control GFP 
infected animals, there were few Olig2+, CC1+ oligodendrocytes within the core of the lesion (Fig. 
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Figure 5. Systemic, cell-type specific, in vivo CRISPR knock in of Myc is specific for OPCs. a, 
Schematic outlining the control and Myc overexpressing AAV vectors. For the general mechanism 
of action refer to Figure 1a in Chapter 5 of the thesis.  b, Representative images of in vitro infection 
of CRISPR AAV in dissociated P2 mouse brain reveals transgene GFP expression is limited to Olig2 
expressing OPCs. c, Schematic overview of in vivo CRISPR experiment. d, Schematic of the integra-
tion site of transgene in 3’ UTR of Pdgfra and PCR of homogenized mouse cortex in N=2 aged ani-
mals per treatment category shows gene fragment knock-in in correct genomic loci three weeks post 
tail vein injection of AAV. P1 represents forward primer within transgene and P2 represents reverse 
primer in 3’ UTR of Pdgfra gene locus. e, qPCR for Myc from N=3 homogenized aged mouse cortex 
3 weeks post AAV tail vein injection of either GFP or Myc overexpression vector. ∆∆CT normalised 
to housekeeping gene Tbp. f-g, Representative image and quantifications of un-lesioned white/grey 
matter of the spinal cord reveal the efficiency of our in vivo CRISPR system and of the expression 
specificity of Pdgfra for Olig2 expressing OPCs—only ~10% of GFP positive cells are not Olig2+. 
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Figure 6. Myc overexpression enhances regeneration in vivo. a, Schematic overview of the AAV and 
lesion timeline. b, Representative images of EdU labelled, Olig2,GFP co-stained lesioned aged spinal 
cord 3 weeks following tail vein injection of AAV. Lesion border outlined with white line and scale bar 
represents 100µm. c-d, High power representative images and quantifications of EdU incorporation 
in GFP/Olig2 stained aged lesion cores. e-f, Representative images and quantifications of CC1/Olig2 
co-labelling per mm2 in aged lesion cores. Throughout figure means represent averages from N=3 ani-
mals, scale bars, unless otherwise indicated, show 50µm, and * represents a 1 way ANOVA value of 
<.01. g, Schematic overviewing the role of Myc in determining the age state of OPCs. Dr. Chao Zhao of 
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6e-f). In the Myc infected animal, however, there was an almost 4-fold increase in the number of la-
beled CC1+ and Olig2+ oligodendrocytes within the lesion core. Together, these results reveal that the 
controlled-expression of Myc can functionally re-activate aged OPCs within the context of a demye-
linating lesion; Myc does not just cause the proliferation of  aged OPCs into the lesion area, but also 
their differentiation into oligodendrocytes.  
Discussion
Here we present our findings that partial reprogramming of aged OPCs does not require all four of the 
reprogramming factors: Oct4, Sox2, KLf4, and Myc. Rather, the transient overexpression of Myc in 
aged OPCs in vitro can reactivate OPCs, allowing for high levels of OPC proliferation and differentia-
tion (Fig. 6g). Conversely, we have shown that the treatment of Myci on neonatal OPCs removes cells 
from the cell cycle and, even upon Myci’s withdrawal, neonatal OPCs are unable to differentiate into 
MBP expressing oligodendrocytes. Using transcriptomics and assessing DNA damage, we have also 
shown that, regardless of the physiological age of the cell, OPCs age-state can be re-written through 
the manipulation of Myc activity. Finally, using an in vivo CRISPR, dual-AAV system, we have shown 
that the OPC-specific overexpression of Myc can dramatically increase the rate of OPC activation and 
differentiation, even in the context of an aged lesion environment. Together, this work highlights the 
importance of Myc in enabling aged stem cell populations to activate and subsequently regenerate 
damaged tissue. 
Reprogramming factors and partial reprogramming
Previous reports have identified that the transient tissue-wide overexpression of all four original 
reprogramming factors can attenuate the hallmarks of ageing and prolong lifespan (Ocampo et al., 
2016b). They argue that the brief overexpression of these factors drives cells to reprogramme—not 
to pluripotency—but to a younger more rejuvenated cell type. Despite this, the authors neither seek 
to understand the role of each individual factor, nor identify the underlying mechanism driving this 
rejuvenating phenotype. 
The exact role of each reprogramming factor even in the derivation of induced pluripotent stem cells 
remains largely unknown (Plath and Lowry, 2011). The field’s consensus is that proliferation is the 
first step to complete reprogramming. It is hypothesized that Myc acts first, causing changes in cell 
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energy metabolism, forcing the cell back into the cell cycle. In a hallmark study in which each re-
programming factor is individually over-expressed in somatic cells and then CHIP-sequenced for 
each respective factor, the authors found that Sox2, Nanog, and Klf4 act in concert, binding the pro-
moter regions of largely the same ES cell specific pluripotency genes (Sridharan et al., 2009). Myc, 
however, binds to the promoter sequences of cell cycle genes, and of energy metabolism genes. The 
authors further demonstrate that Myc is the first affecting transcription factor during the first steps of 
reprogramming and is largely dispensable once the cells are in the later stages of pluripotency. After 
5 days of Myc expression, the other reprogramming factors begin to do their job—the total process of 
reprogramming taking 8-10 days. 
In the previous study, OSKM expression was induced globally in a transgenic mouse with doxycycline 
for 2 days, followed by 5 days of doxycycline withdrawal (Ocampo et al., 2016b). Repeated rounds 
of treatment of doxycycline prolonged longevity. However, if previous reports are true that Myc is 
the dominant transcription factor acting upon chromatin in the first days of reprogramming, then the 
observed effects from this partial reprogramming study are likely attributable to the activation of 
Myc. Furthermore, the ageing field has long-viewed slowed cell cycle and loss of ATP production as 
the underpinnings of the ageing process (López-Otín et al., 2013). Myc alone can induce enhanced 
mitochondrial respiration and cell cycle, so it seems likely that Myc alone is the reprogramming fac-
tor responsible for the rejuvenation-effect seen in partial reprogramming. Future work must look at 
whether global, transient, Myc overexpression alone can recapitulate the results of this previous study. 
Since the original derivation of iPS cells using OSKM (Takahashi et al., 2006), follow up work has 
found different combination of transcription factors and small molecules that can induce pluripotency 
(Huangfu et al., 2008; Yu et al., 2007). Myc expression itself has been shown to be dispensable, if 
replaced with two other transcription factors Nanog and Lin28a. Valproic acid, a histone deacytelase 
inhibitor, can significantly improve iPS cell generation. One study even found that all four original 
reprogramming factors can be replaced with antibodies that induce the expression of each reprogram-
ming factor (Blanchard et al., 2017). Overexpression of OSKM remains the most robust method for 
generating iPS cells, yet the relevance of these pathways for iPS cell generation remains unknown 
for partial reprogramming. Recent work in our group has shown that the transient overexpression of 
many of the individual reprogramming factors not tested in this study have a surprising phenotype on 
adult OPCs. For instance, the overexpression of Lin28a seems to direct adult OPCs to an astrocytic 
fate.  Future work will be to determine whether any of these additional factors can similarly rejuvenate 
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aged OPCs. 
Myc, OPCs, and rejuvenation
While Myc activation can reactivate aged OPCs both in vitro and in vivo, the roles of Myc in the nor-
mal development and ageing of OPCs remain unknown. In this chapter, we found that the inhibition 
of Myc activity with a small molecule inhibits OPC proliferation and differentiation. While the loss 
of proliferation and differentiation is the phenotypic sign of OPC ageing, the Myc inhibited neonatal 
OPCs neither resembled aged OPCs transcriptomically nor in terms of their DNA damage. One possi-
ble explanation for this is our reliance on a small molecule to inhibit Myc in neonatal OPCs; the small 
molecule could have sub-toxic effects on cells, impacting cell behaviour in ways other than just by 
inhibiting Myc. If this is the case, then the treatment of neonatal OPCs with the Myc inhibitor is an 
inappropriate method for depleting Myc activity in neonatal OPCs. A better strategy than the one pre-
sented in this chapter would be to genetically knock-down Myc expression with either a siRNA or with 
CRISPR. With this approach, we could determine whether the effects of neonatal OPC Myc depletion 
are a biological phenomenon or simply a side effect of the small molecule’s toxicity. 
A major limitation to the work presented in this chapter is our lack of understanding of the role of Myc 
in normal CNS development and homeostasis.  It is possible that the effects of the overexpression of 
Myc in aged OPCs are epiphenomenological and that Myc has no role in normal OPC biology or in 
OPC ageing; rather, Myc overexpression simply activates other secondary genes that do have a role 
in OPC function. This would also explain why the inhibition of Myc in neonatal OPCs does not drive 
an aged-like transcriptomic profile. If Myc has no role in normal developmental OPC function, then 
Myc inhibition would not cause ageing. Future work must further characterise the role of Myc in OPC 
development, homeostasis, and regeneration by re-analysing Myc expression patterns in existing tran-
scriptomics databases. Another strategy in development is to repurpose the Nested CRISPR system to 
knock out Myc in neonatal OPCs and in young adults with lesions in vivo. If neonatal OPCs lose their 
proliferative capacity or if young adults have less efficient remyelination, then we could determine 
whether Myc has a role in regulating OPC function. Neonatal OPCs depleted of Myc both in vitro and 
in vivo using RNAi/CRISPR could then be sequenced to determine if they possess aged-like transcrip-
tomes. If Myc depletion does not affect OPCs in development or in regeneration, then likely the loss 
of Myc is not what underlies the ageing process and Myc has no role in the biology of OPCs. If that is 
the case, then the re-introduction of Myc in aged OPCs has no biological precedent and the observed 
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phenotype is pure epiphenomena.
In this chapter, I show that transient Myc overexpression causes aged OPCs to regain their prolifera-
tion capacity. Conversely, I show that transient inhibition of Myc with a small molecule causes neona-
tal OPCs to stop proliferating. However, a major limitation to this work in this chapter is that I do not 
address whether these two phenotypes are stable after the short 5 day experimental time-course. Do 
aged OPCs transfected with Myc continue proliferating after the exogenously supplied Myc mRNA is 
depleted? Do neonatal OPCs lose their proliferative capacity even after the Myci small molecule has 
been removed from the media? If our hypothesis is correct and transient Myc overexpression causes 
cellular rejuvenation in aged OPCs, then I would expect that, long term, these OPCs would continue to 
proliferate in growth factor media, as neonatal OPCs do.  If this phenotype is not stable, then transient 
Myc over-expression does not cause true rejuvenation; rather, it causes a transient burst in cellular 
activity that cannot be maintained long term. These longer term experiments are currently ongoing in 
our group and are crucial to understanding the capacity of Myc to fully rejuvenate aged OPCs. 
With the in vivo CRISPR system, we found that transient overexpression of Myc enhances the regen-
erative capacity of OPCs in vivo in an aged lesion environment. However, the implications of this 
study are limited due to the short time course and limited readout of the experiment. The reasons for 
our experimental approach are largely due to the limited number of aged animals that we have avail-
able.  This is because aged animals are expensive to house and require regular and time-consuming 
maintenance. With limited aged animals, I had to compromise on the experimental approach. I settled 
on looking only at 14 days post lesion as it was a time point I would expect the lesion to have both 
proliferating OPCs and newly differentiating oligodendrocytes. I could therefore quantify both the 
number of proliferating OPCs and differentiating oligodendrocytes. However, the study does not look 
at the long-term remyelination of the lesion and it remains unknown whether the Myc-activated OPCs 
continued to proliferate, even after the lesioned area has remyelinated. If this is the case, then likely 
we have transformed a fraction of the OPCs to become cancerous. These long-term remyelination 
studies are necessary for us to understand whether Myc should be considered as a  therapeutic target 
for remyelination. 
Activity, ageing, and Myc
Myc is a canonical oncogene (Schwab et al., 1983; Seeger et al., 1985). Constitutive and long-term 
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overexpression of Myc leads to the formation of tumors across the body. Myc even has a established 
role in the formation of glioblastoma (Trent et al., 1986). Yet, overexpression of Myc in vivo tran-
siently causes a lower incidence of tumor formation and prolonged longevity. Similarly, we describe 
here the role of Myc in regeneration, not in tumour formation. The exact difference between cancer 
formation and stem cell regeneration/rejuvenation remains an area of active investigation. Moreover, 
this dual role of Myc as tumor-driver and as the underpinning factor required in regeneration poses 
fundamental questions for the field of regeneration. 
There has been increased interest in investigating the relationship between pluripotency and cancer. 
One study investigated the gene networks as somatic cells attain pluripotency and compared them to 
various primary cancers (Kim et al., 2010). The authors identified a group of Myc-associated genes 
as the underlying commonality between these groups of cells. The authors hypothesize that cancer 
cells resemble partially reprogrammed somatic cells in the sense that they are undifferentiated, do not 
commit to a particular lineage, and they maintain the capacity to self-renew. These findings bolster the 
hypothesis that there is a cancer stem cell, a sub-population of hyper-proliferative and dedifferentiated 
cells that drive the expansion of a tumour (Wong et al., 2008).
If stem cell gene networks and cancer gene networks share many similarities, then it remains unclear 
how adult stem cells maintain multi-potency without causing tumor formation. A recent hallmark pa-
per identified shared transcriptional networks between cancer and adult activated stem cells following 
the wounding of the skin epithelia (Ge et al., 2017). The initiation of tumour formation transcriptomi-
cally matches the initiation of wound repair; both groups of cells experience the upregulation of prolif-
eration genes that are involved in cell proliferation and growth. The authors identify that the divergent 
moment between cancer formation and the return of the stem cell to quiescence following wound heal-
ing, is the capacity for adult stem cells to appropriately epigenetically silence the pro-growth genes. 
An additional paper from the same group found that repeat wounding of the same epithelial region 
leads to the progressive epigenetic opening of the pro-growth  domains, a process that could eventual-
ly lead to cancer formation (Naik et al., 2017). Together these papers put forward the hypothesis that 
tumor formation is caused by repeat stress of the same stem cell population, causing the opening of 
epigenetic domains around oncogenes, and the inability for the stem cell to become quiescent. 
Despite this, repeat albeit transient OSKM overexpression does not drive tumorigenesis (Ocampo et 
al., 2016a). Moreover, iPS cells, which are effectively immortalized cell lines, can integrate into a 
164 Chapter 6: Activity-state via the oncogene c-Myc describes the age state of CNS progenitor cells
blastocyst, forming all three germ layers without tumor formation. Taken together, these papers high-
light the importance of gene dosage, environment, and gene-expression timing on cell behavior. Low 
level ‘micro-dosing’ of Myc prolongs lifespan while transient bursts of stem cell activation progress 
towards cancer, as shown in the repeat wound healing experiments. Moreover, hyper-activation of 
reprogramming cells and their removal from their native niche allows for a complete developmental 
reset without tumorigenesis. Future work must continue to study the relationship between stem cell 
activation, rejuvenation, and cancer. If rejuvenation therapies are ever to enter the clinic, it will be 
important to fully characterize a safe non-tumorigenic amount of stem cell activity. 
In vivo CRISPR and rejuvenation
In Chapter 5 of this thesis, I showed the capacity for AAVs combined with NHEJ to create cell-type 
specific gene knockouts. Here, I re-purpose the same underlying principles to create a cell-type spe-
cific gene over-expression system. We use this in vivo CRISPR technology to directly determine the 
effect of overexpressing a specific gene in a given adult stem cell population in the context of tissue 
homeostasis and injury. Currently, graduate students in our group are re-purposing this system and are 
building vectors with each of the reprogramming factors to determine whether additional factors can 
enhance remyelination in the aged CNS. In other instances, I am helping researchers in our group to 
knock-in additional genes into the Olig2 locus to determine the transcription factors necessary to drive 
trans-differentiation of OPCs into peripheral nervous system Schwann cells. These are just some of 
the ways that this OPC-specific overexpression system can help  researchers rapidly dissect the role of 
individual genes/reprogramming factors in OPC biology.  
Chapter 7
Final remarks and conclusions
Cell-cycle first, then differentiate
Remyelination is the process by which OPCs of the CNS replace lost oligodendrocytes following a 
demyelinating insult. However, with ageing, remyelination fails, and this has been attributed to the 
inability of OPCs to differentiate (Kuhlmann et al., 2008). To understand the mechanisms underlying 
OPC differentiation and its failure, primary neonatal stem cells or iPS-cell derived tissue-specific 
stem cells are often used as a proxy for understanding adult stem cell biology (Barres et al., 1994; 
Huang et al., 2011; Hubler et al., 2018).  This is because primary neonatal and iPS cells readily ex-
pand, so researchers have more cell material with which they can experiment. However, there is an in-
creasing body of work highlighting key differences between adult stem cells and neonatal or iPS-cell 
derived stem cells. In previous unrelated work with others, I have shown that pluripotency derived 
differentiation protocols often create cells that more closely resemble foetal cells than they do adult 
cells (Pagliuca et al., 2014). Moreover, in this thesis, I have shown that neonatal and aged OPCs have 
vastly different transcription profiles. 
One obvious distinction between foetal and neonatal OPCs from aged OPCs is cell cycle. While the 
younger OPCs are actively engaged in cell cycle, aged OPCs slow their cell cycle time longer than 
100 days (Young et al., 2013). As these younger stem cell populations are already activated, most 
previously reported OPC studies focus solely on describing the pathways that differentiate these ac-
tivated cells into oligodendrocytes. While these signalling pathways are likely relevant for the aged 
OPC, they are alone unlikely to be sufficient drivers of remyelination in the aged CNS. In this thesis, 
isolated aged OPCs neither readily undergo cell cycle nor differentiate into oligodendrocytes even in 
response to well-established neonatal OPC proliferation and differentiation protocols (Barres et al., 
1994). In other quiescent adult stem cell populations, such as muscle, the stem cell must first activate 
and undergo cell-cycle prior to differentiating (Gurevich et al., 2016). The same may be true for the 
OPC; in homeostatic adult CNS, there is some evidence that OPCs first undergo either symmetric or 
asymmetric division before differentiating into oligodendrocytes (Zhu et al., 2011). 
A conflicting study reports that adult mice OPCs differentiate without proliferation (Hughes et al., 
2013). In this study, the authors use a Ng2 reporter mouse and in vivo imaging to show that cells can 
lose Ng2 expression without first proliferating. This work is done in 2-3 month-old animals, tracking 
individual Ng2 cells for 40 days. If other reports are correct, however, then 100% of Pdgfra expressing 
OPCs at this age in this region of the brain cycle within a 40 day window (Young et al., 2013). This 
work confounds the findings from Hughes et al., 2013, and bolsters an alternative hypothesis: that the 
tracked Ng2 cells simply come from a recently divided OPC. I hypothesize that OPCs must divide 
before differentiation. If OPCs cannot spontaneously differentiate without first undergoing cell cycle, 
then quiescent non-cycling aged OPCs will likely be unresponsive to differentiation signals.  I argue 
that one must first activate the mechanisms that drive aged OPC proliferation in order to cause OPC 
differentiation. 
Using this as a paradigm for adult OPC stem cell biology, I have looked for signals that drive OPC 
proliferation. Throughout this thesis, I find methods that enhance OPC proliferation, also enhance 
OPC differentiation. The clearest example of this is that the overexpression of Myc—a canonical 
oncogene—in aged OPCs both in vivo and in vitro, leads to a significant increase in OPC differentia-
tion. These results show that, while aged OPCs do not efficiently differentiate into oligodendrocytes, 
aged OPCs that have been forced back into cell cycle with Myc do. Future work must further dissect 
the signals that cause proliferation in adult and aged OPCs. Doing so will identify novel therapies to 
promote remyelination in the aged brain. 
A convergence of pathways
 
Throughout this thesis, I have examined methods for re-activating adult and aged OPCs. I have dis-
cussed three parallel pathways that can activate the adult OPC: Wnt-agonising proteins, mechanical 
signalling mediated via Piezo1 signalling, and the activity of the oncogene Myc. There is increasing 
evidence that these disparate signalling pathways converge, wherein stiffness regulates beta-catenin 
localisation, which in turn regulates Myc activity (Benham-Pyle et al., 2015; Mouw et al., 2014). Of 
the two studies highlighting this interconnected pathway, both were performed on immortalised cell 
lines, and both found that stiff materials causing mechanical strain drive the localisation of nuclear 
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beta-catenin which, in turn, upregulates Myc. These findings are in contrast to our results in the brain 
that a soft environment drives OPC proliferation and differentiation.  As Wnt signalling and Myc drive 
proliferation, then a stiff environment—not a soft environment—would drive OPC proliferation. 
Despite this, our hypothesis that a soft environment confers stem cell plasticity is not out-of-step with 
the broader stem cell field. Rather, a number of papers have similarly shown that a soft environment 
supports self-renewal in embryonic stem cells, iPS cell formation, and in muscle stem cells (Caiazzo et 
al., 2016; Chowdhury et al., 2010; Gilbert et al., 2010). The reports that Wnt and Myc are necessary for 
embryonic stem cell self-renewal in vitro further challenge these mechanics findings (Scognamiglio et 
al., 2016). In our sequencing work and unpublished work from collaborators, we find that embryonic 
stem cells and OPCs cultured on soft hydrogels have an increase in Myc-family genes. These find-
ings complicate the prevailing view from cancer mechano-biologists that stiff environments drive cell 
self-renewal programmes.  
There are a number of explanations that could account for these conflicting findings which link niche 
mechanics to canonical signalling pathways and cell activation-state. One possible hypothesis is that 
all cells are different, and that matrix mechanics differentially affect cells in the CNS and in embry-
onic stem cells versus immortalised cell lines. The finding that all cells exhibit different responses to 
niche mechanics is well-established (Engler et al., 2006). In this study, mesenchymal cells cultured 
on different stiffness hydrogels preferentially differentiate into either neurons, muscle, or bone. Mam-
mals  have multiple organs, each of differing mechanical environments (Swift et al., 2013). If all cells 
respond to niche mechanics differently, then future work must attempt to understand the mechanisms 
by which each cell population responds to their respective niche mechanical environments.  
The gated ion channel Piezo1 could be the mechanism underlying these diverging cellular responses to 
niche mechanics. A well-established mechano-sensor (Coste et al., 2010), Piezo1 is inactive in a soft 
environment but activates in stiff environments, causing an increase in intracellular Calcium cations. 
These secondary ion messengers relay to the cell the surrounding environmental mechanics. Calcium 
signalling is a highly versatile signal that can regulate many cellular processes such as cell contractili-
ty and proliferation (Berridge et al., 2003). As such, depending on the intracellular calcium-dependent 
proteins, calcium signalling could drive diverse cellular events. The diversity in cell activity following 
intracellular calcium flux would reconcile the different and conflicting reports highlighting the role 
of Piezo1. In some cell-types, Piezo1 activity directly inhibits oncongenic Ras signalling (McHugh et 
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al., 2010). In the skin epithelium, however, Piezo1 activity drives cell proliferation following injury 
(Gudipaty et al., 2017). As each cell population contains its own set of calcium-dependent proteins, 
there will likely be many roles for Piezo1 across the many different cell populations. Mechano-sensors 
such as Piezo1 that convey niche mechanics via broadly-acting ion currents, may well explain the 
capacity for individual cell-types to respond differently to niche mechanics.  
While it is plausible that each organismic niche retains its own unique mechano-response mechanism, 
it could also prove true that embryonic and adult stem cells behave differently from other differentiat-
ed cell types. As mentioned, a large body of evidence suggests that soft niche environments promote 
stem cell activation/self-renewal. However, most mechanistic work of mechano-biology has studied 
either the effects of niche mechanics on directed differentiation or on immortalised cancer cell lines. 
If a soft environment is indeed unique to stem cells, then perhaps stem cells contain an undescribed 
mechanism for activation in response to ‘softness’. Future work must explore how stem cells are acti-
vated in a soft environment and must better understand the evolutionary reasons why stem cells prefer 
softer environments for self-renewal. 
A niche theory for cellular ageing 
In this thesis, I explore whether the ageing process is fixed or if cells can be coaxed to rejuvenate. 
We find that with niche environment, mechanics, or with the over-expression of Myc, we are able to 
force the aged cell back into cell cycle and rejuvenate it. Taken together, these results pose a new set 
of hypotheses for the ageing process: cells themselves do not immutably age; rather, the organism 
and the cellular niche ages which, in turn, activates the intracellular ageing pathways. This hypothesis 
emphasises that both cell-non-autonomous and cell-autonomous ageing processes are fundamentally 
linked and one cannot be understood without the other. 
Finally, I propose that the ageing process begins once the mammalian organism switches from a pro-
growth developmental programme to a steady-state homeostasis programme. Once the brain reaches 
maximal size, negative feedback from the niche confers to the adult stem cell in order to slow cell 
growth and temper its activity. I hypothesise that this process results from a loss of circulating hor-
mones, niche growth factors, and the capacity of stem cells to sense maximal niche cell-density via 
mechano-sensors such as Piezo1.  Once the CNS stem cells slow their cell cycle, tissue turn-over and 
re-modelling slows, thus beginning the ageing process. This process feeds forward, wherein prolonged 
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stem cell inactivity leads to canonical intracellular ageing pathways, impairing regeneration in the 
context of  CNS injury or disease. Again, when these cells are removed from their niche, adult CNS 
stem cells can functionally rejuvenate, suggesting a largely niche mediated ageing process. 
In this thesis, I show the effects of the overexpression of Myc in an in vivo environment using CRIS-
PR/Cas9. We show that Myc overexpression in the context of a re-myelinating lesion accelerates OPC 
proliferation and differentiation. In follow-up work not presented in this thesis, I have found that 
Myc overexpression in OPCs did not lead to an increase in OPC proliferation in homeostatic tissues, 
as indicated by the low levels of EdU incorporation. I hypothesise that, despite oncogene activity, a 
healthy non-cancerous OPC will not re-enter cell cycle in its native niche environment. This is because 
environmental negative-feedback-acting ion channels such as Piezo1 limit cell growth. Future work 
will be to explore the intersection of pro-growth pathways such as Myc and stiffness-sensing pathways 
such as Piezo1. For instance, I hope to explore whether Myc overexpression in a Piezo1 null OPC is 
sufficient to drive proliferation in un-lesioned homeostatic cortex. 
Recent work indicates that the OPC is the underlying cell-type in the formation of cancerous gliomas 
in the CNS (Filbin et al., 2018). As oncogenic activity alone appears to have minimal effect in the ho-
meostatic CNS, I hypothesise that additional OPC mutations are required for the formation of glioma. 
Using publically available sequencing databases, I will look at environmental-sensing machinery to 
understand how gliomas maintain growth capacity in a growth-adverse adult/aged CNS and whether 
or not OPC-derived gliomas have a modified environment stiffness-sensing programme. Doing so, I 
hope to harness certain aspects of glioma formation (e.g. the capacity to self-renew in the stiff aged 
CNS) with the goal of promoting healthy OPC activation in the diseased adult CNS. 
Gene therapy for age-related disease 
In this thesis, I have shown novel genome engineering methods for the adult and aged rodent CNS. 
Using adeno-associated viruses (AAVs) and CRISPR/Cas9 technology, I describe a nested CRISPR 
system by which a single intravenous injection can lead to OPC-specific modifications, widespread 
across the CNS. Using multiple gRNAs and synthetic nested gRNA cut sequences, I show that this 
system can be multiplexed, allowing for sequential DNA-editing events depending on gene expres-
sion. Together, these findings present a tool for neuroscientists by allowing for the rapid testing of 
single-genes in specific-cell types.  
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Recent work has shown a base-editing ‘Camera’ system in which a modified Cas9 creates single nu-
cleotide changes to a known region of the genome (Tang and Liu, 2018). Driven by a pathway-specific 
promoter sequence, this base-editing Cas9 records in a known region of the genome whether or not 
a given pathway is expressed. The system can be multiplexed with multiple gRNAs under multiple 
promoters, allowing for the record of sequential steps within a signalling pathway. While the CRISPR 
‘camera’ allows for the authors to efficiently record epistatic events within the canonical Wnt signal-
ling pathway, the applicability of the system is limited by its reliance on known promoter sequences. 
Moreover, the system is limited to in vitro studies under a controlled environment.  The nested CRIS-
PR system, however, is not limited by promoter sequences; rather, using successive rounds of knock-
in gRNAs that can be expressed in the 3’ UTR of any gene, the nested CRISPR system could be used 
in vivo to do epistatic analysis on previously un-described cellular events. As shown in this thesis, the 
successive use of stop codons, ribozymes, and poly-A sequences allows for the sequence of cellular 
events to be recorded. For instance, in this thesis I show that, for every Pdgfra-expessing cell, if the 
cell subsequently expresses Piezo1, the cell will express GFP. As such, the nested CRISPR system 
could be used to record previously-undescribed cellular events in specific-cells in vivo. 
While the applicability of the nested CRISPR system could be broad for neuroscientists studying ro-
dents, there is not likely a therapeutic application for this CRISPR approach. The targeted, highly-ac-
curate gene editing of specific-cell types within the human body would be an advance in medicine with 
broad implications. However, the CRISPR system can make mistakes that could lead to large scale 
genome vandalism (Kosicki et al., 2018). Moreover, the reliance on non-homologous end joining ma-
chinery to knock-in the gRNA DNA fragments means that non-specific DNA insertions are possible 
(Suzuki et al., 2016). To overcome the limitations of the CRISPR system, the Cas9 enzyme has been 
modified with point mutations and its nuclease activity deleted (Konermann et al., 2015). This nucle-
ase-null Cas9 can be fused to transcriptional activation or repressive elements to drive endogenous 
gene expression. Complexing with a gRNA, this Cas9 system can be used to transiently drive/repress 
gene expression anywhere in the genome, without irreparably changing the DNA itself. For many 
age-related diseases for which gene dosage needs correcting, this CRISPR technology could prove 
truly revolutionary.     This modified Cas9, however, is bulky and well exceeds the size constraints of 
an AAV. Future work will need to find methods for shrinking the size of the Cas9 protein itself, such as 
removing unneeded nuclease elements in order to package this CRISPR activation/repression machin-
ery into a single AAV system. Combined with a tissue-specific promoter, such a system would allow 
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for transient, cell-type specific gene expression manipulations across the CNS. 
Conclusions
This thesis investigates four questions in the field of OPC biology: What is the niche of the OPC? How 
does this niche change and affect OPCs with ageing? Is OPC rejuvenation different from forced stem 
cell re-activation? Can these age-related pathways be therapeutically targeted in OPCs in an in vivo 
environment? Using light-sheet microscopy, I have shown that OPCs live on the blood vessels of the 
adult CNS, while their progeny, the oligodendrocyte, reside in the parenchyma. These OPCs express 
the stem cell marker Lgr5 and agonising Lgr5 in vitro allows for efficient OPC proliferation and differ-
entiation. I have found that, with ageing, CNS tissue progressively stiffens by 2-3 fold. OPCs, perhaps 
in their vascular niche, sense this stiffening via the mechano-sensing ion-channel Piezo1 and thereby 
exit cell cycle. Attenuating Piezo1 activity alone is sufficient to re-activate adult and aged OPCs, 
allowing for increased proliferation and more efficient CNS repair following injury.  As increased 
OPC activity underlies enhanced regeneration, I found that transient overexpression of the oncogene 
Myc can alone functionally rejuvenate aged OPCs. Finally, I have created a novel dual-AAV CRISPR 
system which efficiently targets and genome engineers OPCs in the adult and aged mouse. Doing so, 
I have been able to rapidly study the effects of single genes, such as Myc and Piezo1, in aged OPCs 
in vivo. By adapting principles of adult stem cell biology from other better-understood tissue niches, 
I have identified novel pathways that govern adult and aged OPC activation. More importantly, with 
genome engineering I have developed a set of tools that may help to rapidly expand our understanding 
of ageing OPC biology. 
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